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Optimal nutrition in the first 1000 days, from conception to the sec-
ond year of life, has the potential to shape the individual health sta-
tus during both childhood and adult life. This is particularly relevant
to preterm infants, whose intrinsic immaturity makes nutritional man-
agement a daily challenge for the neonatologist.
Very little attention has been paid by scientific research to comple-
mentary feeding (CF) for preterm infants, and both the European [1]
and the Italian [2] guidelines are specifically intended to guide the
introduction of solid foods to “healthy term infants”.
A recent survey promoted by the Italian Society of Pediatrics, con-
ducted among primary care paediatricians, has documented a wide
variability in clinicians’ attitude towards timing of CF introduction
and type of foods proposed to start CF [3].
As for timing, CF introduction might theoretically follow two different
criteria: a 5 kg weight cut-off was originally proposed in the mid-90s
in the UK (COMA report [4]); however, such a minimum weight does
not take into account the infants’ development and can be reached
very late by infants born extremely preterm. For this reason, a second
criterion, which takes into account infants’ age and maturation, has
been later proposed by dieticians’ working groups and professional
associations in the UK [5]: a temporal window between 5 and 8
months uncorrected age has been identified as the time when virtu-
ally all former preterm infants should have acquired the develop-
mental skills which allow the consumption of foods other than milk,
such as the progressive disappearance of the protrusion reflex of the
tongue, the reduction of reflexive suck in favour of lateral tongue
movements, and the gradual appearance of lip seal. Furthermore,
this time window is the optimal one for introducing new flavours
and textures in term infants, and, even if it is not known how this
sensitive period is affected by preterm birth, it is highly likely that
the later preterm infants are introduced to new flavours and textures,
the less likely they are to accept a wide variety of foods.
Even if no specific guideline is available, there is consensus that the
introduction of CF in preterm infants should be strictly individualized,
and that the timing should be guided more by the infant’s develop-
mental acquisitions than by nutritional issues. Nevertheless, given
the intrinsic risk for preterm infants of extrauterine growth retard-
ation, a careful choice of high-protein, energy- and nutrient-dense
solid foods should be performed.References
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Children with medical complexity (CMC), who may also be known as
“complex chronic” or “medically complex”, have multiple significant
chronic health problems that affect multiple organ systems and
resulting functional limitations, high health care need or utilization,
and often the need for or use of medical technology. Children and
youth with special health care needs (CYSHCN), who require health
and related services for a chronic physical, developmental, behav-
ioural, or emotional condition beyond what is typically required for
children, (5) have long been designated as a priority population of
interest for health care policy. CMC, a subset of CYSHCN because of
their extensive and costly health care use, are increasingly recog-
nized as requiring additional and specific consideration from physi-
cians, payers, and policymakers. Approximately 1% of children, most
of whom are CMC, account for up to one-third of overall health care
spending for children, an increasing percentage of paediatric hospi-
talizations, and recurrent hospital admissions. Evidence suggests that
CMC have among the highest risk of all children for adverse medical,
developmental, psychosocial, and family outcomes. CMC are also po-
tentially eligible for paediatric palliative care (PPC). Emilia Romagna
Region and Fondazione Isabella Seragnoli are working since 2012 to
develop a regional model for PPC that will also include a paediatric
hospice. To better organize the PPC network a survey was adminis-
tered to the entire region health authority. The data were collected
at individual level mostly through a set of closed questions, the re-
sults of the survey were used to investigate patients’ characteristics
and complexity, health conditions and offer. Table 1 is summarising
the main results:
Neurological diseases affect almost 50% of the patients, followed by
congenital diseases (Figure 1). As expected and differently from adult
palliative care, oncologic diseases only represent 4% of the patients.
Prevalence results to be very heterogeneous among provinces, re-
vealing a different sensibility and knowledge on the topic of PPC. Re-
gional prevalence, which is 8.44 cases every 10.000 residents belowle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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strengthen the necessity of spreading the knowledge of PPC.
Patient’s complexity is also demonstrated by the high percentage of
devices and supports needed. In fact, on average 32% of the patients
has a gastrostomy, 22% has respiratory support and 15% of the pa-
tients does have both gastrostomy and respiratory support.Table 1 (abstract A2). Personal Information - Main results
Province Patients at 31/12/
2017
Prevalence




Bologna 170 10,81 8,17
Forlì-Cesena 21 3,31 11,38
Ferrara 20 4,31 13,00
Modena 100 8,41 8,93
Parma 67 9,39 10,99
Piacenza 38 8,65 11,82




Rimini 45 8,12 9,91
Total 601 8,44 9,35
Fig. 1 (abstract A2). Main observed pathologiesA3
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IgE-mediated food allergy (FA) has been emerging as a significant
health issue which may impair the disease-related quality of life,
both of patients and their family members. It represents a major
cause of life-threatening hypersensitivity reactions whose preva-
lence is increasing significantly. The diagnostic work-up of FA istraditionally based on a meticolous and detailed medical history
collected with the parent and/or patient and cutaneous tests. As
an alternative to the latter, it is possible to search the serum for
specific IgE with commercial extract. However, these investiga-
tions are limited by the risk of false positive responses mainly
due to the presence of cross-reactive allergens. The current gold
standard for FA diagnosis is the oral food challenge, i.e. the ad-
ministration of the suspected culprit food in clinical setting. It is
highly demanding as risky for severe anaphylaxis and time- con-
suming. In some cases, to detect serum IgE against specific mo-
lecular allergenic components (component-resolved diagnosis,
CRD) could be useful in order: to examine the possibility of
cross-reactions or primary co-sensitizations; to determine the risk
of clinical severity after allergen exposure; to investigate the risk
of false positive results with extracts containing ubiquitous aller-
gens ("Pan-alllergens"); to analyze cross-reactivity between pollens
and food; and to evaluate the opportunity to perform oral food
challenge(s) [1].
In terms of treatment, the current standard approach is relegated
to strict dietary avoidance along with education on prompt rec-
ognition of symptoms, and emergency treatment of adverse reac-
tions. However, several allergen specific- and nonspecific-
therapies are under investigation. Allergen immunotherapy (AIT)
is the only currently available treatment that targets the etio-
pathophysiology and may modulate the natural history of IgE-
mediated diseases. Based on a systematic review and metaanaly-
sis [2], the European Allergy and Clinical Immunology Academy
(EAACI) has recently stated that OIT can be recommended as a
treatment option to increase the threshold of reaction in children
with persistent cow’s milk, egg or peanut allergy [3]. However,
there are still several gaps to be filled in the current body of evi-
dence, including safety issues. In this perspective, omalizumab
-an anti-IgE monoclonal antibody-, alone or combined with oral
immunotherapy, might represent a promising treatment option
[4,5]. In the near future, well-designed studies are awaited in
order to overcome the current gaps in the evidence and furtherly
promote implementation strategies with the final goal of a treat-
ment tailored on each specific clinical sub-group.
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Although Internet offers many opportunities to improve the
provision of health services to citizens and at the same time to
reduce costs, there are risks that physicians should know and not
underestimate. When faced with difficulties from the use of Inter-
net applications, the healthcare professionals adopt a spontan-
eous and empirical approach, often resorting to the help of
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tions emerge. To avoid simplistic behaviors that can put patients'
health at risk, international organizations, such as the American
Medical Association (AMA), the American College of Physician
(ACP) and the British Medical Association (BMA), have produced
guidelines/directives that provide a reference base to use. Among
the many services offered by the Internet, the course focuses on
e-mail and social media. Even if e-mail is a routine tool in health-
care, many don’t know how to manage it in a correct way. The
use of e-mail will be explained distinguishing between two types
of patient-physician communication: the first characterized by the
absence of a preexisting face-to-face interaction, the other char-
acterized by the presence of a preexisting contractual relationship
between patient and physician. Physicians increasingly use social
media to communicate with patients. In these interactions,
healthcare professionals forget that Internet is a public space
where it is important to not share patient’s confidential data and
to have behaviors in line with a correct professional ethic. The
features that hinder the use of WhatsApp in the communication
with patients will also be discussed. The use of computer and
electronic medical report are mandatory for the pediatrician of
primary care. But some attentions are required in their use, prin-
cipally for privacy problem. Also, we examine the resources for
printing, scanning, storage in ambulatory work setting. The aim
of the course is to help physicians to manage e-mail and social
media in a suitable way; on the other hand, we will give advice
so that the computer technology represents an aid and not a
hindrance during the daily ambulatory work.A5
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Background
The improvement of health care has led to a transformation of some
acute to chronic diseases. The consequence was the appearance of
co-morbidities not previously evident. This has increased the com-
plexity of the follow-up with even an increase in accesses to the hos-
pital. This has created the need, given the reduction of resources and
therefore of beds to find an alternative system that would allow the
patient to be able to remain "safe" at home. Telemonitoring is there-
fore developed, a branch of telemedicine to monitor vital parameters
for a pathologist and subsequently also those concerning co-
morbidities.
Material and method
Let us then move on to the Oxitel tool, which allowed a rudimentary
remote monitoring of platforms that allow us to know the patient's
state of health in a precise manner. The next step was to make the
platforms easier to use and portable. The platform of which I speak
to you today is precisely the last born. It allows both telemonitoring
and remote diagnostics to be performed. All devices are CE certified.
Results
We expect, as in other projects carried out by us, a rationalization of
access to the hospital, less decay of vital parameters and in particular
of lung function, and finally an empowerment of the patient who will
learn to better manage his pathology.
Conclusion
Patients will take measurements from their home that will be down-
loaded and interpreted by the attending physician, or by the doctor
of the reference hospital center. There is the possibility of using the
active 24/24 operations center which aims to carry out the triage
and then eventually alert the attending physician. This type of plat-
form highlights the sudden evolution of technology that, in addition
to leading to more appropriate and precise measurements, also leads
to greater patient adherence to the home telemonitoring programfor ease of use. Lastly, the decrease in incongruous accesses is no
less important
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This paper has been developed as an analysis and deployment of
an innovative technology devoted to the support in nursing and
medicine for patients. By means of an analysis of the Italian
(North western area of the country) and French (ProvenceAlpes-
Côte d'Azur region) hospitals, the research goal has been to ex-
plore how new technologies can be applied to medicine. The ac-
tivity included the analysis of the knowledge and the education
of nurses referring to the implementation and application of tele-
medicine and telenursing technologies, to better support patients
in their treatment. It is highlighted how the cultural and trad-
itional aspects of resources’ education plays an important role to
the application of eHealth as a whole. The report includes a pres-
entation of how the telemedicine is applied in foreign countries,
like United Kingdom. There the General Practice centers are
adopting new technology (Apps and digitized medical records)
for supporting the full treatment cycle of patients.
A7
Lung ultrasound in infants with acute bronchiolitis
Carlotta Biagi, Anna Mingozzi, Luca Pierantoni, Marcello Lanari
Pediatric Emergency Unit, Department of Medical and Surgical Sciences
(DIMEC), St. Orsola-Malpighi Hospital, University of Bologna, Bilogna, Italy
Correspondence: Carlotta Biagi (carlottabiagi@yahoo.it)
Italian Journal of Pediatrics 2019, 45(Suppl 3):A7
Background: The variable course of acute bronchiolitis (AB) and the
lack of current scoring systems that could highly predict the progres-
sion of this disease result in frequent hospital admission and misuse
of diagnostic tests. Chest X-ray (CXR) is still performed in a high per-
centage of infants with AB, mainly to rule out concomitant pneumo-
nia. In this context, lung ultrasound (LUS) is recently emerging like a
point-of-care tool that could help the clinician in the management of
multiple pulmonary diseases. The aim of this study was to assess the
accuracy and reliability of LUS for the diagnosis of concomitant
pneumonia in infants with AB and to evaluate the correlation be-
tween LUS findings and clinical severity of bronchiolitis. Moreover
we calculate the inter-observer agreement between sonographers of
different experience levels.
Material and methods: We enrolled infants admitted to our hospital
in 2016-2018 with a diagnosis of AB and undergone CXR because of
clinical suspicion of concomitant pneumonia. LUS was performed in
each child by a novice pediatrician sonographer blinded to the
patient's clinical, laboratory and CXR findings. Moreover, an explora-
tory analysis was done to calculate the inter-observer agreement be-
tween two sonographers (experienced radiologist and pediatrician)
who independently performed LUS. The diagnosis of pneumonia was
established by an expert clinician on the basis of the British Thoracic
Society guidelines. The study was approved by the ethics committee
of our institution, approval number 13/2016/O/Sper. Parents of all
the eligible patients gave informed written consent.
Results: Ninety six hospitalized infants with AB were enrolled. A final
diagnosis of concomitant pneumonia was made in 27 patients. Sensi-
tivity and specificity of LUS for the diagnosis of pneumonia were
96.3% and 85.5% respectively, while CXR showed a sensitivity of
96.3% and specificity of 76.8%. Considering the patients with uncom-
plicated AB, a significant correlation emerged between the detection
of subpleural consolidations and the need for oxygen therapy during
the hospital stay. There was good to excellent agreement between
the novice and expert sonographer.
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 4 of 64Conclusions: This study shows the good accuracy of LUS in diagnos-
ing pneumonia in infants with AB. Added benefit of LUS included
high inter-observer agreement. Moreover, if confirmed in future stud-
ies, LUS may emerge as a useful technique to predict the need of
supplemental oxygen in infants with bronchiolitis and to help clin-
ician in the management of this disease.
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Respiratory syncytial virus (RSV) is a common cause of hospital ad-
mission for respiratory tract infections [1]. Most frequently RSV may
cause bronchiolitis, which could precipitate acute respiratory failure
requiring intensive care and ventilatory support. According to a re-
cent study, in about 140.000 children hospitalized for RSV-associated
acute respiratory illness, up to 22% of these patients required admis-
sion to a pediatric intensive care unit (PICU).[2] Co-morbidities, such
as prematurity, congenital heart disease, genetic abnormalities,
chronic lung disease, sepsis or neuromuscular diseases, were import-
ant contributors for worse outcomes [2]. In a large study on children
with severe community-acquired RSV infections, one-third of 604 pa-
tients were intubated and mechanically ventilated.[3] Co-morbidities
and transfer from a peripheral hospital were associated with a higher
rate of mechanical ventilation (MV) [3]. Interestingly, the increasing
use of humidified high-flow nasal cannula (HFNC) oxygen and con-
tinuous positive airway pressure (CPAP) is changing the admission
patterns and ventilation requirements for bronchiolitis [4,5]. Non-
invasive ventilation (NIV) seems to be the first treatment choice in
most units, with CPAP seemingly more effective than HFNC in redu-
cing escalation toward invasive MV [6]. However, several patients fail
to respond to NIV, requiring tracheal intubation and MV. Beside con-
ventional MV and high-frequency ventilation (HFV), new ventilatory
modalities have been tried in RSV bronchiolitis, showing promising
results both in invasive and non-invasive scenarios. Interesting pre-
liminary data have been reported on neurally adjusted ventilatory as-
sist (NAVA), an unique mode of assisted MV that delivers inspiratory
pressure proportionally to the electrical diaphragmatic activity [7]. In
11 children with severe RSV bronchiolitis failing CPAP, non-invasive
intermittent positive-pressure ventilation was provided using NAVA,
comparing asynchrony and ventilator response time with standard
pressure support (PS) mode. Patient-ventilator inspiratory asyn-
chronies and trigger delay were significantly lower in NAVA than in
PS mode [8]. In another study in infants with severe bronchiolitis,
NAVA NIV was associated with respiratory unloading during the tran-
sition from nasal CPAP to NAVA, showing a marked improvement of
several work of breathing indices [9]. Finally, in 23 infants treated
with invasive MV for severe bronchiolitis, NAVA had less trigger
delay, improved ventilator response time and reduced work of
breathing when compared with pneumatically triggered breaths [10].
In summary, RSV-associated respiratory illnesses still carry a high bur-
den in the PICUs, in terms of morbility, bed-occupancy and costs.
Further research is needed to validate the role of NAVA and other
new ventilatory modes to reduce invasive MV in these patients, as
well as lenght of PICU and hospital stay.
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We present a web application (URL: http://ecoanche.dmi.unict.it), im-
plemented on the AMP (Apache/MySql/PHP https://en.wikipedia.org/
wiki/LAMP_(software_bundle) platform and the MVC PHP Laravel
framework (http://laravel.com), devised to carry out a remote con-
tinuing education programme, aimed at offering training in the read-
ing and interpretation of neonatal ultrasound hip images.
Developmental dysplasia of the hip (DDH) is the most frequent path-
ology of the musculoskeletal system in infants. Thus, screening for
DDH is a recommended practice for all newborns, because early
diagnosis and treatment are paramount to guarantee the best pos-
sible outcome for this pathology [1]. Known available tests for DDH
screening are the clinical examination (Ortolani-Barrow maneuver)
and the ultrasound examination. Execution of the latter, which is
more sensitive than the former, is mandatory before DDH therapy is
prescribed. For an ultrasound study of the hip to be reliable, it must
be carried out by expert and well-trained operators [2]. In Italy, to
date, hip ultrasound training courses are few and mainly theoretically
oriented. In order to obviate, at least partially, to this lack of training
opportunities, we present a novel, remote training, e-learning
programme, aimed at enabling trainees to comfortably perform re-
mote reading and reporting on a set of ultrasound images of both
normal and pathological hips. The e-learning experience is organized
as follows. There are two categories of users: administrators (domain
experts) and trainees. Platform administrators load and maintain a
dataset of normal and pathological hip ultrasound images. Some of
these will have been obtained through incorrect scanning and
trainees should acquire the ability to detect and discard them. With
a correctly acquired hip image (i.e., one obtained in the “standard
plane”), the trainee will be able to draw lines and circles on a canvas
having the image itself as the background. For this purpose, the
HTML5 Canvas library is employed on a bitmap, or “canvas”, mod-
elled as a x-y plane [3]. The system analyzes points, lines and circles
drawn by the trainee user and, through the appropriate mathemat-
ical formulae, computes the relevant intersection coordinates, angles
and diameters, and automatically produces a report based on com-
puted data, in accordance with the interpretation standards chosen
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 5 of 64by administrators. All images annotated by trainees will be checked
and corrected by administrators, so as to provide the former with
useful feedback. Finally, the platform will be made available to the
scientific community as a very effective means to agree shared inter-
pretation and reporting standards for neonatal hip ultrasound
imagery.
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Background
The use of media device, such as smartphone and tablet, is currently
increasing, especially among the youngest [1]. The youth spend more
and more time with their smartphones consulting social media,
mainly Facebook, Instagram and Twitter because of the necessity to
use it for the adolescents as means to construct a social identity and
express themselves. On average, children are getting their first smart-
phones youger than in the previous years, around age ten. For some
children, smartphone ownership starts even sooner as young as
seven years, according to internet safety experts. Also in Italy,
twelve-thirteen years is the the age of first access to nowadays [2, 3].
Materials and methods.
We reviewed the last 10 years literature to find out the possible con-
sequences of tablets and smartphone use in adolescence.
Results.
In literature, smartphones and tablets use is associated to potential
benefits, such as the availability of education tools for studying, chat
apps for connecting with friends and the wealth of information on
the web. But there are also negative outcomes of media use by ado-
lescents on:
– learning. Social media use correlates to lower academic
performance and a reduced concentration [4];
– sleep. An excessive use of smartphones is associated to a poor
quality of sleep and a shorter sleep time [5,6];
– sigh. The increased use of smartphones may result in dry eye
disease, eye irritation and fatigue, burning sensation,
conjunctival injection, decreased visual acuity, strain, and
fatigue acute acquired comitant esotropia [7,8];
– addiction. Many adolescents use compulsively their
smartphones to listen music, check emails and social apps,
even during a face-to-face communication [9]. Smartphones ad-
diction has been linked to psychological disorders, such as low
self-esteem, anxiety, depression mood, and loneliness [10];
– physical symptoms. Musculoskeletal disorders, such as neck or
shoulder pain, and sedentary lifestyle, with consequently risk of
obesity, are associated to a prolonged use of tablets in
adolescents [11,12];
– cyberbullying and online addictions. Research has consistently
shown that time spent on line is correlated with cyberbulling
involvments [13];
– Hikikomori. This phenomenon of social withdrawal is becoming
widespreading in sever countries [14].Conclusions.
Smartphones and social media are increasing used by adolescents,
influencing their mood and their style of life. Clinicians and parents
must be aware of the possible neuropsychological side effects of
media device use among adolescents.
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Background
Media device, such as smartphone, tablets and other mobile phones
are actually overused, especially by adolescents and young adults.
Overuse of mobile phones can affect social and psychological well-
being and health and may let to addiction Addiction is defined as a
obsession with a certain activity causing a disturbance of dailies ac-
tivities [1]. In a recent survey on media device use, 70% of re-
sponders admit that they check their phones in the morning within
an hour of getting up and 56% that they check their phones before
going to bed. Moreover, 44% of responders stated that they would
feel very anxious and irritable if they did not interact with their
phones within a week [2].
Materials and methods.
We reviewed the last 10 years literature to find out the possible con-
sequences of media device addiction in adolescence.
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Media device addiction have been related to to excessive money on
mobile phones, use of media device in socially or physically inappro-
priate situations such as while driving or during a meal. Many adoles-
cents use compulsively their smartphones to check emails and social
apps, even during a face-to-face communication [3]. Smartphones
addiction has been linked to psychological disorders, such as low
self-esteem, anxiety, depression mood, and loneliness [4]. In fact, a
prolonged used of mobile devices may led to adverse effects on rela-
tionships, as well as to anxiety if separated from a mobile phone or if
there is not a sufficient signal. Addiction may also led to
phenomenon of social withdrawal, called Hikikomori [5]. The appear-
ance of people, especially teenagers and young men, who stopped
going to school or the workplace and spent most of the time with-
drawn into their homes for months or years, appeared in Japan by
the late 1990s. One decade later, in 2010, it has been definited as “a
situation where a person without psychosis is withdrawn into his/her
home for more than six months and does not participate in society
such as attending school and/or work”. In the last years, following
further advances in Internet society, hikikomori has become increas-
ingly recognized in several Western Countries [6]..
Conclusions.
Smartphones and social media, mainly Facebook, Instagram and
Twitter, are increasing used by adolescents, influencing their mood
and their style of life. Clinicians and parents must be aware of the
possible neuropsychological side effects of media device use among
adolescents and in particular of the risk of addiction.
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Background
Pediatric bacterial meningitis is a real neurologic emergency. An early
diagnosis and a prompt start of empiric antimicrobial therapy are
essentual, but in some cases they can’t prevent the death or the neu-
rologial sequelae. Moreover, clinical symptoms such as fever, head-
ache, meningismus, and an altered level of consciousness are
suggestive of meningitis. However they may be absent, expecially in
the very young children, leading to a delay in both diagnosis and
therapy [1].
Materials and methods
We reviewed the last 10 years literature to find out the possible way
to prevent bacterial meningitis.
Results
In literature a number of risk factors of meningitis are reported, in-
cluding socioeconomic factors, age, genetic variation of the host and
underlying medical conditions. They are associated with increasedsusceptibility to invasive bacterial infections in both children and
adults [2,3] . Widespread implementation of vaccination policies
against meningococcal, pneumococcal and Haemophilus influenzae
type b diseases has led to a significant decline in the frequency of
bacterial meningitis over the past years [4]. Anyway, prevention still
remains a priority because of the devastating outcomes and risk for
outbreaks. Moreover, vaccination may provide direct and indirect
protection and reduce the incidence of bacterial meningitis. For ex-
ample, in England, within three years, the vaccination campaign
against Neisseria meningitidis C resulted in a reduction in incidence
of both vaccinated and unvaccinated children [5].
Conclusions.
Vaccination against common pathogens has decreased the burden
of disease and is actually the only effective way to prevent some of
bacterial meningitis.
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Celiac disease (CD) is an immune-mediated enteropathy triggered
by dietary gluten-containing cereals in genetically susceptible in-
dividuals and results in a wide-range of intestinal and extraintes-
tinal manifestations. Short stature is the most common
extraintestinal feature of CD and may be the only symptom of
the disease. The pathogenesis of growth failure is probably due
to malabsorption or abnormality in the endocrine growth axis. A
lack of adequate nutrient availability seems to inhibit regular hor-
mone generation, like in patients with undernutrition. In celiac
children, the introduction of a gluten-free diet (GFD) increases
the intestinal absorption of both macro and micronutrients lead-
ing to an increase in both height and weight. However, some ce-
liac children with short stature fail to display catch-up growth
despite a strict GFD as the growth failure in CD patients is not
completely due to undernutrition. This finding is confirmed by re-
ports of overweight or obese children at the time of CD diagno-
sis. After starting a GFD, the celiac child usually returns to the
normal growth curve for weight and height. If the catch-up
growth does not occur, after 1-2 years of GFD, in the presence of
seronegativity for specific celiac antibodies, an evaluation of GH
secretion in response to two pharmacological stimuli is
mandatory. However, only 0.23% of patients with short stature
show an association between CD and GH deficiency (GHD) sug-
gesting that this association is uncommon [1]. In CD patients
with GHD, substitutive therapy should be promptly started at
standard doses to achieve complete catch-up growth. The long-
term effects of GH treatment in patients who follow a strict GFD
are similar to those observed in children with idiopathic GHD [2].
The association between CD and autoimmune diseases is due to
the common genetic predisposition such as HLA-DQ2 or DQ8
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 7 of 64haplotypes and, the most frequent is between CD and Hashimoto
thyroiditis. Therefore, in celiac patients anti-thyroid antibodies
should be monitored annually and in the presence of seropositiv-
ity, is mandatory a thyroid echography. More rare is Graves dis-
ease characterized by the presence of antibodies anti-TSH and
thyroid parenchyma disomogenous and vascularized at echogra-
phy. Another widely that between CD and Diabetes mellitus type
1 (T1DM). In most documented association is cases, CD is diag-
nosed months or years after the onset of T1DM. Finally, anti-
pituitary and anti-hypothalamus autoantibodies have been de-
tected in celiac GHD children without catch-up growth after GFD,
suggesting the onset of autoimmune hypophysitis [3].
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Macrophage activation syndrome (MAS) is a potentially fatal compli-
cation of rheumatic diseases, particularly of systemic juvenile idio-
pathic arthritis (sJIA). MAS is caused by excessive activation and
proliferation of T lymphocytes and of macrophages with overproduc-
tion of cytokines. MAS is a life-threatening condition associated with
high mortality rates. Therefore, early recognition and immediate
therapeutic intervention are critical [1].
Actually, the mainstay of treatment of MAS is high-dose glucocorti-
coids, cyclosporine, and in more difficult instances, etoposide. The
utility of biologic drugs in MAS treatment remains unclear.
Although TNFα inhibiting agents have been reported to be effective
in occasional MAS patients, other reports describe patients in whom
MAS developed while they were on TNFα-inhibiting agents.
Since in sJIA MAS episodes are often triggered by the disease flare,
biologics that neutralize IL-1, a cytokine that plays a pivotal role in
sJIA pathogenesis, have been tried by some authors. There are sev-
eral reports of sJIA-associated MAS dramatically benefiting from ana-
kinra, a recombinant IL-1 receptor antagonist, however, are also
reported patients who developed MAS while being treated with ana-
kinra. Canakinumab, a monoclonal antibody directed against IL-1β, is
an effective treatment in sJIA, it does not appear to have a significant
effect on reducing the risk of MAS [2-3].
IL-6 blockade, via the anti-IL-6 receptor monoclonal antibody toci-
lizumab, has proven highly efficacious in treating sJIA. There are no
reports of MAS treated specifically with tocilizumab. In a phase III
clinical trial in sJIA, MAS was observed in some patients receiving
tocilizumab [2-3].
High serum levels of IL-18 have been observed in sJIA and patients
with higher levels of IL-18 also appear more likely to develop MAS.
However, in many sJIA patients, plasma IL-18 levels remain elevated
even in clinical remission. A phase II clinical trial in patients with
Adult Onset Still Disease (AOSD) with tadekinig, the recombinant IL-
18 binding protein, showed that approximately 50% of the recruited
patients met the primary outcome [4].
IFN-γ and IFN-γ-induced chemokines, CXCL9 and CXCL10, are signifi-
cantly elevated in MAS patients compared to sJIA patients without
MAS. Emapalumab, an anti-IFN-γ monoclonal antibody, is alreadyapproved for the treatment of primary HLH patients. A clinical trial in
patients with MAS in the context of sJIA is ongoing and preliminary
results are highly promising [5].
Currently, the mainstay of treatment of MAS remains immunosup-
pressive therapy. However, in the immediate future, new target ther-
apy will allow a better disease control.
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Background
The prevalence of coronary arteries (CA) congenital anomalies is 1-
2% in the general population with a wide spectrum of clinical mani-
festations from total innocuity to sudden cardiac death. Since med-
ical, surgical and transcatheter therapies are always developing there
is still lack of knowledge about long–term outcome for each ana-
tomic subtype.
Materials and methods
Clinical charts of 53 patients (25 M, mean age 14.3 ± 8.6 years) with
isolated CA anomalies or associated with minor congenital heart de-
fects (CHD) in the period 1/01/2004 - 12/31/2018 were retrospect-
ively reviewed in order to analyze risk factors for poor outcome.
Results
Eight patients (15%) had an associated CHD. Twenty-one patients
(39.6%) had an abnormal coronary origin from the pulmonary artery
or its branches (17 with anomalous origin of the left CA from the pul-
monary artery - ALCAPA), 18 patients (34%) had single or multiple
CA fistulae, 12 patients (22.6%) had an anomalous CA from the op-
posite sinus (ACAOS). The most used preprocedural diagnostic tech-
nique was CA computed tomography (42 % of the patients). Thirty
three patients underwent surgical interventions aimed at restoring
physiological coronary circulation, 16 (48.5%) of them for ALCAPA re-
pair. On the other side 34 (64%) patients underwent at least one car-
diac catheterization; 13 (38.2%) of them for interventional purpose
(mostly embolization of CA fistulae). ALCAPA repair was safe and ef-
fective in the medium to long-term follow-up as above 75% of the
patients had a complete normalization of left ventricular function at
> 6 months of follow-up after surgery. We recorded 7 cases of post-
operative significant pericardial effusion; 6 of them had a diagnosis
of anomalous origin of a CA from the pulmonary artery and one with
left-ACAOS. One other ALCAPA patient was diagnosed with intracar-
diac thrombosis. There were no adverse events after diagnostic or
Fig. 1 (abstract A16). Serum C3 levels at the onset
Table 1 (abstract A16). Variables analysed at the onset
Atypical PIGN Typical PIGN P value
Age of onset (years) 5.84 ± 0.514 5.054 ± 0.261 n.s.
eGFR ml/min/1.73 m2 79.71 ± 7.354 92.45 ± 2.888 n.s.
Proteinuria mg/24 hours 1033 ± 253.9 1095 ± 128.1 n.s.
Serum C3 levels g/l 0.580 ± 0.081 0.340 ± 0.023 < 0.05
Serum C4 levels g/l 0.216 ± 0.013 0.219 ± 0.011 n.s.
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 8 of 64interventional cardiac catheterizations. Only 3 patients with ACAOS
and one with ALCAPA achieved the combined end-point of death-
cardiac transplantation showing a cumulative rate of 7.5%. All the pa-
tients with left-ACAOS mentioned above required a variable run of
extracorporeal membrane oxygenation during the hospitalization
beacause of intractable low cardiac output syndrome.
Conclusions
In skilled hands surgical and catheterization procedures are safe and
able to restore phisiological CA circulation. Overall long-term survival
for CA anomalies is excellent but some anatomic subtypes like left-
ACAOS carry a high risk of sudden death. A further piece in the puz-
zle is required in the modern era of preparticipation screening.
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Background
The complement system is recognized as a functional bridge be-
tween innate and adaptive immune responses, leading to integrated
host defense against infections.
The pathogenetic role of hyperactivation/dysregulation of comple-
ment has been evaluated in several kidney diseases. Traditionally,
genetic dysregulation of complement alternative pathway (CAP) is
described as the main pathogenetic mechanism of atypical hemolytic
uremic syndrome (aHUS) and C3 glomerulopathy (C3G) [1]. Growing
evidence suggests the pathogenetic role of genetic dysregulation of
CAP in other renal diseases, such as (Shiga toxin-producing Escheri-
chia coli) STEC-HUS or atypical post-infectious glomerulonephritis
(PIGN) [2].
Materials and methods
201 PIGN patients (121 M, mean age: 5.6 yrs) were retrospectively
studied from 2001 to 2017; atypical cases underwent a kidney bi-
opsy. In selected patients, molecular analysis of complement genes
(Next-generation sequencing) was performed. The following variables
were analysed at the onset in both typical and atypical cases: sex,
age, glomerular filtration rate (GFR), proteinuria, serum C3 and C4
levels.
Results
35/201 patients (17.4%) underwent a kidney biopsy; 16/35 (45.71%)
showed a morphological pattern of C3 glomerulopathy (C3G). In 16/
16 children molecular analysis of complement-related genes was per-
formed revealing polymorphisms and/or gene mutations in 12/16
cases (5 p.V62I in CFH gene; 3 homozygous polymorphism c.332C>T
in CFH gene; 3 allelic variants V62 and H402 in CFH gene; 1 heterozy-
gous gene mutation in CFH - p.G133R; 2 p.A473V in THBD gene; 1
new splice variant c.4851-1G>A - C3 gene; 1 p.R102G and p.P314L in
C3 gene, 1 c.897 T>C in MCP gene). Serum C3 levels were signifi-
cantly lower in typical PIGN compared to atypical cases (0.34 +/- 0.02
vs 0.58 +/-0.08; p < 0.05 (Figure 1). Glomerular filtration rate at the
onset was lower in atypical PIGN, even if not statistically significant.
No differences observed in age of onset, proteinuria and serum C4
levels (Table1).
Conclusions
The role of complement system in aHUS and C3G has been widely
studied over the last years. Nevertheless, genetic dysregulation of
CAP has been suggested as possible pathogenetic mechanism in
other kidney diseases such as PIGN, a common form of glomerulo-
nephritis in paediatric age. Prognosis is usually good; however, a few
patients present with atypical features, such as persistent low C3
and/or persistent proteinuria and/or decline in renal function. In ourexperience, these patients can reveal a genetic defect in the regula-
tion of CAP, suggesting PIGN and C3G as a spectrum of multifactorial
glomerular disease with either primary or secondary complement ac-
tivation triggered by infection [3].
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The term exercise-induced-bronchoconstriction (EIB) defines the
acute and transient airways narrowing occurring during or immedi-
ately after exercise. EIB may occur both in asthmatic and non-
asthmatic patients. EIB affects from 40 to 90% of individuals with
asthma [1] and approximately from 8 to 10% of children without
asthma. Children with EIB typically experience chest tightness, short-
ness of breath, cough, wheeze, due to bronchoconstriction which
generally begins 3 minutes after exercise, peaks in 10-15 minutes
and resolves by 60 minutes. Patients with atopic asthma may present
EIB more likely when exercise includes exposure to the relevant aller-
gen or when asthma is not optimally controlled. The diagnosis of EIB
is based on the combination of clinical symptoms and documented
dynamic changes in airway function during or after exercise. Exercise
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 9 of 64testing necessary for the diagnosis of EIB and to differentiate EIB
from other causes of exercise-induced dyspnoea. The standard
test is represented by cycle ergometer or treadmill test. However,
to prevent poor collaboration, children can perform a free-runing
test which is easy, reproducible, inexpensive and improve the
compliance [2,3]. The test is performed under surveillance in a
level corridor or outdoor, the child must be encouraged to run
as fast as possible for 6 minutes, enough to rise the heart rate to
80 to 90% of the predicted maximum (calculated by 220-age).
FEV1 (forced expiratory volume in one second) should be re-
corded at baseline and following exercise for at least 15 minutes.
A test is positive if FEV 1 decreases by 15% or more [1]. Children
who present bronchoconstriction should stop practicing, use
short-acting-beta2-agonists and rest until his/her respiration has
normalized. The optimal treatment for EIB is to prevent the onset
of bronchoconstriction. The pharmacological measures include
pre-exercise administration (about 15 minutes before) of inhaled
short-acting beta-agonists (SABA). When SABA therapy is ineffect-
ive, or patients practice intermittently in an unpredictable way
during the day, like children usually do, the administration (at
least two hours before) of a leukotriene receptor antagonist may
be considered [4]. Among nonpharmacological measures that
may help to reduce EIB we mention a warm-up before exercise,
practice where the air is warmer, and the humidity is higher.
Education should focus on recognizing of symptoms, having a
correct inhaler technique, controlling the underlying and contrib-
uting factors. The aim of the management is to ensure that exer-
cise is not avoided in children with EIB.
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The transition from pediatrics to adult clinics represents a difficult
moment in the management of any chronic pediatric onset disease,
particularly in patients with Type 1 diabetes mellitus.
It is necessary to start a structured care pathway that can facilitate
the passage of the management of the diabetic young person from
the Pediatric to the Adult structure, avoiding the drop-out of patients
(around 30%) in this critical phase of life. The transition must be
scheduled around the age of 18, except for specific needs motivated
by the individual patient. The transfer must be gradual and not trau-
matic with the involvement of both care teams . The Pediatric Diabe-
tology Reference Center will organize annual meetings (or school
camps) together with diabetologists and patients who are considered
ready to pass, in order to present the new care team. In each Adult
Center a dedicated structure must be expected in accordance with
the recommendations of the National and International Scientific So-
cieties (SIEDP-SID-AMD and ISPAD). In addition to the Diabetologist,the team should include other professional figures such as the dedi-
cated nurse, dietitian and, where possible, the psychologist.
Tasks of the Pediatric Diabetologist:
 Identify the young people "ready" for the transition, explaining
the reasons, and adapting the care modalities to the
characteristics of the adult's structure (cadence of the visits,
education for goals of care) .
 Identify together with the young person the Adult Diabetology
Center to which to refer (according to logistic needs or
motivated by lifestyle).
 Provide an information booklet (service card) drawn up by the
adult center .
 Prepare a detailed clinical sheet with all the characteristics of
the patient (History, onset modality, comorbidity, possible
complications, current therapy, compliance with self-
management)
 Present the new care team.
 Inform the family doctor.
Tasks of the Adult Diabetologist:
 Provide an information booklet (service card)
 Establish the headquarters of the transition structure which
must have a dedicated space and visiting hours.
 Identify the professional figures that are part of the Transition
Team.
During the follow-up it’s necessary the connection between the
teams, for the verification of the continuity of care. The patient after
six months / 1 year should complete a satisfaction questionnaire.
Only by the collaboration of all the structures provided for the pro-
tection of healt we can get the best metabolic control, ensuring the
therapeutic goals of a potentially disabling chronic disease.A19
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It has been recently recognized that the nutrition of the first 1000
days of life can influence health up to adulthood. Around 6 months
of age all infants start to consume solid foods. This period of time,
previously called “weaning”, is now defined as “complementary feed-
ing”, thus acknowledging that the main source of energy in the first
year of life is human milk or formula. Even though the industry is
committing itself to improve the quality of formulas, their nutritional
content is quite different from that of human milk. Up to the end of
the first year of life, i.e. in the lapse when milk is still the main source
of energy, breast- and formula-fed infants should be treated differ-
ently when they start to introduce solid foods, according to the dif-
ferent nutritional contents of human milk and formula. Although
complementary feeding is heavily influenced by local habits and cul-
ture, new scientific information should be the basis of anybody’s
choices, so as to respect the child’s right to health. In order to offer a
healthy and adequate diet to infants we must know what, when and
how much food we must offer, according to whether they take hu-
man milk or formula. When – For many years children have been
weaned too early, in contrast with WHO recommendations to start
solid foods at 6 months of age, i.e. 180 days of life. What – Breastfed
infants should be offered protein- and iron-rich foods, such as meat
and fish, whereas formula-fed infants should be offered vegetables
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 10 of 64and cereals, in order to stimulate their taste for new flavours and to
not increase the proteins’ intake. How much – Mothers frequently
overestimate portions to be fed to their infants, so paediatricians
need to inform them about the right amounts of food to offer, so
that they don’t overfeed them. In conclusion, healthy complementary
feeding models should:
1. 1 start solid foods at 6 full months: 180 days, according to
WHO recommendations.
2. 2 start with different solid foods considering whether the baby
is breast or formula-fed.
3. 3 remember that what the baby eats has the same importance
as the way the baby is fed.
4. 4 consider that this is the time when most of the future health
is programmed.
A20
Common pediatric drugs: “wise” use and off-label prescription in
out-patient settings
Romeo Carrozzo (romeo.carrozzo@virgilio.it)
Family pediatrician, ATS Bergamo, Bergamo, Italy
Italian Journal of Pediatrics 2019, 45(Suppl 3):A20
“Off-label use” refers to the use of pharmaceutical drugs for an un-
approved indication or in an unapproved age group, dosage, or
route of administration. In pediatric practice, off-label prescription is
widely employed both in in-patients and out-patients settings. How-
ever, this misuse may lead to inefficient treatments and adverse drug
reactions. The need for a regulation of the market for pediatric drugs
has moved in the 2000s both the Food and Drug Administration and
the European Medical Agency to set systems of requirements, re-
wards and incentives to ensure high quality standards for drug re-
search in pediatrics. Under those rules, the drug market has
produced a larger amount of safe drugs for children. In Italy, several
laws have faced the off-label use, stating that the off-label prescrip-
tion might be appropriate in specific scenarios, such as the efficacy
of the off-label drug demonstrated in scientific reports, and the lack
of suitable alternatives among approved medications. In such cases,
the inform consent to the patient has to be provided. Clinical guide-
lines and literature reviews seldom recommend the employment of
off-label drugs in pediatric practice. Nonetheless, the availability of
new drugs and constant reviews of the information for medical prod-
ucts challenge pediatricians for their practice, and underline the im-
portance of a periodical update for physicians dealing with children
in out-patients settings.
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BACKGROUND
Glanzmann Thrombasthenia (GT) is a rare inherited condition character-
ized by a platelet aggregation defect caused by mutation of genes en-
coding for integrin αIIb e β3 that constitute the fibrinogen platelet
receptor. GT is clinically characterized by early onset bleeding disorders;
diagnosis is based on absent/reduced platelet aggregation following
the stimulation of physiological agonists, prolonged bleeding time orPFA-100 closing time and abnormal clot retraction time[1-7]. The stand-
ard treatment for GT consists of local measures for mucocutaneous
bleeding, anti-fibrinolytic therapy and platelet transfusion. Recombinant
activated factor VII has been shown to be effective in patients with
platelet antibodies and refractoriness to platelet transfusions. Allogenic
bone marrow transplantation, the only curative treatment, is reserved
for patients not responsive to common therapies. Gene therapy is cur-
rently under investigation[7-11].
CASE REPORT
DG was admitted to neonatal intensive care unit in the first day of
life due to widespread ecchymoses and desaturation. Oxygen ther-
apy, broad-spectrum intravenous antibiotic therapy and repeated
intramuscular therapy with vitamin K1 were undertaken. Blood tests
showed anemia, platelet count and coagulation indexes were normal.
Infectious examinations, performed on blood and cerebrospinal fluid,
were negative. Cranial ultrasound showed areas of hyperechogenicity
in thalami and in parietal lobes, brain computed tomography and
magnetic resonance confirmed the presence of parenchymal, sub-
arachnoid and subdural hemorrhagic foci in the right temporal lobe
and parietal-occipital regions associated with edema. Due to this
finding antiedema therapy with mannitol was started. Once the
acute phase has been resolved, the child arrived at our Center at the
age of 3.5 months for the persistence of ecchymoses. The coagula-
tion tests (PT, aPTT, fibrinogen, Von-Willebrand factor, ristocetine co-
factor, factor VIII) were confirmed as normal, the platelet aggregation
test showed severe defect in response to ADP, collagen, epinephrine
and reduced to ristocetin. Further evaluation showed total GpIIb defi-
ciency and reduction of GpIIIa (25%) and GpIb (75%); GpIIb/IIIa recep-
tor expression was 0.3% after activation with ADP and PAR1-AP
whereas p-selectin exposure was 59.4% with PAR1-AP and 20% with
ADP. A serious defect of platelet function compatible with the diag-
nosis of GT is thus identified. Platelet function tests were extended
to the family and the asymptomatic father was identified as a carrier
of the defect.
CONCLUSION
This case report underlines the importance of an accurate assess-
ment of hemorrhagic signs and symptoms that associated to a de-
tailed anamnesis and appropriate laboratory diagnostics allow to
identify rare coagulation disorders, even in cases with unusual clinical
expression as intracranial haemorrhage in neonatal age.
Informed consent to publish has been obtained from parents of this
patient.
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Sickle cell disease (SCD) is the most common genetic disorder
worldwide, mostly prevalent in some areas affected by crushing
humanitarian crisis. The high refugee influx across Mediterranean
sea has increased the prevalence of this disorder, previously very
low, in some Southern European countries, such as Italy [1].The
World Health Organization has recognized SCD as a global public
health problem and the nations greatly involved in the European
refugee crisis are required to develop accessible health care to
these vulnerable populations, especially children [2]. The Italian
Society of Thalassemia and Hemoglobinopathies (SITE) and Italian
Association of Pediatric Hematology Oncology (AIEOP) responded
to these needs with the following initiatives: the creation of a na-
tional working group focused on SCD, the development of tai-
lored guidelines to the Italian health care system, the training to
emergency department and frontline health care physicians in
diagnosis and treatment of acute events with a specifically de-
signed algorithm, the implementation of screening for SCD in ref-
ugees by a point-of-care screening devices [1-3].
Pediatric hematologists representing 54 different centers across
Italy produced a document consisting of 27 chapters and 242
recommendations, tailored to the Italian health care system which
greatly differs US, UK and France where previous recommenda-
tions for standard of care in childhood SCD have been produced
[2]. Management of pain, severe infections, cerebral stroke, acute
chest syndrome and pulmonary disorders, spleen sequestration
and splenectomy, transfusion and hydroxyurea therapy were
some of the most relevant issues addressed in the document,
available at the AIEOP website [http://www.aieop.org/web/]. In
order to offer a faster and more feasible document to emergency
providers and paediatricians, an algorithm with interactive win-
dows was developed to guide physicians in the management of
acute and often life-threatening complications due to SCD [4]. In
the absence of a nationwide screening, the majority of SCD pa-
tients are diagnosed because of acute symptoms which cause fre-
quent accesses to the emergency departments [3]. The principal
aim of the algorithm was the training of operators and front line
paediatricians in a fast and appropriate approach to the acute
events, in order to ensure the right priority access to the evalu-
ation and subsequent diagnosis and therapy [3]. The document
can be downloaded from the SITE webpage [http://www.site-ita-
lia.org/]. Further documents were focused on the management of
severe infections in SCD and splenectomised patients who are athigh risk of this life-threatening complication [5] and on hydroxy-
urea therapy in SCD children [6].
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Pain is a major cause of admission to the Emergency Department
and represents an everyday matter of concern for hospitalized chil-
dren, but its management is often inappropriate. Though a plenty of
guidelines, recommendations and training strategies are available,
pain evaluation, measurement and treatment is still lacking in all age
groups and in different situations. Different factors could explain it,
namely the false believes that pain is not a priority, in particular in
the emergency setting, that children do not feel pain as much as
adults, and that analgesics might delay correct diagnosis. On the
contrary, prompt and adequate control of acute and procedural pain
is well known to enhance the prognosis significantly, and represent a
strict ethical, deontological and juridical duty for all the healthcare
professionals. Cornerstones of adequate pain management are: ac-
curate evaluation and measurement with validated scales; early treat-
ment; and wise use of non-pharmacological and pharmacological
strategies. First, pain should be evaluated and recorded throughout
all the permanence of children in the Hospital, since admission to
Emergency Departments to discharge home. Standardized validated
scales should be known and used by nurses and doctors regularly,
both to define the best strategy to control pain for each child and to
monitor its efficacy.
Second, non-pharmacological techniques should be always used, ran-
ging from the Hospital environment features to behavioral and relat-
ing aspects. This is very important to obtain children and their
families’ alliance to defeat pain and to reduce drugs doses, in par-
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 12 of 64ticular during procedures. Third, available pharmacological strategies
should be well known and drugs should be administered properly in
terms of indication, time and dosage. Adequate pain control should
be guaranteed also on discharge, in alliance with outpatient settings
and general practitioners. Adequate pain management should be
guaranteed for all the children accessing Hospitals, in particular those
who experience chronic pain and those more vulnerable because of
neurological impairment and other special needs. Better manage-
ment can be achieved through deep collaboration between pediatri-
cians, intensive care specialists and nurses, and supporting specific
skills development in pediatric training programs.
A24
How to recognise signs and signals of discomfort in adolescent
age
Serenella Castronuovo (serenella.castronuovo@gmail.com)
Family pediatrician, Gruppo di Studio Nazionale Adolescenza della SIP,
Nettuno (RM), 00048, Italy
Italian Journal of Pediatrics 2019, 45(Suppl 3):A24
Adolescence is the transitional phase of growth and development
between childhood and adulthood.
Adolescence is the period in the life of a person during which many
physical and psychological changes take place: adolescents need to
adapt to them, they may have to solve issues with their personal, so-
cial and sexual identity. The Word Health Organization (WHO) defines
an adolescent as any person between ages 10 and 19. This age range
falls within WHO’s definition of young people, which refers to individ-
uals between ages 10 and 24. The onset of the majority of the psy-
chological diseases take place between 12 and 19 years of age [1].
Pediatricians "should be" the first operators to intercept, in addition
to the somatic pathologies, also the initial stages of emotional and
social discomforts. Only 13% of the pediatricians feel they are pre-
pared and adequate for the management of adolescents [2].
In accordance with the preliminary results of a SIP survey [3]:
 80% of the adolescents experiment emotional discomfort
 50% feel the need of a psychological support (but 84,2% of
them have not asked for any help)
 15% of self-harm cases
For this reasons, in Italy the periodical "Health Evaluations" made by
family paediatricians are very important. Prevention is a key objective
of the evaluations: it is realized through a plan of filter medical exam-
inations which take place each at the appropriate age in which the
various issues can be detected. Adolescents do not love to go to the
paediatrician, and for this reason the Health Evaluation is a good oc-
casion for the doctor to put in evidence potential physical and psy-
chological discomforts and, above all, having a talk with the patient.
It is necessary to organise the medical practice in order to guarantee
the right environment and time to adolescents. It is also necessary to
plan the evaluation in order to safeguard the patient privacy. What
to look for:
▪ Difficulty or inability having relations with peers
▪ Clearly inappropriate or potentially dangerous behaviours
▪ Abuse of alcohol, tobacco, drugs
▪ Inexplicable reduction of school performances
▪ Latent feeling of unhappiness and melancholy
▪ Low self-esteem
▪ Depression or free floating anxiety
▪ Isolation and Internet dependency
▪ Food behaviour disorders and/or alteration of the body image
▪ Signs of self-harm
The following tests (available for free) help to identify signs of
discomfort:
 Questionnaire SDQ-ITA from 4 to 16 years-of-age, used inter-
nationally [4] [5] Questionnaire Child & Adolescent Behaviour Inventory [6][7]
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Among chronic lung diseases, non-cystic fibrosis bronchiectasis
(NCFB) has recently received growing attention, mainly due to its
increase prevalence worldwide, its impact on quality of life, and
the current poor outcomes. An inappropriate medical approach
to bronchiectasis may actually be associated with rapid decline in
lung function and worse prognosis. Therefore, an early diagnosis
and prompt optimal management is crucial, especially in children
where disease progression may be delayed or even resolved in
some cases [1,2]. Disease monitoring, acute exacerbation prompt
identification and treatment and prevention of infections in the
clinical management of NCFB will be reviewed. Unfortunately, the
current treatment strategies have been extrapolated from those
used for children with cystic fibrosis or adults with NCFB. The
proposed methods used to monitor disease progression include
1) clinical signs and symptoms (i.e. change on cough quality and
frequency, anthropological measurements), 2) lung function (i.e.
pulmonary functions tests, PFTs), 3) imaging and sputum charac-
teristics (i.e. color, volume, microbiology). However, PTFs may be
hampered in youngest children, and bronchoalveolar lavage (BAL)
may be required in those uncapable of expectorating [3,4]. Early
identification and treatment of acute exacerbations is an integral
part of clinical surveillance. Systemic antibiotics treatment should
be actively administered to control airway infection during acute
exacerbation [5]. At the same time, given the fact that NCFB chil-
dren are at higher risk of more severe infectious complications
and proned to new infections, prevention is an increasing con-
cern in order to avoid further lung damage due to infections.
NCFB children should fulfill the national immunization plan for
high-risk groups [6]. Airway clearance therapy can be helpful in
improving respiratory function and quality of life. Treatment op-
tions depend on the child’s age and ability to cooperate in treat-
ment. Given the wide variety of airway clearance techniques, the
best effective and patient-tailored physiotherapy techniques and
devices should be chosen [7-9]. Airway hyper-responsiveness can
be found in NCFB children. However, there is insufficient evi-
dence to suggest the routine use of inhaled corticosteroids or
ICS-LABA combination [10]. Inhalation of hypertonic saline can be
helpful in enhancing mucociliary clearance or reducing cough in
children, whereas evidence for effectiveness or inhalation of other
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 13 of 64mucoactive agents in children with bronchiectasis is lacking [11].
Finally, nutritional aspects is another concern in the management
of children with NCFB. To date, limited studies on nutritional data
are available, but failure to thrive and lower BMI are associated
with poor prognosis [12].
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Background
The prevalence of FAS in the European Region has been estimated
at 37.4 per 10.000 (Italy 82.0 per 10.000); while the prevalence of al-
cohol consumption during pregnancy in the same region is 25.2%
(Italy 33.1%). Style of alcohol consumption in the young female
population increased the risk for having a child with FASD. Safe
amounts of alcohol during gestation have not been established.
Therefore, medical authorities recommend no alcohol during
pregnancy.
Small amounts of alcohol do not cause gross morphological abnor-
malities but may induce behavioural and memory impairments and
reduced brain volume. Alcohol cross the blood-brain barrier disrupt-
ing the brain developing and potentiating oxidative stress. FASD
diagnosis based on several signs and symptoms is a permanent
condition.Materials and methods
Studies:
1. The first was conducted on 96 pregnant women in follow-up
at the ambulatory of Gynaecology and Obstetrics (Sapienza
University of Rome);
2. the second study investigated 44 pregnant women during the
second trimester of gestation in follow-up to the ambulatory
of the same hospital.
Gynaecologists assessed drinking habits during pregnancy through a
food diary. Then, pregnant women fill out the three structured ques-
tionnaires (AUDIT‐C, T‐ACE, and TWEAK). After the interviews, preg-
nant women were asked to provide a sample of their urine to assess
the concentration of EtG. Following in time the morphologic ultra-
sound was carried out to all participants of study 2. EtG determina-
tions were performed with a cut-off established at 100 ng/mL, a
value indicating occasional alcohol drinking.
Results
Study 1: 34.28% of pregnant women overcame EtG cut-off. No direct
correlation was found between EtG value and the alcohol screening
interviews showing lower levels of alcohol consumption, although T-
ACE revealed the same at-risk percentage.
Study 2: Fifteen of the enrolled pregnant women had EtG value
higher than 100 ng/mL (34.09%). ANOVA revealed that the fetuses
exposed to alcohol had significantly longer interorbital distance and
also increased front-thalamic distance (P's < 0.02) (Ferraguti et al.,
2019).
Conclusions
Findings show that assessed maternal alcohol consumption during
pregnancy only with screening instruments may significantly under-
estimate alcohol use. The evaluation of maternal alcohol consump-
tion during pregnancy by urine EtG may identify at-risk mothers and
disclose FASD-related damage in the fetus.A27
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Especially in pediatric dermocosmetology the safety of use is the fun-
damental parameter that must be respected in the formulation of
cosmetic products that are formulated for children.
Safety is based, even before that on the data of the finished
product, on the toxicological characteristics of each ingredient
that is used. It is up to the formulator and the safety assessor to
choose adequate raw materials respect to purity, hypoallergenic
charatheristic, low irritant power and a toxicological profile that
allows to establish a very high MOS (Margity of Safety). Other
fundamental points in the evaluation of safety are the presence
of perfumes and preservatives and studies on the finished prod-
uct conducted with scientifically acceptable methods. When creat-
ing products for children, it is necessary to consider how the
child's skin presents significant morphological differences with
that of the adult: high TEWL (trans epidermal water loss), slightly
alkaline pH, poor buffer capacity, immature melanocytes with
lower melanin content, thickness lower dermis and epidermis,
saprophytic flora (microbiome) in development, quiescent seba-
ceous production, poorly developed hydrolipidic film, low concen-
tration of NMF (skin hydration factor), desquamation, high cell
turnover. During pediatric age, in various conditions both patho-
logical and paraphysiologicalthe the function of the epidermal
barrier can be inefficient, making the baby's skin susceptible to
the onset of disease and vulnerable to chemical agents and
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 14 of 64microbial aggression. The cosmetics intended for children must
therefore be designed and formulated in such a way as to pre-
serve and respect the delicate skin balance typical of the little
ones' skin, which is not yet completely mature and developed. In
summary the dermo-cosmetological support in pediatric age is of
primary importance for:
- Maintain good skin physiological status
- Soothe any irritative effects of both topical and systemic medical
therapies
- Complete medical treatment
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Emilia-Romagna was one of the first regions of Italy to promote the
construction of childcare facilities.In the second half of the nine-
teenth century, settlements of shelter and marine colonies for chil-
dren suffering from rickets and scrofula spread. At the beginning of
the twentieth century the first pediatric hospitals were established
(in Parma and Modena), the three pediatric clinics of Bologna, Parma
and Modena and the pediatric divisions of the civil hospitals of
Parma, Ferrara and Reggio-Emilia. As in the other regions of Italy, in
the smaller cities of Emilia-Romagna, the creation of the first depart-
ments for the shelter and care of sick children took place inside the
“Brefotrofi” e “Istituti Provinciali per l’infanzia”, while the clinics and
dispensaries became part of the "Aiuti Materni" and spread especially
after 1925, following the rules establishing the National Opera for
Maternity and Childhood. The scientific activity of the first pediatri-
cians from Emilia-Romagna is evident above all in the pages of na-
tional pediatric journals, four of which are published in this region,
and in congresses organized by the Italian Society of Pediatrics, start-
ing from the one held in 1890 in Rome.
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Background
This survey aimed at collecting information related to the therapy
and management of respiratory diseases requiring the use of ICS, in
view of a Consensus document endorsed by the main Pediatric Sci-
entific Society soon to be drafted.
Methods
All the members of the Italian Society of Pediatrics (SIP) were submit-
ted this on – line survey , collecting data about the use of ICS for the
treatment of respiratory diseases
Results
One thousand-two pediatricians were involved in this survey, sub-
divided as follows: 392 (39%) primary care pediatricians, 388
(38%) hospital pediatricians, 31(3%) university pediatricians, 164
(16%) professional pediatricians, and 27 (3%) post-graduate stu-
dents in Pediatrics.Good adherence to recommendations in litera-
ture for the treatment of allergic rhinitis was found: oral
antihistamines are used by 607 (61%) of the interviewed in case
of secretory allergic rhinitis while 649 (65%) use spray nasal corti-
coids for the obstructive type.For the treatment of the asthma at-
tack ICS are not used by 54% of the interviewed sample, high
dosage is used by 28% , low doses are used by 18% ICS are not
used as a maintenance therapy for low recurret forms by 54% of
the sample, low doses are used by 44% while high dosage is
used by 2% . In case of frequent recurrence these percentages
change: ICS are recommended in high doses by 67% of the sam-
ple and a low dosage is indicated by 31% of the interwieved.For
recurrent wheezing, percentages were very similar for treatment
only in case of need (49%) or as a maintenance therapy. Both forasthma and wheezing ,treatment time before control appeared af-
fected by participants’ work setting. Closer controls were preferred by
primary care, hospital or professionals if compared to university pedia-
tricians. Preference for the use of some specific steroid molecules ac-
cording to the different pathologies also emerged. Parents’influence on
these choices resulted of no relevance.
Conclusions
Over 10% of S.I.P members were involved in this survey. A good
management of the child affected by recurrent asthma or wheezing
is shown as well as the choice of close control visits accounting for
more accurate treatment adjustments to the small patient’s needs.
An excessive use of corticosteroids for the treatment of asthma was
found, expecially for the acute asthma attack as well as for the dos-
ages used in the prevention of recurrences.
As a result of this survey, improvements in the implementation of
good clinical practice is to be expected , triggering the organization
of specific training courses.
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Infectious diseases are commonly reported in internationally adopted
children (IAC). In this population, the estimated prevalence of tuber-
cular disease is <1.0%, while the prevalence of latent tubercular in-
fection (LTBI) is about 15%. The published screening protocols for
tuberculosis in IAC are discordant and the use of tuberculin skin test
(TST), Interferon Gamma Release Assay (IGRA), or both is still under
debate. Several studies have been conducted to evaluate the per-
formance of these tests, but in the absence of a gold standard test
for the diagnosis of LTBI, no conclusive data are available. When both
tests are performed, discordant results are difficultly interpreted. The
possibility of discrepant results (mainly TST + / IGRA-) may be due to
a lower specificity of TST compared to IGRA (which is not or minim-
ally influenced by previous BCG vaccination, nor non-tuberculous
mycobacterial infections, or repeated TSTs). However, although IGRAs
showed overall higher specificity than TST, they may display a lower
sensitivity in children under 5 years of age. In Italy, the national
guidelines for the diagnosis of tuberculosis in immigrants, published
in 2018, suggest the possible use of both TST or IGRA, even sequen-
tially, but recommend the use of TST in immigrant children aged less
than 5 years. Other experts, and the most recent US guidelines, sug-
gest the use of IGRA even in children aged from 2 to 5 years, if a
good follow-up can be assured. In young children. However, IGRA
are the preferred assay when the tested children are unlikely to re-
turn for TST reading. Some experts suggest that an initial negative
TST/IGRA should be repeated after 3 or 6 months from the child’s ar-
rival, since the first test may be falsely negative, especially in recently
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Sarcomas represent a very heterogeneous group of mesenchymal
malignant tumors that are relatively frequent in adolescents. Survival
outcomes for adolescent with sarcomas lag behind those of children
diagnosed with histologically similar tumours: for most histotypes,
the survival
decreases with advancing age. The clinical management of these tu-
mors may be complex in this age group, partly due to tumor associ-
ated factors, but also because of the management of these patients:
delays in diagnosis, trial availability and participation, aspects of the
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 15 of 64organisation of care (with an emphasis on age-specific needs), na-
tional centralisation of sarcoma care, international consortia. As a
matter of fact, different approaches have been adopted by pediatric
and adult medical oncologists dealing with the same disease. How-
ever, nowadays constant efforts from international collaborations be-
tween pediatric and adult oncologists of sarcoma groups have
optioned in converging towards a common therapeutic strategy,
while improving quality of treatment, as well as research advances
dedicated to this at-risk age group of patients with sarcomas. Two
aspects may be of particular interest, in more details. First, the out-
come of adolescents and young adults with rhabdomyosarcoma is
decidedly worse than that generally seen in childhood. It is supposed
that rhabdomyosarcoma patients, regardless of their age, would re-
ceive better treatment when following guidelines derived from the
large pediatric experience. Second, the impact of new targeted
agents in the pediatric population has not paralleled the progress
seen in adult sarcoma patients. Increased international collaboration
between pediatric and adult sarcoma groups is of critical importance
to facilitate the transfer of potentially effective new agents from
adults to children and adolescents, and to improve research pro-
grams dedicated to young patients.
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Puberty is a period of transition characterized by the develop-
ment of secondary sexual characteristics, maturation of the go-
nads and achievement of reproductive capacity. Precocious
puberty has been defined as the onset of breast stage II develop-
ment before the age of 8 years in girls and genital stage 2 devel-
opment before 9 years in boys. The timing of onset of puberty in
girls has been decreasing all over the world. In fact, although in
the male the classic chronological limit of 9 years is more widely
accepted, there has been a decrease of at least one year of the age of
appearance of physiological puberty in the female determining a rele-
vant discussion on the possible similar reduction of the cut-off for age
of definition of precocious puberty in girls from 8 to 7 years. This secu-
lar trend, first recognized in the developed countries, has been noted
in developing countries as well. This has been attributed to improved
nutrition and effects of environmental endocrine disrupters. Based on
the origin of pubertal activation, precocious puberty can be classified
as gonadotropin-dependent (PPC), due to the early activation of the
hypothalamic-pituitary-gonadal axis with consequent increase in the
pulsatile secretion of LH and subsequent gonadal activation; or
gonadotropin-independent (PPP), as expression of excessive produc-
tion of sex hormones, without activation of the hypothalamic-pituitary-
gonadal axis. Many factors are involved in pubertal initiation, but the
understanding of pubertal regulation has undergone a sea change with
the discovery of the kisspeptin system. Currently, mutations in the kis-
speptin system, as MKRN3 and DLK1, have been identified in sporadic
and familial cases of central precocious puberty. The diagnosis is based
on physical exam findings indicating advancing puberty and on labora-
tory test. The gold therapeutic standard for children with PPC consists
of agonists of hormones that release gonadotropin, used with the goal
of regression or stabilization of the pubertal signs, decreases the
growth rate, the progression of bone age and height preservation. To
date, new pharmaceutical formulations have been developed in order
to improve the adherence to treatment and its therapeutic efficacy that
will soon change the approach to subjects with PPC in the coming
years. Instead, PPP treatment is influenced by the causes determining
the activation of puberty.However, many areas remain to be explored
such as targeted therapies and aspects of clinical management. Furtherinvestigation into psychological effects and additional data regarding
long-term outcomes, is needed.A33
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Introduction
Falls are a relevant problem in regards to frequency and severity
in paediatric settings [1-7]. The prevention of Risk for Falls is a
goal that Health Institutions and Health Professionals have to aim
to (8,9). The prevention is only possible with an appropriate falls
risk assessment instrument that identifies patients that need spe-
cific prevention measures whit specifics tools like as Pediatric Fall
Risk Assessment Scales (PFRAS) [10-18]. The only existing docu-
ment, the “Humpty Dumpty Fall Scale” (HDFS), is validated only
in English [19].
Materials and methods
The study consists of 4 steps. First step: linguistic and cultural valid-
ation [20]. Second step: evaluation of the predictive properties. Third
step: modifications of the scale to improve its performance. Fourth
step: creation and simulation of a new scale with a better predictive
performance, using epidemiological and clinical data gathered in
step 2. For the validation we have used the forward-backward trans-
lation and a pilot test with nurses and a convenience sample of 100
paediatric inpatients for the evaluation of clarity, validity and reliabil-
ity. During step 2 the validated Italian HDFS was used with 1500 hos-
pitalized children in Tuscany [21, 22].
Results
The Italian version, HDFS-ita, had a validity of SICV=0,92 and an inter-
rater reliability of K di Cohen=0,965. The predictive performance was
poor (sensibility 77,8%, specificity 36,6%, AUC of the ROC curve:
0.593). A new version of the HDFS-ita, the HDFS-ita-M with only three
items and a cut off of 7 was created to be used in subjects between
1 and 16 years. This scale had a better but still not satisfying per-
formance in regards to predictivity (sensibility 77.8%, specificity
53.3% AUC of the ROC curve:0.670). With the data collected during
step 2 a new scale was developed with satisfying statistical and clin-
ical performances (sensibility 88.9%, specificity 41.9% AUC of the
ROC curve:0.820). This 6 item scale with a cut off of 7 can only be
used for subjects from 1 to 16 years. Its temporary name is “Meyer-
Tuscany Fall Scale”.
Conclusion.
The HDFS-ita-M can immediately be implemented cancelling four of
the 7 items of the HDFS-ita. The “Meyer-Tuscany Fall Scale” can be in-
troduced after a test period and validity and stability inter-rater reliabil-
ity measures, possibly with similar methods as in step 2 of this study.
Acknowledgements. We thank the members of the Tuscan Pediatric Fall
Scale Study Group.
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Acute respiratory infections (ARI) represent the main cause of mor-
bidity and hospitalization in pediatric patients and in 2016 were the
second leading cause of death in children between 1-5 years after
prematurity, with an etiology attributable (95% IU) to Streptococcuspneumoniae (52.25%), Haemophilus influenzae B (7.36%), RSV
(6.29%) and influenza virus (1.28%) [1, 2, 3].
The Italian Society of Pediatrics, among the criteria to define a child
suffering from recurrent respiratory infections, indicates the following
conditions:
- more than six respiratory infections/year;
- more than a respiratory infection of the upper airways per month
between September and April;
- more than three respiratory infections of the lower airways/year.
The etiological agents vary depending on the respiratory tract affected
and in 80% of the cases it is because of a virus, a percentage that rises
up to 95% in infections of the upper airways. In the lower respiratory
tract from 4.5 to 40% of cases there is a positive for bacteria, even in
these cases up to 50% of patients have a concomitant or previous viral
infection. The engraftment of respiratory viruses is favored by a genetic
predisposition or by exposure to environmental factors and determines
a situation of local inflammation, which in turn favors the entry of other
viruses and respiratory bacteria, shaping a real infection of the respira-
tory tract. The main microorganisms responsible for respiratory infec-
tions are: RSV, Influenza A/B virus, Parainfluenza virus, Adenovirus,
Enterovirus, Metapneumovirus and Bocavirus. As for the bacteria Strep-
tococco pyogenes, Pneumococcus, Haemophilus Influenzae, Myco-
plasma pneumoniae and Chlamydia pneumoniae. Although with a
non-predominant pathogenic significance the most detected virus is
the Rhinovirus, present in 45% of infections involving the upper air-
ways, often in co-infection with other microorganisms [4, 5].
An accurate medical history is essential for the selection of suitable diag-
nostic tests. The Laboratory offers the possibility of performing first-level
tests (rapid tests for antigen research) useful for immediate screening of
a single pathogen (VRS, Influenza, SGA). Since the symptoms associated
with ARI are common in viral, bacterial and fungal infections, it is particu-
larly useful to use tests that allow a wide-ranging investigation to be per-
formed for the differential diagnosis between different respiratory
infections and other diseases. Molecular assays (real-time multiplex PCR)
respond to this need as they allow to quickly distinguish between the dif-
ferent etiologies favoring a correct management of the therapy and
where necessary the isolation of the patient [6].
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Healthcare professionals represent important behavior patterns
and a reliable source of scientific knowledge that can provide ac-
curate and accurate information to patients and the community.
The numerous professional figures involved and the multiplicity
of procedures and tasks carried out make the definition of risks
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 17 of 64for personnel working in the health sector very complex. Among the risks
associated with socio-health care, the infectious one, occupies a special
place due to the complexity of the determinants, the increasing epi-
demiological trend due to the conditions of coexistence in closed envi-
ronments, the increase in the proportion of immunocompromised, fragile
and / or elderly, the increased frequency of invasive therapeutic diagnos-
tic procedures, the spread of antibiotic-resistance phenomenon. In the
health work context, in particular, the vaccination protection of the oper-
ator is accompanied by the maintenance of a functioning health system
and the protection of patients, especially at high risk, by limiting the
transmission of the disease in a semi-open population. An assessment of
the adhesion determinants shows that health professionals are willing to
get vaccinated if they believe in the protection given by the vaccine, if
they are worried about their patients and their families, if they have easy
access to vaccines, if the vaccines are provided for free.
According to health professionals it is fundamental: a clear institu-
tional vaccination strategy, on all prevention issues and which regu-
larly involves competent doctors, hygienists and hospital infection
control personnel.
To encourage adherence to vaccination in the health sector, necessary
actions are required: sending an invitation letter, availability / dissemin-
ation of a vaccination schedule, offering incentives, such as: vacation
days / free hours, promotional material ( pens, pins, stickers, screen
savers), repeat vaccination campaigns regularly, contact all new em-
ployees and medical, nursing and other health professions students.
It is important to favor an active role of the competent doctor in
guiding workers towards choices and behaviors favorable to health,
including vaccinations. Through the computerized vaccination regis-
try, the competent doctor will be able to know the vaccination status
of each health worker for the correct management of the programs
and the improvement of vaccination coverage. In this process it is
also important to disclose the consequences of non-vaccination,
through prevention campaigns that include elements such as the re-
fusal form or the obligation to wear masks for unvaccinated workers,
which has led to an increase in the use of vaccines in the field hos-
pital. To ensure a policy of disseminating vaccination compliance in
operators in the various health facilities, it is necessary to invest in
their technical and scientific training on vaccinations and on the abil-
ity to communicate and interact with users on prevention issues. A
good knowledge of all aspects (eg use of vaccines, medical legal as-
pects of vaccination or lack of vaccination) ensures the collaboration
of health personnel with adequate training in the various medical,
surgical and emergency branches, raising awareness on the rationale
of vaccination for subjects at risk for condition and pathology.
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Child Abuse (CA) represents a diagnostic challenge due to its com-
plex presentation. Although the consequences of failing to diagnose
CA may be life-threatening, a wrong diagnosis may have devastating
sequelae too [1,2,3]. The Child protection unit “Bambi” is located at
“Regina Margherita” Children Hospital in Turin and it is a multidiscip-
linary team composed by pediatricians, psychologists, nurses, socialworkers and medical examiners. The aim of the Bambi unit is to
recognize and diagnose child abuse in all its forms (sexual abuse,
maltreatment, neglect). Every year, in the last years, above 200 chil-
dren are visited in the unit. This number is increasing constantly; we
think this is not related to the increasing of the phenomenon but a
result of a better detection of cases from social workers, prosecutors,
doctors, teachers and police. CA diagnosis is always a multidisciplin-
ary diagnosis, since a single element is not enough to detect abuse,
and multiple evaluations are required [4,5,6]. From 2012 to 2017, the
Bambi unit visited 1294 children from 0 to 18 years old suspected to
be abused: 65% children were females. Among this children 43%
were evaluated because of suspicion of sexual abuse, 38% because
of maltreatment, 6% neglect, 7% more than one kind. Regarding sex-
ual abuse, the incidence is higher in females (82%), while maltreat-
ment is equally experienced by both genders (50%). Mean age for
children suspected to be abused was 7y5m, for maltreatment 7y4m,
for neglect 6y6m. The median age of patients was 7y5m. From 2015
to 2018, we saw 719 children, among whom 37,8% reported intra-
familiar physical maltreatment, 3% extra-familiar physical maltreat-
ment, 12,1% extra-familiar sexual abuse, 31,2% intra-familiar sexual
abuse, 14,6% neglect, 2,2% intoxication.
About 80% of the children seen in the unit are reported to the au-
thorities due to suspicion of any form of abuse[7].
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Background
The unaccompanied minors migrants (UMMs) flow in Italy has in-
creased significantly since 2014 with 12,212 UMMs’ arrivals reported
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 18 of 64in 2018. The Italian ministerial guidelines on reception of foreigners
recognize UMMs particular vulnerability, due both to developmental
age and migrant status, and define the areas of need to be investi-
gated during the stay of minors in reception facilities.However, they
do not suggest clear and shared tools to use.
Objective
Based on the socio-economic determinants of the health paradigm,
the aim of our study was to structure a shared and comprehensive
tool for evaluating UMMs’ needs, in order to support children assess-
ment in reception facilities.
Methods
Results of a systematic review on need assessment tools for UMMs’,
performed on Pubmed, Scopus and grey literature, were discussed with
the National Working Group for Migrant Children of the Italian Society
of Paediatrics in order to develop an original tool. This was successively
submitted to a panel of experts (Paediatrician, Neuropsychiatrist, Social
Operators, Bioethicist) using the Delphi methodology in two rounds.
Results
Most of the questionnaires found in the literature focused only on
aspects related to psychological health (80% of the 27 studies in-
cluded in the analysis). On the contrary, the questionnaire produced
by our working group investigates physical, mental, spiritual health
and legal, educational and social needs, focusing on the subjective
perception of well-being and needs satisfaction. This questionnaire,
still undergoing the validation phase, has been planned to be self-
administered with the support of cultural mediators and/or operators
of the reception facilities.
Conclusions
Given the absence of validated and shared tools, the validation of a
questionnaire that evaluates the overall needs of UMMs is necessary
both to improve and standardize the assessment, and to evaluate in-
directly the hosting country ability to meet and to respond ad-
equately to the detected needs.
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Moderate (gestational age [GA] 32-33+6 weeks) and late (GA 34-
36+6) preterm infants (LPIs) account for over 80% of preterm in-
fants born worldwide, with a 20% increase in LP births docu-
mented in the US over a ten years period. Even if many LPIs are
similar in size to term infants, they are physiologically immature
and have higher risk of developing medical complications which
result in higher mortality, morbidity, and hospital readmission.
Until recently, most of the scientific literature has focused on
more immature and higher-risk infants, such as very-low-birth-
weight infants, and very little attention has been paid to respira-
tory and nutritional issues affecting LPIs.
Many LPIs require early nutritional support, as, for these infants,
gestation is interrupted during a period of intense gastrointestinal
(GI) development. For this reason, LPIs present with a variable de-
gree of GI immaturity, including inability to coordinate suck, swal-
low and breathing, which makes oral feeding quite challenging,
and alterations in GI motility and absorption. Difficulties in
achieving an adequate nutrition translate into faltering growth
during the neonatal period and into a higher risk of short stature
in the first years of life. Furthermore, they have potential nega-
tive consequences in terms of neurodevelopment, because brain
structural and functional development are not fully completed
when LP birth occurs. Nutritional requirements of LPIs have been
shown to be greater than those of full-term infants. Breastfeeding
represents the optimal nutritional choice also for LPIs, buteffective milk transfer is often impaired by GI immaturity of these
infants. Therefore, LPIs and their mothers require additional and
specific breastfeeding support, which should be provided by ad-
equately trained personnel. However, when breastfeeding alone is
insufficient to satisfy the elevated nutritional requirements of
LPIs, additional milk intake should be provided, when possible,
with supplemental expressed own mother’s milk. When own
mother’s milk is lacking, the choice of an adequate infant formula
is fundamental, and should be individualized considering the in-
fant’s characteristics and specific nutritional needs. During hos-
pital stay, the provision of an infant formula containing long
chain polyunsaturated fatty acids is recommended, while, after
hospital discharge, the use of a post-discharge formula, which
has a higher calorie and protein content than a term formula,
should be encouraged especially in infants small for gestational
age or with significant extrauterine growth retardation.
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Background
Diabetes mellitus is associated with various oral manifestations in
paediatric subjects too. Some oral complications, such as periodontal
disease, may be a possible risk factor for poor metabolic control in
subjects with diabetes and can lead to a two-way relationship.
Materials and methods
The authors reviewed the literature to classify oral conditions related
to diabetes mellitus in paediatric age. Studies that had low or no as-
sociation between diabetes mellitus and oral manifestations were in-
cluded too.
Results
In paediatric subjects, diabetes mellitus is associated with different
frequency to the following oral clinical manifestations: periodontal
disease (increase of Plaque Index, Gingival Index, Bleeding on Probing),
dental caries (increase of dmft /DMFT), salivary changes (decreased of
salivary flow), alterations of the oral microbiome, pulp inflammation,
periapical pathology, taste alterations, neuro-sensory alterations, al-
teration of dental eruption times. The frequency of some oral mani-
festations is related to the time of diagnosis and the glycaemic
control of diabetes mellitus.
Particular attention was paid to salivary changes in the diabetic sub-
ject and the two-way relationship between diabetes mellitus /peri-
odontal disease and diabetes mellitus /periapical pathology, in
particular for preventive and interceptive purposes.
Some studies present conflicting results on the association between
diabetes mellitus and dental caries.
Conclusions
The prevention and interception of some oral complications of diabetes
mellitus are fundamental both for oral health, but also for the general
health of the subject, influencing positively glycaemic control.
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Newborn feeding is a complex and dynamical system that re-
quires the proper integration of physical and neurophysiologic
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nutritive or nonnutritive as it involves milk transport or not, re-
spectively. Mature sucking includes two components, suction and
expression. Suction corresponds to the negative intraoral pressure
that draws milk into the mouth. Expression corresponds to the
compression and/or stripping of the tongue against the hard pal-
ate to eject liquid into the mouth [2]. During nutritive sucking,
the correct synchrony of sucking, swallowing, breathing, and
esophageal activities is critical for safety in order to prevent sim-
ultaneous milk entry into the trachea and esophagus. Efficient
nutritive sucking leads to increased transition from tube to breast
feeding, shorter hospital stays and safe discharge. On the other
hand, nonnutritive sucking matures earlier and occurs at a faster
frequency (2 cycles/s) than nutritive sucking (1 cycle/s). It is an
activity confined within the oral cavity that is independent of the
swallow, respiratory, and esophageal functions. Swallows are min-
imally involved and no milk is ingested as the pharyngeal phase
of swallowing is not activated, allowing sucking and respiration
to function at a more rapid pace. Therefore, nonnutritive sucking
is a good marker for sucking itself but is not predictive of nutri-
tive sucking competency and readiness to oral feeding [3].
Healthy premature infants typically achieve independent oral
feeding skills by 36–38 weeks of postmenstrual age while ex-
tremely preterm and infants who have neurodevelopmental prob-
lems or other comorbidities (pulmonary bronchodysplasia,
cardiopathies, GERD) often require longer time. The prevalence of
dysphagia in premature infants born at <37 weeks of gestation
and preterm with a very low birth weight (<1500 g) is around
10.5% and 24.5%, respectively. [4] The American Academy of
Pediatrics stated that oral feeding sufficient to support appropri-
ate growth together with the ability to maintain normal body
temperature and sufficiently mature respiratory control are the
essential physiologic competencies before hospital discharge of
the preterm infant [5]. Consequently, neonatal dysphagia or ab-
normalities of swallowing are associated with delayed full oral
feeding, longer hospital stays and tube feeding at discharge.
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Introduction
Acute appendicitis (AA) is still the most common indication as
surgical emergency in children [1]. For over 100 years, surgical re-
moval of the appendix has been considered a dogma [2]. 2 Now-
adays there is a growing consensus in literature to suggest that a
conservative treatment using antibiotics may be effective as well
as surgical treatment in adult patients with diagnosis of AA [3].
Data in pediatric population are scarce [4]. The main aim of ourretrospective study was to evaluate if abdominal ultrasonographic
specific findings associated to clinical and laboratory examination
improve diagnostic accuracy of acute uncomplicated appendicitis
(AUA). As second aim we evaluated the efficacy of conservative
treatment of AUA.
Methods
In this retrospective study all patients with diagnosis of AUA who re-
ceived a conservative treatment were enrolled. Data collected were:
duration of symptoms, sign and symptoms at the diagnosis, findings
at abdominal ultrasonography, type of treatment performed (conser-
vative vs surgical treatment), follow-up at 24/48 hours and follow-up
at 6 and 12 months.
Results
Of a total of 1131 admissions for abdominal pain, only 551 were AA
(412 complicated vs 139 uncomplicated). All of the AUA (139 patients)
at the diagnosis presented the typical findings at abdominal ultrason-
ography, and every patient were treated with antibiotics in the first 24
hours. After 24/48 h only the 22% underwent surgical treatment while
the 78% (109) were responder-to-treatment and consequently dis-
missed continuing the antibiotics at home. Only 6 of 109 patients dur-
ing the long-term follow-up were admitted for relapsing symptoms.
2(33%) of them after 6 months newly started antibiotic therapy while
1(16%) at twelve months of follow-up underwent surgical treatment for
complicated appendicitis and 3(50%) during the long-term follow-up
didn’t received any treatment.
Conclusions
Clinical and laboratory examinations are not sufficient for the diagno-
sis and they can only suggest the diagnosis of AA. Nowadays ultra-
sonography is the gold standard for diagnosis of AA and especially
in order to distinguish if appendicitis is complicated or not. We ob-
served in our study that the severity of appendicitis correlates with
decreased submucosal integrity rather than with appendiceal diam-
eter. Moreover, US is useful to discriminate between patients
responding or not responding to conservative treatment. The high
rate of responder to antibiotic treatment showed how conservative
treatment is safe and effective in patients with AUA. Therefore, for a
better therapeutic outcome, it is essential to make a proper selection
of patients who can be treated conservatively.
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Despite increasing knowledge about the disease pathogenesis, dia-
betic ketoacidosis (DKA) is frequently observed in newly-diagnosed
Type 1 Diabetes Mellitus (T1DM), requiring hospitalization and strict
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and educational interventions, patients are regularly followed in the
outpatient section. Otherwise several conditions, sometimes life-
threatening, cause acute metabolic decompensation in established
diabetes, requiring hospitalization. The incidence of recurrent DKA in
the US has been estimated at 8 per 100 person-years. As regards in-
sulin treatment, one problem frequently encountered is Continuous
Subcutaneous Insulin Infusion (CSII) malfunctioning, responsible for
acute DKA. In 2013 among 13.9% Italian children and adolescents
with T1DM on CSII a rate of pump failure 0.165 failure patient-year
has been reported. When infusion is interrupted the lack of subcuta-
neous long-acting analogue insulin reserve, available in patients on
basal-bolus regimen, is responsible for metabolic imbalance quickly
leading to hyperglycemia. Frozen insulin, due to inappropriate vials
storage, is another cause of acute DKA, especially in CSII users. Insulin
allergy, otherwise rarely encountered after availability of human insu-
lin preparations, is another serious adverse event requiring
hospitalization, with a prevalence of 2.4%. Insulin allergy could elicit
immediate reactions, usually induced by an IgE-mediated mechan-
ism. Clinical presentation includes erythema and swelling at site of
injection, urticaria, angioedema, rhinitis, bronchospasm and anaphyl-
axis, requiring urgent desensitization treatment. Another cause of
acute metabolic decompensation is intentional insulin omission as in-
appropriate compensatory behaviour, mostly in females, for weight
loss as expression of eating disorder including “diabulimia”, or other
severe psychological disturbances. Other acute complications leading
to hospitalization in long-standing patients include acute appendi-
citis, pancreatitis and kidney injuries. As regards neurological involve-
ment acute chorea and central venous thrombosis have been
described. Patients with T1DM with adequate metabolic control are
not more susceptible to infections as compared with peers, other-
wise infectious diseases may lead to DKA up to 32% of cases. The in-
fections include bacteria (49%), viruses (49%), and tuberculosis (2%).
DKA with tuberculous meningitis, herpes simplex type 2 encephalitis
and group B streptococcal meningitis have also been reported. Ileo
psoas abscesses, rhinocerebral mucormycosis have been described. A
retrospective analysis using the Pediatric Health Information System
(PHIS) database on youth with DM who presented to the Emergency
Department (ED) or were hospitalized for infection management
from 2008 to 2014 reported respiratory infections were the most
common type of infection followed by skin and soft tissue infections
for both ED care and inpatient hospitalizations. Hospital admission
for DKA may be influenced by a wide spectrum of risk factors. Identi-
fication of valid predictors for DKA may offer the opportunity to pre-
vent both acute complications of type 1 diabetes in high-risk
individuals.
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The declining birth rates in all Mediterranean countries, with Italy
bringing up the rear, is paralleled by an increasing demand of
prenatal testing aiming at monitoring the embryo’s and fetus’s
wellness. In general, these tests are analyzing either the esti-
mated 3% risk of defects or genetic diseases’ pending in each
pregnancy, or the risks related to family history or maternal life-
style and pregnancy history. Notable risk factors include ad-
vanced parental age, which increases the chance of de novo
mutations, and segregation of distinct mutations from parents. A
self-evaluation assessment based on family and maternal/preg-
nancy history is adequate for establishing if a given pregnancy
has a standard or an increased genetic risk, thus demanding tar-
geted monitoring. Advances in genetics, in particular increased
availability of next generation sequencing (NGS) techniques, has
widened the possibility to investigate in deep the genetic make-up of embryo and fetus, thus changing the traditional prenatal
testing protocols. The main revolutions in prenatal diagnosis in-
clude the following: 1. Anticipation of diagnosis, from second to
first trimester to preimplantation stage. Technical miniaturizing al-
lows investigation of the genome based on single cells’ analysis.
Researches are attempting to edit the diseased embryos, rising
ethical concerns about precision and safeness of this experimen-
tal approach. 2. The shift from invasive to non-invasive diagnosis,
based on the screening of biochemical markers, and, in recent
years, of free fetal DNA in maternal blood. These tests predict
with variable accuracy the risk of aneuploidy, or the presence of
some genomic imbalances and Mendelian disorders. 3. The shift
from a risk-guided to a technology-driven prenatal diagnosis.
Availability at reduced costs of NGS has increased the demand of
exome and genome sequencing often overlooking the limits of
these techniques in term of incomplete coverage of critical genes
and inability to interpret many variations of uncertain signifi-
cance. 4. The shift from “prevention” of birth of an affected new-
born based on pregnancy termination, to disease’s cure based on
new drugs and gene therapy. For several diseases target of pre-
natal diagnosis, including cystic fibrosis, spinal muscular atrophy,
thalassemia and others, promising precision medicine protocols
are becoming available, arguing for the need of continuous up-
date of the prenatal genetic testing scenarios, in order to offer to
prospective parents the best opportunities.
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Fragile-X syndrome (FXS) is one of the most frequent inherited
cause of intellectual disability with a prevalence of about 1:5,000-
7000 in men and 1:4,000-6,000 in women. FXS is caused by an al-
teration of the Fragile X Mental Retardation-1 gene (FMR1) on
Xq27.3 band. More than 99% of individuals with FXS have a
FMR1 loss- of-function, caused by an increased number of CGG
repeats in the 5'untraslated region (typically >200). This “full mu-
tation” determines a hypermethylated state of the deoxycytosine
residues located at the FMR1 promoter. This results in loss or
heavy reduction of the protein product (FMRP) and gives rise to
the expression of the cytogenetic fragile site (FRAXA). The disease
is caused by the absence of the FMRP protein. Different kinds of
FMR1 alterations (deletions encompassing the gene, intragenic
deletions/duplications, single-nucleotide variants) are responsible
for the remaining molecular diagnosis of FXS. Genetic tests gen-
erally focus on the number of CGG repeats and the FMR1 alleles
are usually categorised according to this number in Normal (5-44
repeats), Intermediate (45-58 repeats) and Pre-mutation (59-200
repeats) alleles. The probability of affected offspring is greater
the more repeats are.
Fragile-X syndrome shows a clear genotype-phenotype correlation. In
male full mutation children (hemizygotes) clinical picture is charac-
terised by moderate development delay/intellectual disability, preva-
lently involving language, typical cranio-facial dysmorphisms and an
high prevalence of neuropsychiatric disorders [1]. Particularly social
anxiety is frequent and often associated to other autistic-like features
with about 60% of affected males reaching diagnostic criteria for aut-
ism spectrum disorder [2]. Anyway fragile-X children maintain an ad-
equate preferential relationship with his main caregivers and show
milder social impairment than autistic children without the syn-
drome. About 20% of patients are affected by epileptic seizures with
onset in early infancy. Different kind of seizures are reported and
these are usually pharmacoresponsive and self‐limited, disappearing
in adolescence.
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istics. It is possible to observe an increase of the hyperactivity and
social anxiety, onset of obsessive-compulsive and, in the most severe
cases, psychotic symptoms. Mitral valve prolapse has been observed
in 50% of adult patients. Female full mutation patients (heterozy-
gotes) show a mild physical and behavioural phenotype. Premutation
patients generally have a normal appearance and normal intelligence
but half of them shows neuropsychiatric disorders [3]. Female carriers
can have a premature ovarian failure, while a late-onset ataxic syn-
drome with tremor has been reported in premutation male carriers.
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Background
in Italy in the last century there have been significant demographic
changes.
The aim of the study is to analyse the changes of birth rates and
neonatal and infant mortality in Italy.
Materials and Methods
The presented data was obtained from the most recent data from
the Italian Statistics Bureau (ISTAT). Neonatal and infant mortality
rates were calculated as the number of deaths occurring before 28
days of age and the first year of life respectively for every 1000 live
births. Children were considered Italian citizens if at least one of their
parents had Italian citizenship; they were considered immigrant resi-
dents living in Italy if neither parent had Italian citizenship.
Results
During 2018, 449,000 children were born. This was 128,000 less than
that of 2008, at the beginning of economic crisis, and less than half
of those born in the 60s.
The mean age of women at childbirth was 32 years and 9% of births
in Italy occur in women over 40 years old. The number of those born
with medically assisted procreation techniques has increased and in
2016 they were 13,582, or about 3% of total births. In 2018, foreign
parents, who represent only 8.7% of the all population, contributed
significantly to the birth rate with 67,000 births (14.9% of all births).
In 2016 mean neonatal and infant mortality was 2 and 2.8 per thou-
sand live births respectively but varied across the different regions of
Italy. Children born in the southern regions have a 36% higher risk of
mortality compared to those born in the northern regions. Infants
born to immigrant parents have an infant mortality rate that was
56% higher than those born to Italian parents.
Discussion
The decline in birth rates in Italy is linked to the reduction of the
number of potential parents, due to the recent economic crisis and
to the frequent postponing of the age of procreation by many work-
ing women. The possible interventions to improve the birth rateshould include a series of fiscal policies in favor of families with chil-
dren, interventions to help working parents and, above all, the avail-
ability - at low costs - of childcare services.
The main causes of neonatal and infant mortality are linked not only
to economic and social factors, but also to organizational problems
concerning the perinatal care.
Conclusions
A political and social project that puts children at the center of atten-
tion and good governance is indispensable, because children repre-
sent our future.
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In order to prevent chronic malnutrition, artificial feeding plays a
great role for some “special” patients. Enteral nutrition by percutan-
eous gastrostomy is recommended in patients with “normal” bowel
function and long term artificial feeding requirement (encephalop-
athy, cerebral palsy, repeated aspiration pneumonia, etc). Percutan-
eous endoscopic gastrostomy (PEG) is easily and safety performed in
deep sedation/general anaesthesia, with consequent early enteral nu-
trition and drug administration, and a related low incidence of imme-
diate complications. The avoidance of nasogastric tube and its side
effects and a good compliance of patients and caregivers and nurses
are a real advantage of this technique. In anatomy difficulties a surgi-
cal gastrostomy should be performed. A percutaneous endoscopic
gastrojejunostomy (PEJ) could be important for patients affected by
chronic vomit. The style-guided J-tube through the pyloric ring is
endoscopically passed and advanced it to the jejunum (jejunal feed-
ing instead of gastric one), without sedation in endoscopic suite. A
multidisciplinary approach of patients with enteral feding is neces-
sary to share indications, timing and management of PEG/PEJ. GERD
and nutritional intakes must be considered in patients’ follow up.
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Background
Recently, the category of health-related apps has seen significant
growth. An increasing number of health care organizations are using
Mobile Health (mHealth) apps with an understanding of the potential
benefit for monitoring and treating diseases and chronic conditions
and facilitating diagnoses. We analized Cystic fibrosis (CF) that repre-
sents a multi-organ genetic disorder, but its clinical outcome involves
mostly the respiratory system. Respiratory physiotherapy is a fonda-
mental tool for the cure of cystic fibrosis. Viscous mucus secretions
obstruct airways, leading to recurrent and often subsequent chronic
infections. The course of the disease is marked by periodic exacerba-
tions with decline in pulmonary function. Adherence is generally
poor and has been estimated at 50% or less for pulmonary medica-
tions. Telehealth could be useful in improving the adherence to PR
(pulmonary rehabilitation), as a continuous information exchange be-
tween rehabilitation team/caregivers and patient/caregivers. The Tel-
ehealth system allows communicating in real-time health issues of
the patient to the rehabilitation team and improves the collection of
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 22 of 64patient’s data from a retrospective point of view of the majority of
chronic respiratory diseases.
Material and Methods
We realized a survey to evaluate the possible use and the utility of a
future digital application for respiratory rehabilitation in patients
followed by Telemedicine-service in a new future way to practise re-
habilitation. 24 CF patients (age 27,04±8,13) are enrolled and then
their parents (age 40,45±7,26); we asked them to answer ten ques-
tions about for example the use of mobile-phone, the internet con-
nection, which app they usually use, and also if they want to receive
a communication about respiratory rehabilitation. So, we thought a
practice application with the aim to manage the current personal PR
program at home, enabling to administer aerosol therapies protocol,
bronchial clearance techniques, physical exercises, and have access
to personal documents and certifications.
Results
All adult patients and their parents (100%) expressed an excellent
opinion about a possible way of digital application for physiotherapy,
and they want to use it in their daily life.
Conclusions
This future app for respiratory rehabilitation will be a good tool, spe-
cially to improve adherence in medical treatment in patients with
Cystic Fibrosis.A48
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Background Inflammation is a physiologic process aiming to defend
the integrity of organisms against dangerous insults. Fever is a car-
dinal response of inflammation which depends on synergism be-
tween immunological and neurological activity [1,2].
Materials and methods Literature review has been performed about
mechanisms of fever and inflammation.
Results Endogenous pyrogens (TNF, IL-1 and IL-6) are the bridge
leading inflammatory and neurological response. They act both in
peripheric tissue, causing the activation of innate and adaptive immune
response, and in central nervous system promoting production of PGE2
(prostaglandin E2) by COX-2. Cytokine synergy is critical for fever, but
not the all molecules involved in the inflammatory response are re-
sponsible of it. Fever is the main symptom of autoinflammatory disor-
ders, in which uncontrolled activation of innate immune system cause
an over-production of inflammatory mediators.
Conclusions Fever is an ancestral defence response, which mechan-
ism includes the activation of both immune and neurological system.
Peripheral and central activity of cytokines is essential for organising
homeostasis of fever and the alteration of immunological functional-
ity is responsible for autoinflammatory disorders.
Acknowledgements I wish to acknowledge the help provided by Dr. Fab-
rizio De Benedetti and Dr. Claudia Bracaglia.
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Background. Early treatment of developmental dysplasia of the hip
(DDH) is more effective if started at an early stage [1-4]. Ramsey
reported in 1976 [5] that if treated by the 1st month of life, the
treatment duration lasted in average 3.6 months; if between the
1st and 3rd month, it increased to 7 months; if between the 3rd
and 6th month, it increased to 9.3 months. Therefore, the import-
ance of anticipating DDH diagnosis, possibly by the 6th week of
life, is obvious [6]. Early DDH diagnosis not only facilitates early
treatment, but it also reduces the likelihood of avascular necrosis
of the femoral head and early osteoarthritis of the hip and leads
to better results [7,8]. Aim of this study was to evaluate the ef-
fectiveness of early treatment in severe DDH in newborns.
Materials and methods. For this study 72 neonates (66 females, 6
males) with 93 type III hips according to Graf’s ultrasonographic
classification were examined. Out of 72 patients 21 (0 males, 21
females) had bilateral presentation, 21 (3 males, 18 females) had
monolateral presentation with the left side affected and 30 (3
males, 27 females) with the right side affected. Mean age at diag-
nosis was 35 days (range 1-202). The treatment was always per-
formed with the hips in the “squatting” position (100-110°
flexion, 50° abduction). The acetabulum’s growth was ultrasono-
graphycally monitored and the alpha-angle assessed by two sub-
sequent evaluations with an average follow up of 109 days
(range 39-347). The sample was then divided into three groups
based upon patient’s age at diagnosis and treatment beginning:
Group 1 (age < 11 days), Group 2 (age ≥ 11days <42 days),
Group 3 (age ≥ 42 days).
Results The statistical analysis showed a strong dependency (p<0,001)
between the alpha-angle gain (acetabular growth) and the time
of diagnosis and found no statistically significant correlation be-
tween sex (p-value 0,81), affected side (p-value 0,72) and treat-
ment length (p-value 0,864). At follow up in Group 1 91,31 % of
the severe dysplastic hips showed normal values of the alpha
angle (> 60°) while in Group 2 and in Group 3 62.5 % and 48.7
% respectively (Figure 1).
Conclusions The results highlight the mandatory need for an early
treatment of severe hip dysplasia, which, if not started shortly after
birth (4-6 weeks) is considerably less effective and has less predict-
able results. The need of a DDH screening for early diagnosis has
been confirmed [9,10].
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affected by severe DDH reaching a normal alpha-angle (>60°) at the
second Ultrasound-FU in the three groups of the sample. (Sample
based upon patient’s age at diagnosis and treatment beginning:
Group 1 age < 11 days, Group 2 age ≥ 11days <42 days, Group 3
age ≥ 42 days)A50
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Background
To describe the components and the achievements of the ProBA pro-
ject (Progetto Bambini e Antibiotici), a long-lasting multilevel inter-
vention aimed at promoting appropriate use of antibiotics in Emilia-
Romagna Region (Italy).
Method
The project started in 2003 with a KAP survey involving pediatri-
cians and parents on reasons for antibiotic prescription. Guide-
lines development on acute otitis media and sore throat followed
in 2007, a monitoring system on antibiotic prescriptions with an-
nual report was implemented, and information for parents were
provided in the first phase of the project. Starting from 2015, a
second phase of ProBA project was implemented based onprevious experience: guidelines were updated, evidence was dis-
seminated, new tools to monitor results and to provide feedback
were developed. Moreover, an annual public information cam-
paign was launched and progressively enriched with new prod-
ucts. Regional commitment was ensured through clear
identification of objectives and pay for performance incentives
were provided to health professionals. A quantitative and qualita-
tive assessment of antibiotic use in children 0-13 years was per-
formed. According to the European Commission recommendation,
assessment was based on the estimation of two principal indica-
tors: the total antibiotic prescription rate and the ratio of amoxi-
cillin versus amoxicillin-clavulanic acid. Throughout the project,
papers both in Italian and in English language were published to
share findings and experiences.
Results
A substantial decrease of antibiotic prescription rates was registered
in the time period 2005-2017 (from 1307 to 777 prescriptions per
1000 children), along with a relative growth of the use of amoxicillin
(the ratio of amoxicillin to amoxicillin-clavulanic acid increased from
0.6 to 1.3 in the same population). The Italian Medicine Agency AIFA
recently issued a national report on antibiotic use that applies the
same indicators used in ProBA. Figures at national level were: total
antibiotic prescription rate 1047 prescriptions per 1000 children
(quite higher than the one in Emilia-Romagna), and ratio of amoxicil-
lin to amoxicillin-clavulanic acid 0.3 (much lower than the one in our
Region).
Conclusions
The ProBA project is associated with a containment of antibiotic
over-prescription for pediatric care and a relative increase of nar-
row spectrum antibiotics use. A future development of the pro-
ject could be the establishment of a collaborative network with
other Italian regions to define a common set of indicators, to
compare attitudes and practices, to share products and tools de-
veloped within ProBA, and to outline joint objectives of
improvement.
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The advancement of medically assisted procreation technology
has generated radical changes in issues relating to maternal di-
mension and in the psychic structure associated with the child
birth, but it was not accompained by necessary ethical and psy-
chic considerations.
The child of the new conception scenarios seems to be sched-
uled rather then desired, even regardless of the fact that the im-
plementation of the medically assisted procreation tecnique,
sometimes creating negative effects on future mothers and ba-
bies, quiets “the manifestation of most carnal symbols detachs
eroticism from sexuality and breaks the symbolic chain sexual
desire-desire for a child” [1], making it subjectively sterilizing. The
coercion of technique does not allow to experience the fascin-
ation of intimacy and it impacts the course of pregnancy. The
choice of “a baby not matter what”, namely cost what it may,
preclude the relationality and it does not permit the slow process
of mentalizing a child, that can take place only after the process
of infertility grief. The child of the new conception scenarios is
not a child desired for him/herself but “above all it represents a
child having a duty to be conforming to the desire of those who
gave him/her birth” [2].
The speed of these changes did not allow for sufficient meditation
and depressive episode or significant couple conflicts which may
lead to separation often occur, once the child was born (that is once
reached thei narcissistic desire). Mathers and fathers who did not
take part to the generation of the child, who did not take part to the
conception scene (for egg and sperm donation), are often over-
whelmed by alienation and strangeness and this may negatively
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 24 of 64affects the child’s development or future. Or, the child may face with
aging parents (thanks to technology you may have a baby even at
age 60) who are unable to guarantee an appropriate physical and
psychological avalaibility in his/her life and they make him/her
ashamed of having granparents rather then parents. There is also an
issue about foetal reduction (that is prohibited but possible for med-
ical reason) that may lead guilt over eliminating one of the many
coveted children.
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Primary Ciliary Dyskinesia (PCD) is a rare congenital, clinically and
genetically heterogeneous disease caused by abnormal structure
and/or function of respiratory cilia, with impaired mucociliary
transport leading to recurrent respiratory infections and progres-
sive loss of lung function. PCD diagnosis is not easy, since signs
and symptoms of this condition are nonspecific and may vary ac-
cording to the age of the patients. Moreover, diagnostic tests are
complex, time consuming and expensive [1]. However, some pointers
of the disease, such as laterality defects, daily wet cough and persistent
rhinorrhea, may be noticed in the perinatal period and should suggest
to refer the patient to the specialist or at the reference center for PCD,
in order to perform the diagnostic tests and start the related treatments
as soon as possible [1]. In PCD, the recurrence of respiratory infections
causes a continuous and exaggerated neutrophilic response in the
bronchial mucosa, with consequent release of tissue-damaging en-
zymes that, in time, lead to progressive bronchial wall damage and
dilatation, known as bronchiectasis. In bronchiectasis mucus is even
more stuck, which make infections and inflammation more and more
frequent and severe, causing worsening of the lesions and symptoms,
with onset of sputum production and eventually bronchorrea. As
a consequence, bronchiectasis severity correlates with worse pul-
monary function [2]. Bronchiectasis is a consistent finding in adult
PCD patients, but often appears in childhood [3] by 8 years of
age in 50% of cases [4]. Bronchiectasis distribution in PCD has
been shown to have a basal predilection: the most involved pul-
monary lobes are the middle lobe, the lingula and the inferior
lobes, while, unlike cystic fibrosis, upper lobes involvement can
be found in most severe cases and later disease stage. [4]. In
children, bronchiectasis involves firstly the middle lobe, since the
middle lobe bronchus is the longest, narrowest and most hori-
zontal of the lobar bronchi, facilitating mucus stagnation and
plugging. High Resolution Chest Tomography is still the gold
standard test to diagnose bronchiectasis and assess its extent
and severity. Recently, some studies have shown that also chest
Magnetic Resonance Imaging is an accurate and reliable method
to evaluate bronchiectasis in PCD patients [5]. Treatment of
bronchiectasis is mainly based on respiratory physiotherapy and
airway clearance techniques, early administration of antibiotics on
the occasion of respiratory infections and eradication or chronic
treatment of Pseudomonas aeruginosa infection when present [6].
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Healthy lungs have been historically considered to be sterile based on
the results of standard microbiological culture techniques. However,
starting from the 2010s, next generation sequencing has been used on
lower airways samples allowing the identification of low-density micro-
bial communities in a culture-independent way [1]: the lung micro-
biome composition is now well known and described as to be
characterized by the prevalence of bacteria belonging to phyla Firmi-
cutes and Bacteroidetes (mostly Prevotella and Veilonella spp), reflecting
the composition of the microbiome of the oropharynx, since bacteria
arrive to the lungs mostly through micro-aspiration of secretions from
the naso-oropharynx [2]. In the healthy subjects bacteria are rapidly
eliminated from the lower airways, in a continuous and delicate balan-
cing of immigration and elimination, which can be acutely altered dur-
ing respiratory infections or be modified in chronic respiratory diseases,
especially in advanced stages [3]. Asthma is the most common chronic
disease in childhood: its pathogenesis is multifactorial and includes en-
vironmental factors interacting with susceptibility genes during preg-
nancy and in the first years of life. In asthma, as in other respiratory
diseases, the lung microbiome composition changes: as a matter of
fact, many studies have demonstrated that both in children and in
adult asthmatics the lung microbiome is characterized by the preva-
lence of the phyla Proteobacteria (mostly Haemophilus, Moraxella, and
Neisseria spp) and reduced biodiversity [4]. However, it is not clear
whether this change is secondary to the underlying disease or plays a
primary role in its development. Considering what is already known
about the role of early atopy onset and early viral infections in the de-
velopment of asthma, with RSV and rhinovirus as major risk factors, a
primary role of the microbiome seems likely [5]. For example, in in-
fancy, respiratory viral infections can induce the emergence of Proteo-
bacteria, which are also known to be linked to a higher risk of asthma
at 5 years in children born to asthmatic mothers. Moreover, the phylum
Proteobacteria is linked to severity of asthma and bronchial hyperreac-
tivity. The lung microbiome may also interact with the immune system,
modulating inflammation. Antibiotics may alter the lung microbiome
and possibly interfere with all these processes: as a consequence, they
should be prescribed exclusively when necessary, especially in the first
years of life. The potential role of probiotics and prebiotics on lung
microbiome has not been yet evaluated.
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pathophysiology of asthma. Respir Res. 2016;17:163.Table 1 (abstract A54). Vaccine coverage (VC) in preterm newborns
and general population. Birth cohort 2016-2017
Vaccine type VC Preterm General population z p
n % (95%CI) %
DTaP-IPV-HBV-Hib 1 dose 169 99.4 (96.7-99.9) 99.0 0.5 0.601
DTaP-IPV-HBV-Hib 2 dose 164 96.5 (92.5-98.7) 94.8 1.0 0.319
PCV 1 dose 167 98.2 (94.9-99.6) 98.4 0.2 0.836
PCV 2 dose 161 94.7 (90.2-97.8) 94.1 0.3 0.740
Table 2 (abstract A54). Average age of vaccine administration (day:
mean±SD) in preterm and general population. Birth cohort 2016-2017
Vaccine type preterm general population t p
DTaP-IPV-HBV-Hib 1 dose 119.3±81.9 61.0 9.3 0.000
DTaP-IPV-HBV-Hib 2 dose 214.6±105.0 121.0 11.6 0.000
PCV 1 dose 119.0±66.8 61.0 11.3 0.000
PCV 2 dose 209.8±81.8 121.0 14.2 0.000A54
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Background
Despite preterm infants are at high risk for infectious diseases and World
Health Organization recommends that they receive immunization accord-
ing to routine schedules for at term neonates, completeness and timeliness
of vaccinations in this special population is worldwide still lower compared
to general population.
Materials and methods
In our Neonatal Intensive Care Unit a specific program for parents of
preterm infants has been implemented to improve their vaccine liter-
acy, by in-hospital vaccine administration, outpatient follow-up vac-
cination counselling, vaccine-related information through social
media. We have evaluated the efficacy of this program, by the ana-
lysis of coverage and timeliness of first two doses of vaccine (both
Hexavalent and PCV13) in our patients (birth cohort 2016/17), com-
paring their data with data from general population of the same
birth cohort extracted from the 2019 Apulian Regional Vaccination
Register (GIAVA).
Results
We studied 170 preterm infants with average gestational age and
weight of, respectively, 30.1±2.9 weeks (range: 23-33) and 1,456.0±
504.9 grams (range: 400-2,590).
Table 1 and 2 show coverage and timeless of vaccination.
Coverage resulted similar to general population. This result, con-
firming our previous study [1], highlights how our interventions
are consistent with the purpose of overcoming vaccination hesi-
tancy, especially in parents of infants who have experienced
health problems. Furthermore, our results confirms the efficacy of
the active vaccinations administration during hospitalization as a
powerful tool to improve coverage.
In preterm infants, the average age of vaccinations is similar to data
previously published [1] and significant delayed compare to the rec-
ommended timeline (Table 2).
The linear regression analysis shows no association between time
delay with birth-weight and/or gestational age (p>0.05).
Conclusions
Our easy, inexpensive and highly reproducible interventions seem
to increase vaccination coverage in preterm infants. Timeliness
remains still inadequate and carries significant worry in this high-
risk population for preventable infectious disease-related
complications.The “medical” use of web 2.0-based social networks, because of
their widespread distribution, could be a very significant tool, if
adequately monitored, to positively influence parents’ decision
making about vaccination and counteract vaccine hesitancy.
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Chronic intestinal pseudo-obstruction (CIPO) is a rare and severe
gastrointestinal motility disorder characterized by a severe impair-
ment of gastrointestinal motility leading to intestinal obstruction
symptoms in the absence of mechanical causes. Symptoms can
be non-specific, and result in this condition being diagnosed in-
correctly or too late with consequences for morbidity and even
mortality. There is no single diagnostic test or pathognomonic
finding of CIPO, thus the diagnosis is usually clinical and diagnos-
tic work is usually aimed to rule out mechanical obstruction and
to identify any underlying diseases. Treatment is challenging and
requires a multidisciplinary effort with participation of appropri-
ately experienced gastroenterologists, specialized dieticians, sur-
geons, psychologists, and other subspecialists based on the
presence of comorbidities. Medical therapies are mainly aimed to
avoid complications such as sepsis or intestinal bacterial over-
growth and restore intestinal propulsion. So far, only few proki-
netics have proven some efficacy in restoring intestinal
propulsion, thus nutritional support, fluid/electrolyte replacement,
and antibiotics are the mainstay of treatment. Decompression of
distended intestinal segments via intermittent nasogastric tube or
endoscopy is an important therapeutic target. In some cases a
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 26 of 64venting enterostomy, typically placed endoscopically can be help-
ful. Surgery may be indicated as a tool to collect gut biopsy
specimens for histopathology, in emergency situations (massive
bowel distension and perforation/ischemia) and to perform pallia-
tive procedures such as feeding/venting gastro-jejunostomies. In-
testinal transplantation should be considered in patients with
CIPO presenting with life threatening TPN-associated complica-
tions. Although there is little evidence emerging pilot studies
have explored the use of faecal microbiota transplantation in
CIPO with reports of improved symptoms, indirect markers of in-
testinal obstruction and small intestinal bacterial overgrowth.
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Background
The WHIM syndrome is a primary immunodeficiency caused by auto-
somal dominant mutations in the C-X-C chemokine receptor type 4
(CXCR4) [1]. Reported frameshifts, nonsense or deletion mutations re-
sult in the truncation of 10 to 19 amino acids from the C-terminus of
the cytoplasmic domain and account for the gain-of-function activity
[2]. The acronym refers to warts, hypogammaglobulinemia, infec-
tions, and myelokathexis, the abnormal retention of mature neutro-
phils in the bone marrow. Neutropenia associates with lymphopenia
and monocytopenia leading to panleukopenia, the recurrence of pul-
monary infections may evolve to chronic lung disease by early adult-
hood, and the specific susceptibility to chronic infection with Human
Papilloma Virus (HPV) may expose patients to risk of malignancy [3-
5]. Stating the role of CXCR4 since the embryonic brain and heart
system development, other than hematopoiesis, the syndrome may
feature congenital heart disease and neurological abnormalities [6-7].Conventional treatments include Granulocyte-Colony Stimulating
Factor, immunoglobulin therapy and/or antibiotic prophylaxis; the
promising results reported with the CXCR4 antagonist plerixafor [8]
paved the way to the future treatment of this condition with CXCR4-
based therapies.
Material and methods
We investigated molecular, biological, clinical, radiological, and im-
munological features of 21 patients who referred to the Department
of Brescia. Genetic testing was performed by Sanger sequencing,
functional tests were performed by flow-cytometry, and data were
collected from medical records or by a case report form.
Results
Patients have a median age of 22 years, with 1.6±3.8 at the time of
clinical onset, but 9±10 at the time of molecular diagnosis. GOF mu-
tations were identified in 18/21, while three patients presented a
novel frameshift mutation with a not-GOF biological pattern (the
L317fsX3). Warts occurred in 62% of patients, bacterial infections in
90%, the Tetralogy of Fallot in 19%; 4 out of 6 investigated patients
had abnormal cerebellar morphology. All patients had severe neutro-
penia at onset (150±105 cells/mmc), monocytopenia was reported in
13/21 (61%), lymphopenia in 16/21 (76%), always associated with B
lymphopenia. Hypogammaglobulinemia was present in 46%. No
genotype- phenotype seemed significant.
Conclusions
WHIM syndrome may exhibit heterogeneous molecular and clinical
phenotypes, and it should always be suspected in cases of severe
congenital neutropenia. The diagnosis is confirmed by molecular
testing, but functional tests are required to characterize the muta-
tion. Novel clinical trials will explore CXCR4-targeted therapies to re-
verse panleukopenia and control HPV manifestations. Meanwhile,
HPV vaccination should be recommended in all affected patients and
immunoglobulin treatment suggested since early childhood to pre-
vent the development of chronic lung disease.
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The choice of enteral nutrition for infants, children and adolescents
must be founded on a careful evaluation of the caloric, nutrient and
electrolyte needs, and based on the following criteria: patient’s age
and type of pathology, presence of food allergy or intolerance and
mode or route of administration (through SNG or PEG or PEJ) [1,2,3].
Standard enteral formulas contain macro- and micronutrient needs;
therapeutic enteral formulas contain also specific pharmaconutrients
that may attenuate hyperinflammatory responses, enhance the im-
mune responses to infection, or improve gastrointestinal tolerance.
Polymeric formulas are useful in patients with integrity of the gastro-
intestinal tract. The use of semi-elemental formulas is indicated in
children with compromised GI function and in case of post-pyloric
enteral administration.
Elementary formulas are indicated only in cases of severe allergy, not
responding to extensive hydrolyzates formulas. Clinicians must care-
fully consider different use of specialty formulas, paying close atten-
tion to the quality, patient population, clinical end points, cost and/
or facility of administration for patients.
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Chronic non communicable diseases (NCDs), such as those re-
lated to overweight and obesity, represent major health issues
worldwide. It is commonly accepted that an early intervention in
the pediatric age, or even earlier, during pregnancy, has a posi-
tive impact in reducing life course risk of NCDs [1]. Italian data in
infants and children, aged between 6 and 36 months, show some
alarming results. Infants and toddlers eat too much proteins, sim-
ple sugars, unhealthy fats and salt; on the contrary, their iron in-
take is below recommendation [2]. Some few, useful rules in
pediatric nutrition are important for an healthy life. Breastfeeding,
as recommended by World Health Organization (WHO), should be
exclusive in the first 6 months of life and should be continued
during the complementary feeding period, until 12 months, or
even afterward. Complementary feeding should not be started
before the completed fourth month of age. Energetically ad-
equate foods should be introduced, paying attention to limit the
protein intake and to favor the intake of iron-rich foods. High
protein intakes in the early life has been associated with a later
increased risk of overweight and obesity [3].
Intake of simple sugars, above all those from snacks and sugar-
added beverages, should be limited or preferably avoided at all;
it has been demonstrated that substituting sugar-sweetenedbeverages with water decreases body fatness development in the
adolescence [4]. Similarly, polyunsaturated fatty acids (PUFAs)
should be preferred in the diet of infants and children: literature
data showed that quality of the ingested fats is more important
that their quantity in a healthy diet [5]. Other favorable eating
habits include the limited sodium intake and the regular break-
fast consumption. Starting from childhood to decrease salt intake
may prevent development of arterial hypertension in later life [6].
As for breakfast, it has been demonstrated that children who skip
it have a lower diet quality, characterized by an increased caloric
intake from consumption of unhealthy snacks [7]. Healthy eating
habits start with good food choices, and reading product labels
is the first important step toward awareness of the importance of
a healthy nutrition as a prevention strategy for NCDs.
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Updated reports on epidemiological data collected over the last
decade clearly indicate a dramatic increase of sepsis and septic
shock worldwide, from birth to ageing, leading to almost 6 mil-
lion deaths per year [1]. Approximately 2,202 babies every
100,000 live births develop neonatal sepsis with a mortality rate
ranging 11–19%; this corresponds to 3.0 million cases of neonatal
sepsis annually [2]. In May 2017, the United World Health Assem-
bly and the World Health Organization (WHO) adopted a reso-
lution to improve, prevent, diagnose, and manage sepsis. Sepsis
was recognized a global health priority, marking a quantum leap
in the global fight against this disease. Thus, the early and accur-
ate diagnosis, the clinical course and the long-term outcomes of
neonatal sepsis remain notable laboratory medicine challenges
[3]. Diagnostic microbiology stands at the epicenter of the
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tations, blood culture remains the gold standard; automation has
substantially reduced the time needed to detect circulating bac-
teria and currently almost 90% of positive blood cultures are de-
tected within 24 h of incubation. Attractive alternatives to
culture-based techniques are mainly based on the Polymerase
Chain Reaction (PCR) for amplifying a specific region in the bac-
terial genome to levels sufficient for detection and identification
of the bacteria. Conventional biochemical tests for evaluating the
inflammatory response include C-reactive protein (CRP), procalci-
tonin (PCT), fibrinogen, and haptoglobin. Despite many hundreds
of published clinical studies involving ten of thousand of patients,
no one so called emerging biomarker has come definitively to
the bed side and passed the test of time by being incorporated
into routine clinical practice. Among the plethora of potentially
emerging biomarkers, the soluble CD14 subtype (sCD14-ST), also
called presepsin, seems to fulfill most of the characteristics of an
ideal biomarker for managing neonatal sepsis. In a recent meta-
analysis, both pooled sensitivity and specificity of sCD14-ST were
91.0% and the diagnostic odds ratio was 170.28 [4]. Recently, the
potential role of metabolites has emerged as key issue for the
early diagnosis and prediction of neonatal sepsis [5]. Several
metabolic pathways may be altered in neonatal sepsis, including
those involved in the acute phase response, hypoxia, oxidative
stress, energy supply. In a recent study on urine of septic new-
borns, we found a significant increase of glucose, lactate and
acetate as well as a significant decrease of tamarind 4-Hydroxy-
benzoic acid (THBA), ribitol, ribonic acid and citrate [6]. Metabolo-
mics seems to promise impressive improvements in managing
sepsis by characterizing human from microbial metabolites (Ro-
setta Stone of microbiomics), by monitoring the effectiveness and
the toxicity of the antibiotic treatment and by predicting clinical
outcomes [7].
References
1. Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S.
Recognizing sepsis as a global health priority- a WHO resolution. N Engl J
Med. 2017;377:414-17.
2. Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Rein-
hart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a
systematic review. Lancet Respir Med. 2018;6:223-30.
3. Iroh Tam PY, Bendel CM. Diagnostics for neonatal sepsis: current
approaches and future directions. Pediatr Res. 2017;82:574-83.
4. Bellos I, Fitrou G, Pergialiotis V, Thomakos N, Perrea DN, Daskalakis G. The
diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis. Eur J
Pediatr. 2018;177:625-32.
5. Eckerle M, Ambroggio L, Puskarich MA, Winston B, Jones AE, Standiford
TJ, et al. Metabolomics as a driver in advancing precision medicine in
sepsis. Pharmacotherapy. 2017;37:1023-32.
6. Fanos V, Caboni P, Corsello G, Stronati M, Gazzolo D, Noto A, et al.
Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset
neonatal sepsis. Early Hum Dev. 2014;90 Suppl 1:S78-83.
7. Fattuoni C, Pietrasanta C, Pugni L, Ronchi A, Palmas F, Barberini L, et al.
Urinary metabolomic analysis to identify preterm neonates exposed to
histological chorioamnionitis: A pilot study. PLoS One. 2017;12:e0189120.A60
A baby with neurological, endocrine and feeding disorders:
management issues
Daniela Fava1, Flavia Napoli2, Natascia Di Iorgi 1, 2, Anna Elsa Maria
Allegri2, Mohamad Maghnie 1, 2
1 Università degli Studi di Genova, Genoa, Italy; 2 Clinica Pediatrica,
IRCCS Istituto Giannina Gaslini, Genoa, Italy
Correspondence: Daniela Fava (galanti.fava@gmail.com)
Italian Journal of Pediatrics 2019, 45(Suppl 3):A60
Case report
A 3-month-old male with progressive obesity was referred for in-
vestigations. On admission, he presented apparent febrile seizuresand cushingoid features. He was then transferred to the ICU depart-
ment because of a refractory Status Epilepticus. The patient was
born full term by c-section because of failure to progress. At birth
he presented a poor Apgar scores and umbilical artery acidosis re-
quiring intubation. He was passively cooled for 72 hours. Hormonal
testing showed ACTH and TSH deficiencies which have been ad-
equately replaced. On ICU admission, he was stabilized with intra-
venous antiepileptic drugs and transferred to the neurology
department: clinical examination, EEG and MRI were suggestive of
severe and prolonged hypoxic-ischemic encephalopathy. Altered
thermoregulation and hypothermia were reported; RBCs and albu-
min were transfused due to anemia and hypoalbuminemia. Since
his Status Epilepticus he presented dysphagia and a nasal enteral
tube was placed for feeding. The care of the critically ill infant was
further complicated by severe hypernatremia and hypokalemia: the
baby was transferred to our endocrinology department. After
neurological and gastroenterological evaluationsi, t was decided to
perform a gastrostomy for enteral feeding in order to prevent aspir-
ation pneumonia, dehydration and malnutrition and to make it eas-
ier to manage the child at home. The parents, who initially
disagreed with the gastrostomy procedure, gave their consensus
after an extensive discussion. Positive aspects: Child's parents were
young, with a medium-high level of education, well integrated into
the social context and belonged to a large family with great possi-
bility of being supported from relatives and friends. Parents trusted
medical staff. The baby had no other vital organ involved except
the brain, had a good response to medical therapies and no situa-
tions occurred requiring cardio pulmonary resuscitation. Negative
aspects: Case management from three different departments.; No
psychological assistance for parents and staff; Lack of directives on
what to do in case of emergency; Communication difficulties.
Conclusions
Communication is time for care.
Outline simple goals: one problem at a time in the present, medium
and long-term.
Facilitate a quick and easy return home by: 1) shared-decision mak-
ing involving the parents into an education program on managing
the child; 2) activating a multidisciplinary care pathway, including the
pediatrician and local health services.
Informed consent to publish has been obtained from the parents
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Background
Osteopathy is a manual therapy based on the evaluation and soft
mobilizations of the musculeskeletal and fascial systems, based on
the following principles:
– Structure and function are related and interdependents
– The whole body is a dynamic unit of function
– The body has an inherent therapeutic potency by itself [1].
Dr. Still is the founder of osteopathic medicine. The application in
children is due to the work and dedication of Dr. Viola M. Frymann
(1921-2016), physician, founder of the Osteopathic Center for Chil-
dren in San Diego (California) and international reference point for
neonatal and pediatric osteopathy [2-3].
The main reasons for consultation are musculoskeletal and postural
problems, disorders related to development, and gastrointestinal
functional disorders. Osteopathic approach have a potential role also
in prevention, integrated into primary care. It could be considered
also for children with neurological problems as complementary treat-
ment in the rehabilitative program. [4-8] Pediatric osteopathy require
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 29 of 64specific competences and training and is considered safe for chil-
dren. [9]
Materials and Methods
Since 2010 osteopathy is included in a program of Early Intervention
in the Service of “Neurodevelopmental Follow up" in Desenzano del
Garda Hospital (Italy). The Service is dedicated to newborns at risk
for developmental disorders and offer a program of early interven-
tion [10-14]. This program consists of:
– Pediatric and neurological examination
– Osteopathic evaluation and treatment, performed by physicians
with experience in traditional pediatric osteopathy, following
teachings of Doctor Viola M. Frymann
– Home program to promote development involving parents to
create stimulating environment, improve relationship and support
motor and sensory development, according with recent knowledge
about child development and brain maturation. [15-18]
Results
During 8 years of experience, the Service take care of 530 newborn,
referred from Neonatology Department and Territorial Services. Mean
age at the first evaluation is 2 months.
Children present following conditions: prematurity, dystocial or hypoxic
birth, postural and orthopedic disorders, congenital syndromes and
neurological problems, gastrointestinal functional disorders. When ne-
cessary medical advice from other specialists is requested, in a multidis-
ciplinary perspective. The proposed integrated approach is helpful in
many aspects: postural setting, motor behavior, neuromotor develop-
ment, gastrointestinal functions, infant-parent relationship.
Families accepted the proposed follow up program. No child had
any adverse effects.
Conclusions
Our experience encourages to explore the potential of osteopathy in
neonatal and pediatric care. The integrated osteopathic approach
could be considered a model of early intervention to promote devel-
opment in newborn at risk.
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Background
One out of three children with epilepsy is drug-resistant. Children
with drug-resistant epilepsy must undergo timely and thorough in-
vestigations to assess eligibility for epilepsy surgery. Subtraction ictal-
SPECT co-registered to MRI (SISCOM) is a promising imaging tech-
nique that has been used in the recent years for the localization of
the epileptogenic zone (EZ) in adults. We aimed to determine its
feasibility and efficacy in children who are candidate for resective
epilepsy surgery.
Methods
We retrospectively analysed all pediatric patients (≤16 years old) with
drug-resistant epilepsy that had entered the screening protocol for
epilepsy surgery in the University Hospital of Leuven (Belgium), from
2009 to 2018. Fifty-one SISCOM in 44 patients (24 males and 20 fe-
males) were included. Mean age was 9 years. SISCOM results were
matched with the localization of the EZ as determined by seizure
semiology and video-EEG, and compared to traditional imaging tech-
niques. Results
SISCOM was feasible in terms of chronic medication manage-
ment, need for rescue antiepileptic therapy during hospitalization
and need for procedural sedation, even in very young children.
Major quality outcomes in terms of operative timings were satis-
fied: 1) radiotracer injection occurred within 30 seconds from
seizure onset in 91.4% of the patients; 2) ictal SPECT was per-
formed within two hours from injection in all patients (mean: 40
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 30 of 64minutes). SISCOM localized the EZ in 51%, and additionally latera-
lized the EZ in 17.6%, achieving significantly better results than
ictal-SPECT, PET and MRI. SISCOM successfully localized the EZ
even in 25% patients with non-informative video-EEG and in
27.8% with negative MRI. Of the 16 patients (36.4%) finally se-
lected for surgery, 87.5% were seizure-free at 12 months (vs
29.6% of those who were not operated). Overall, a localizing SIS-
COM was associated with a good final outcome (Engel I-II) in
75% of the patients.
Conclusion
SISCOM is feasible in children, and adds precious non-invasive pre-
surgical information with a potential prognostic value, especially
when the EZ cannot be localized by EEG and MRI.
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The aim of this work is to clarify the complex phenomenon of
motherhood at early age, analyzing the risk and protection fac-
tors of these new parents. The transition to the motherhood, in
the case of the adolescents or underage, seems to be a particu-
larly stressfull phenomenon because it conflicts with physical,
emotional, cognitive and social challenges which are typical of
this period of development. The phenomenon of motherhood at
early age is certainly characterized by greater vulnerability and is
related to pregnancy (obstetric complications and high risk of de-
pression), lifestyles that put the health of the fetus at risk (abuse
of substance, alcohol, drugs), increase job difficulties (parents less
present in moments of care), low levels of instruction, less social
support and unstable relationships. The children of the under-
aged mothers are at greater risk of development problems (such
as: prematurity, lower academic performance, greater socio-
emotional difficulties, behavioral problems) and also the mother-
child attachment is characterized by the risk of greater criticality:
a lower wealth of verbal communication, lower emotional close-
ness, punitive tendencies and devaluation of the cognitive skills
of little child. The attachment of these children to young mothers
is avoidant and disorganized, as a result of a limited availability
on the maternal emotional level. All these factors characterize the
new parental figures as high educational risk. Therefore, we are
in front of a social need that we cannot ignore, but a global
take-over of motherhood in the adolescence becomes necessary,
considering the cognitive, emotional, relational and social aspects
of the future mother. In this perspective, it will be useful pre-
sented to you an experimental protocol being implemented at
the Complex Neonatal and Neonatal Intensive Care Unit of
Taranto.
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Monitoring is repeated or continuous observations or measure-
ments of the patient, his or her physiological function, and the
function of life support equipment, for the purpose of guiding
management decisions, including when to make therapeuticinterventions, and assessment of those interventions. The earliest
acquisition of physiological data date back to 1625 when San-
torio, who lived in Venice at the time, published his methods for
measuring body temperature with the spirit thermometer and for
timing the pulse rate with a pulsilogium, a device he created in-
spired by Galilei’s pendulum. Since then, things are keeping on
evolving. Nowadays, monitoring of vital signs is the most efficient
method for collecting accurate readings. Modern medicine relies
on these data, inserted in the clinical context, to make accurate
diagnosis, treatment planning, illness progression and follow-up.
Individual devices can be used to measure separate aspects of
the patient’s health, but combination monitors are most fre-
quently used, especially in critical-care situations when vital signs
can suddenly fluctuate. The most commonly required vital signs
are heart rate, pulse oximetry, blood pressure, respiratory rate,
temperature, electrocardiogram. Monitoring can be sequential (to
screen children’s illness or deterioration, measure success of treatment)
or more frequent and rigorous or even continuous (for children with
risk factors for deterioration, or for those undergoing high risk treat-
ments). In fact, in those cases in which vital signs can change quickly
and unexpectedly, continuous monitoring reduces the chances of
missed signals due to clinical teamwork overloads or sporadic variabil-
ity. Even outside the intensive care units, repeated measurement may
help early recognition of deterioration, improving morbidity and mor-
tality. For an effective management of clinical worsening in hospitalized
children, signs and symptoms of deterioration have to be recognized
by the ward staff; secondly, staff should be empowered to call
promptly for assistance which should be quickly available and appropri-
ately skilled and this response should improve the outcomes. The mon-
itoring of the vital signs is now part of routine clinical care and it is
essential, alongside with clinical features, because it contributes to early
warning scores designed to detect patients at higher risk of deterior-
ation and possibly resulting in a near or actual cardiopulmonary arrest
which may be preventable. This supports the idea that the quality of
clinical decisions depends in part on the quality of information avail-
able to the decision-maker.A65
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Non-diabetic Hyperglycemia (HY) is a pathological condition that
must be understood and probably not appropriately treated, al-
though is not due to a chronic insulinopenia nor to a chronic in-
sulin resistance. However, while long-lasting HY of diabetic
condition has been known that impacts immune defenses and
that is an important factor able to increase endothelial damage
and degenerative oxide-reduction processes, little is known about
the biological effects of non-diabetic and non-long-lasting HY, in
particular in pediatric age, and validated protocols to manage
this condition are completely lacking. Stress HY is usually defined
as HY>150 mg/dl in the course of physical stress, resolving spon-
taneously after dissipation of acute illness in patients without
known diabetes. Literature and clinical practice allow to design
two different situations: the first during severe and prolonged ill-
ness and during seriously threatening survival, mainly in emer-
gency conditions and in resuscitation departments; the second
during acute illness mainly non-threatening life. Furthermore non
diabetic-HY in pediatric age it is possible as Drugs-induced
Hyperglycemia: the most frequent conditions are secondary to
Steroid therapy or Antineoplastic/immune-suppressor therapy.
Fig. 1 (abstract A67). Ulcerations with central black scar and
erythematous halo on the buttocks and lower back of the patient
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Managing behavioural and psychiatric emergencies in developmental age
is one of the most challenging areas of practice for paediatric, emergency,
psychiatric, and child neuropsychiatric clinicians and is a very serious clinical
and organizational national concern. Although children and adolescent
present to the emergency evaluation for various reasons including psycho-
social problems, the most common are suicidality, psychosis, agitation, ag-
gressiveness, abuse, and eating disorders. The problem of increased access
of young people with psychiatric problems to Emergency Departments
(where processes and facilities may be limited, creating a suboptimal envir-
onment for their care) and more frequent admission to hospital wards, has
been repeatedly documented and is becoming a public health issue. In
fact, the World Health Organization estimates that by the year 2020, the
most prevalent causes of morbidity, and disability for children will be
neuropsychiatric disorders (1). The emergency room contact represents
one of the keys to address the problem and it is a critical link for continuity
of care for mental health needs. More integrated strategies for the child-
hood area combining early evaluation and multidisciplinary intervention
can be of increase benefit to individuals and to social contexts. Today the
current organization of mental health services is going towards these direc-
tion. Geographical variability in service provision has diminished over time:
in many regions substance misuse disorders and mental disorders in chil-
dren and adolescents are treated by specialist services which are part of
the Department of Mental Health with better integration among different
services. It is time to promote closer integration also with the rest of health-
care. Health agencies should pay particular attention to the psycho-physical
conditions of children and adolescents and adequate resources should be
allocated to mental health prevention, detection and intervention pro-
grams. Members of several Italian Scientific Associations (AcEMC, ACP, CNI
SPDC, SIEP, SIMEUP, SINPIA, SIP, SIP-DIP, SISISM, SITOX) have shared a docu-
ment with ten statements, with the aim of providing guidance to improve
the quality of care. Safety, legal issues, training and education, homoge-
neous care paths on the national territory, attention to care rights of a par-
ticularly vulnerable population, and efficient assessment of needs and
appropriate level of intervention required to professionals, are the main is-
sues described in the document.
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Background. Pyogenic granuloma is a common, benign lesion that
needs treatment because of its bleeding tendency. Local
cauterization with silver nitrate represents a relatively easy and cheap
procedure and can be performed in the office. Although generally
safe, silver-containing products can cause several cutaneous and sys-
temic complications such as chemical perilesional burns and argyria.
Moreover topical silver nitrate treatment carries the risk of chemical
burns also in unaffected skin when not used properly.
Case Report. A nine-year-old girl was referred for a few-days history
of discrete, well defined multiple superficial erosions symmetrically
distributed on her buttocks. The lesions had firstly started as pitted
erosions, progressively surmounted by blackish necrotic crusts. The
patient was born in Italy at 40+2 weeks of gestation via vaginal deliv-
ery. Her perinatal history was complicated by maternalchorioamnionitis and perinatal asphyxia, which required admission in
neonatal intensive care unit and resulted in hypoxic-ischemic en-
cephalopathy. Her medical history was characterized by seizures,
spastic tetraparesis, visual disturbances, and alimentary difficulties,
which required gastrostomy. On clinical examination we appreci-
ated multiple, millimetric (1-2 mm of diameter) ulcerations with
central black scar and erythematous halo located mainly on the
right buttock but also scattered on the left buttock and lower
right back (figure 1). Between the ulcers we observed brownish
striae (figure 2) and at the site of gastrostomy we noted also a
residual of pyogenic granuloma treated with silver nitrate pencils
(figure 3). By recording accurately the anamnestic data, the cor-
relation between the gluteal erosions and the treatment of pyo-
genic granuloma was suggested by black stain of the skin due to
the past use of silver nitrate. This data allowed us to make our
diagnosis of silver nitrate burns, which were probably caused by
pulverized medication fallen on examination table during the
treatment of granuloma, and exclude other diagnoses such as
herpes simplex virus infection and Langerhans cell histiocytosis.
Conclusion. As a general rule, it is crucial to make a comprehensive
anamnesis and physical examination. This is particularly true ap-
proaching complex patients as in this case, when a detail could allow
us to make the proper diagnosis without requesting further analyses
or fears of more serious etiologies like abuse.
Consent to publish
Informed consent to publish has been obtained from this patient’s
parents.
Fig. 2 (abstract A67). Brownish striae (black arrowheads)
Fig. 3 (abstract A67). Pyogenic granuloma at the site
of gastrotomy
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In the context of health assistance of newly arrived migrant minors,
medical examination has an important role and requires a special at-
tention; a careful and modulated physical examination is essential toevaluate health condition of migrant children not only to make a
diagnosis but even to prevent other pathologies and to promote fu-
ture well-being. During medical examination different typologies of
migrant should be considered such as adopted children, unaccom-
panied minors, often adolescent boys and girls, children arrived with
family in different ways, by sea, by land or immigrated after a long
separation period from his parents, sons of asylum seekers, and
“tourist migrants” , children coming back from countries of origin of
their parents where they spent an holiday period; it is also necessary
to consider the socio-cultural context where they lived and they
grew up and geographical areas from which they come. Medical
examination starts with a general evaluation which includes the as-
sessment of vital signs: body temperature, pulse rate, breath rate,
blood, pressure, hydration (dehydration signs and symptoms), weight
and height (using the WHO Child Growth Standards) and the assess-
ment of nutritional status; it goes on with an examination by system,
giving particular consideration to important signs that should be de-
tected and relative diagnostic hypothesis. A special attention is paid
to pathologies which are more frequent in children coming from cer-
tain geographical areas, to journey related diseases, to signs of suf-
fered violence and abuse, to aspects related to the culture of origin
of the child, like results of ritual practices and of traditional medicine.
With relation to skin examination, characteristics and peculiarities of
dark skin have been stressed such as the diagnostic difficulties that
can be experienced. Medical examination includes hearing, vision
and oral health assessment, neurological, psychomotor and cognitive
assessment, speech and language assessment, essential to highlight
post traumatic symptoms related to separation, Ill-treatment, experi-
enced or witnessed violence.
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The Quaderni ACP is a bi-monthly magazine published by the
Pediatric Cultural Association (ACP). The target is represented by the
non-super-specialized territorial and hospital pediatrician. The maga-
zine is indexed in Google Scholar and is sent to ACP members in a
paper format, while the online version (http://www.quaderniacp.it) is
in open access.
Quaderni ACP does not host advertising and is entirely financed by
the ACP. It was founded 25 years ago from the merger of “Quaderni”
and “Teaching Aids”. Great attention is paid to health policy and
pediatrician training. In the past seven years the magazine has acti-
vated a distance learning (FAD) based on skills training and with
each dossier integrated with educational cases. This mode allows to
switch from knowledge to skills. Each edition provides 18 ECM
credits with a sponsor free high quality training and low costs. The
path of the articles submitted to the journal is based on a peer re-
view with internal and external referrals to the editorial staff. A spe-
cial form is used to help the reviewer in his report. The articles, if
necessary, are sent back to the authors with comments for
optimization or possible re-presentation. The articulation of the
magazine is based on fixed columns that host contributions from
various authors not only in the pediatric area, but also in other fields
of knowledge (psychological, pedagogical). Quaderni has also a part
dedicated to medical humanities (books, films), often overlooked in
pediatric education. In the last two years the magazine has been
enriched with the “Electronic Pages” that host the ACP pediatric
newsletters (critical reading of articles of main international scientific
journals selected by specially trained groups), a section dedicated to
the environment and child health and a third section that hosts doc-
uments relevant in the area of public health with expert comments.
The aim of the magazine is to create a professional who is attentive
to complexity. There is also a careful look at the young pediatricians
in training who are hosted with their abstracts both at the national
ACP congress and at the yearly Tabiano / Parma congress. The edi-
torial staff works mainly online and with face to face meetings at
least twice a year in order to share the editorial line which is
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working allows a continuous growth of the group of editors through
both a real comparison and a particular attention to the reader.
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Background
Providing future nurses with professional knowledge is an ambitious
and challenging task. Scientific knowledge changes quickly, techno-
logical innovations provide several possibilities. New skills and cap-
acities are required by student nurses in the modern era. Education
has to take into account these factors. Assessment is an important
part of the educational process. This could be supported by modern
technology. New technologies have the potential to give students
the opportunity to show their practical skills and knowledge. Game-
based assessment could provide such opportunity.
Materials and methods
The free game-based learning platform Kahoot! was used to assess
knowledge for four nursing practical sessions planned for the first-
year nursing degree. At the end of the four sessions, students were
asked to evaluate the new assessment method. Data was collected
from an anonymous web survey and the participation was on volun-
tary basis administered. The questionnaire investigated students’
opinions and feelings about multimedial assessment tools and the
Kahoot! experience. Ethics Committee approval was obtained for this
study.
Results
Forty students were involved in the present study and 93% of them
positively evaluated the multimedial tool to assess: knowledge (97%);
capacity (84%) and to clarify doubts (92%). 96% of students evalu-
ated Kahoot! as an easy tool to use. The competitive and playful na-
ture of the test was positively evaluated. Overall, students evaluated
their Kahoot! experience positively at 92% and their multimedial as-
sessment experience at 96%.
Conclusions
Assessment could become an opportunity to express and further de-
velop personal skills. Interactive game-based assessment could be a
method in order to offer this kind of opportunity to students. Feed-
back from the first-year nursing students was positive in our experi-
ence. Multimedial and game-based assessment should be considered
an interesting method to explore. Possibilities to use modern tech-
nologies to develop and assess skills for future nurses should be fur-
ther investigated.
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Background
Health Promotion, a concept codified in 1986 by the Ottawa Charter
and defined by the WHO process that allows people to exercise
greater control over their health and improve it, constitutes the
current reference document for the development of health-oriented
and identifies policies and identifies in the school the privileged
gravitational area in which to send educational messages. The Minis-
try of Public Education promotes health education in carrying out
educational activities in a network with Local Health Authorities,
whose mission is to promote health in integration with schools.Materials and methods
Review of health education projects in schools (years 2017-2019) of 2
Health Centers: ASL Salerno and A.S.Re.M.
Results
Both the projects examined are essentially based on: the drafting of
a catalog of health education projects as a training offer addressed
to schools; programming linked to indications from the Ministry of
Health and Regional Prevention Plans; projects related to general ob-
jectives and quantitative indicators; target recognized in students of
schools participating in the offer; financing deriving from the funds
for prevention. The catalogs examined do not show: projects shared
with schools; identification of specific territorial needs; final objec-
tives; outcome indicators; cost/benefit analysis; no-responder schools
recovery actions; time management; estimation of sustainability; pub-
lication of the results.
Conclusion
The National Health System, characterized by defined resources, as-
signs 5% of the Health Fund to prevention. Sector studies indicate
the quality of assistance linked to the evaluation of the results of the
interventions produced. It is therefore essential for the maintenance
of health education projects, environmental determinants able to
have a positive impact on the implementation area, to improve the
programming and reporting system. In line with the document "Inte-
grated policy guidelines for the school that promotes health" (State-
Regions Conference of 17 January 2019) aimed at the inclusion in
the educational curriculum of school students of all levels of health
promotion as an educational proposal continuous and integrated
throughout the schooling, it would be appropriate for the Healthcare
Authorities to re-qualify the methodological approach to the
provision of health promotion services in schools: activating in the
planning phase the management by objectives which suggests ex-
pected characteristics for the prefixed objective to be specific, meas-
urable, achievable, relevant, timely, implementing reporting based
on cost/ benefit analysis demonstrating equity, efficiency during the
reporting phase and sustainability of the intervention and dissemin-
ating the results obtained to contribute to evidence-based medicine.
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The World Health Organization (WHO) defines obesity as ‘globesity’:
a chronic disease so widespread to be a global epidemic. In our
country, 44% of Italians are overweight. Around 5 millions of people
(10%) are obese and 34% of them have bariatric complications.
However, the identification of obesity as disease is recent: in
medieval Europe, fat was a sign of wealth, prestige, power and often
beauty. It is from the second half of the 19th-century that it becomes
object of medical attention. The Paleolithic is famous for artistic stat-
uettes with “steatopygic” shapes, symbol of fertility. When the food
was poorly available, as in times of famine, only fat women were able
to conceive and to complete the pregnancy. From the Neolithic, men
are hunters as well as breeders and farmers. The forms become thin-
ner and with graceful contours. In ancient Egypt, Pharaohs wives,
ideal figure of beauty, are thin with round hips and breasts. In
Roman times, the forms become wide and pale. From the Greek
Venus to the Junoesque Roman beauties, from the refined Renais-
sance women to the 17th-century, to Michelangelo's cherubs, expres-
sive models of epochs so distant in space and time have in common
the same round lines of a body that nowadays we would define
“fat”.
The Greeks were the first to recognize obesity as a health disorder.
Hippocrates wrote “corpulence is not just a disease in itself but omen
of other diseases”; therefore, obesity’s several secondary pathologies
were already known. The Indian surgeon Susruta linked obesity to
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cise as measure of prevention. In “De medicina”, Aulo Cornelio Celso
wrote “obese are mostly strangled by acute diseases and difficulty in
breathing. The Medical School of Salerno in the Regimen prescribes
“If you want to live healthy and without ills, avoid worries, beware of
anger, drink and eat, but little.” However, it is only after World War II
that the binomial “roundness-beauty” is replaced by “thinness-
beauty” and the press published “Nature or Nurture?” to point out
the role of the genetics, but just think of the natural example of
identical twins, the lifestyle habit, and the most recent studies on
leptins and gremlins… Therefore, if the hereditary component ac-
counts for the 5%, it should not be an alibi to give up the very capil-
lary prevention programs able to significantly reduce the size of the
problem, with also good economic effects.A73
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Introduction
Retrospective, observational, descriptive study of 59 patients admit-
ted to the Intensive Care Unit of Hospital Nacional de Niños from Au-
gust 1st to September 15th, 2014 to determine the prevalence of the
lower tract infections that require intensive care admission, etiology,
risk factors, clinical presentation and treatment.
Materials and methods
In the study were included all the patients between 0 and 13 years
who were admitted to the Intensive Care Unit during the period de-
termined with bronchiolitis or pneumonia diagnosis. For the statis-
tical analysis, frequencies were calculated with the respective
confidence interval for all the quantitative categorical variables and
the central tendency measures for qualitative variables.
Results
RSV was isolated in the immunofluorescence assay in 74% of the pa-
tients. Prematurity and passive smoking were the risk factors most
frequently found. Cough and tachypnea were the main clinical symp-
toms. Mechanical ventilation was required by 71% of the patients.
Conclusions
The prevalence of lower respiratory tract infection at the Intensive
Care Unit at Hospital Nacional de Niños “Dr. Carlos Sáenz Herrea”
during the study period was 60% which demonstrate the important
burden this condition represents in the pediatric population of Costa
Rica, especially in infants.
Antibiotics were prescribed in 95% of patients. These findings have
already been documented by Ferone et al and Alhuarby et al 1,2. The
respiratory syncytial virus was the most prevalent viral agent 3-6 .
More diagnostic tools are required to guide the antibiotic treatment
on this population.
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Cervical cancer is the fourth most common malignancy worldwide.
HPV infection is related to:
– cervical, vaginal, and vulvar cancers
– penile cancers
– oropharyngeal and anal cancers as well as genital warts
The majority of HPV-associated cancers are caused by HPV 16 and 18 [2].
Cancer primary prevention is based on virus avoidance: vaccination
is recommended to prevent HPV infections and related diseases
[http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allega-
to.pdf] [1]. Currently a 9-valente vaccine (including HPV 16 and
HPV 18) was available for use in girls, women, boys and men. For
people who have been adequately vaccinated with 2vHPV or
4vHPV, there is no recommendation regarding additional vaccin-
ation with 9vHPV [https://www.acog.org/Clinical-Guidance-and-
Publications/Practice-Advisories/FDA-Approval-of-9-valent-HPV-Vac-
cine-for-Use-in-Women-and-Men-Age-27-45?IsMobileSet=false]. Pe-
diatricians are mainly and strongly involved in HPV primary
prevention to protect against cancers caused by these viruses:
the vaccine is most effective when given at younger ages. Rou-
tine vaccination is recommended at 11 or 12 y.o., with two doses
and over 15 y.o. with three doses. If the vaccination schedule is
interrupted, the series does not need to be restarted [https://
www.acog.org/Clinical-Guidance-and-Publications/Practice-Advi-
sories/FDA-Approval-of-9-valent-HPV-Vaccine-for-Use-in-Women-
and-Men-Age-27-45?IsMobileSet=false][1]. ACIP recommends vac-
cination with 3 doses for people aged 9 through 26 years with
immunocompromising conditions because immune response to
vaccination might be attenuated[1] [https://www.acog.org/Clinical-
Guidance-and-Publications/Practice-Advisories/FDA-Approval-of-9-
valent-HPV-Vaccine-for-Use-in-Women-and-Men-Age-27-45?IsMobi-
leSet=false]. Vaccine side effects with HPV include similar profiles
with other vaccines: mild pain at injection site, bruising, faintness
and syncope from a vasovagal response. In case of inadverted
administration in pregnancy, no teratological risk are reported [4].
In countries where HPV vaccination programmes have been intro-
duced, decrease in cancer rates is speculated. In Australia, the first
country to establish an HPV vaccination programme in 2007 (more
than 70% vaccine coverage in girls and boys aged 12 and 13 years),
38% reduction in highgrade cervical dysplasia was revealed [4]. What
are the barriers to HPV vaccination? We can identify four parental
vaccine hesitancy or refusal:
– about 10% lack of knowledge
– about 20% of parents consider vaccine unnecessary for their
adolescent
– about 8% of parents belief that adolescent wasn’t sexually
active
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adverse reactions
There is no evidence that demonstrates increased sexual risk behav-
iors in vaccinated adolescents despite parental fear is that the ado-
lescent would become sexually active once the HPV vaccination was
completed [3-4]. Collaborating with parents and the healthcare team,
providers can provide patient centered health promotion care that
will decrease risks of cancer in the future [4].
Increasing vaccination rates for HPV should be a priority for all
healthcare providers who work with adolescents.
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One of the most important dates in the history of Medical Genet-
ics and perhaps of the human race is represented by Tuesday 27
June of the year 2000. On that date, in fact, the prestigious
newspaper "The new York Times" published on the front page
and on all the columns available an article titled: "Genetic Code
of Human Life is cracked by scientists". This date, in my opinion,
marks the end of the Mendelian era and the beginning of what
we can say " genomic and post-genomic era". Before the onset
of the new century, the study of Mendelian diseases had moved
very slowly and this was because the technologies to discover
the chromosomal location / localization of the genes and their
sequences were extremely long. This made it possible to ask and
solve only one question at a time and for this reason the causa-
tive mutation was identified and an attempt was made to explain
the relationship between genotype and phenotype with it. Today
Next-generation sequencing (NGS) is a high-throughput method-
ology that enables rapid sequencing of the base pairs in DNA or
RNA samples. Supporting a broad range of applications, including
gene expression profiling, chromosome counting, detection of
epigenetic changes, and molecular analysis, NGS is driving discov-
ery and enabling the future of personalized medicine. To date,
the major current application of next generation sequencing
(NGS) in diagnostics is through disease-targeted tests for which
multiple causal genes are known. Some studies have already
demonstrated the utility of targeted-NGS (t-NGS) approach in the
study of specific subtypes of inherited condition patients. Here,
we described the diagnostic workflow based on t-NGS that we
developed for the diagnosis of patients affected by Hemolytic
anemias as an example of inherited diseases. In conclusion Next-
generation high throughput sequencing technologies have be-
come available in the last few years and are in continuous devel-
opment and improvement. They have been widely used in many
projects, e.g., whole genome sequencing, metagenomics, small
RNA discovery and RNA sequencing. Their common feature is the
extremely high throughput data generation. As a result, new is-
sues have to be addressed in order to exploit the full potential
of these new instruments: firstly, the data analysis step hasbecome very time consuming and requires a competent amount
of manpower and expertise in bioinformatics; secondly, adequate
computing resources are necessary to handle the data produced.
Last point to address is that is required a continuous between
bioinformatics experts and clinicians to finalize the diagnosis.
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Background
Trauma-related osteomyelitis are uncommon in children, but poten-
tially devastating. The diagnosis of infection is based on a combin-
ation of clinical examination, laboratory data, plain radiography,
advanced imaging (CT, MRI or bone scintigraphy) and microbiological
culture (wound swabs and/or tissue specimen) or molecular diagno-
sis [1, 2]. Current culture-based diagnostic techniques are poor pre-
dictors of infecting organisms because bacteria cannot be identified
using standard culture techniques [1]. Among bacterial pathogens re-
sponsible of osteomyelitis following trauma and/or surgical fixation,
the most frequent is Staphylococcus aureus, including MRSA [3,4].
Aim of our work is to determinate clinical and microbiological char-
acteristics of our pediatric cases with post-traumatic osteomyelitis of
extremity fractures.
Material and Methods
We retrospectively analyzed the cases of 14 children [Table 1] who
developed osteomyelitis after surgical treatment of a fracture. The
median age was 9.6 years (range 3.7 – 16.3 years). The mean period
of recovery was 40.2 days (range 7 – 143 days).
Results
The most frequent localization of bone fractures and subsequent in-
fection were femur (28%), tibia/fibula (28%), ulna/radio (28%), hu-
merus/elbow (14%), pelvic girdle and metatarsal bones. At admission
the mean value of inflammatory index were: ERS 40.8 mm/ h (range
5 – 100 mm/h), CRP 6.85 mg/dl (range 0 – 34.65 mg/dl), WC 8932
mm3 (range 5800 – 16080 mm3). The most frequently identified
pathogens were Staphylococcus aureus (36 %), in one case MRSA, K.
pneumoniae, Pseudomonas aeruginosa, Enterobacter cloacae. In most
cases (43%) no germ was isolated. The most used antibiotics were
ceftriaxone (36 %), rifampicin (36 %), meropenem (29 %), linezolid
(21%), amoxicillin (14%) and vancomycin (14 %). Ciprofloxacin was
largely used (57 %), mainly in the outpatient setting. The mean
period of antibiotic therapy was 5.8 weeks (range 3 – 12 weeks). Half
the patients (50 %) were treated with Kirschner wires and/or external
fixation. Four patients (28%) underwent more than two surgical ap-
proaches. Three patients (22 %) were dismissed with permanent se-
quelae. No deaths were registered.
Conclusions
Osteoarticular infections in children may be a severe complication of
any surgical intervention on a fractured bone. The mean
hospitalization period is often prolonged according to the long-term
therapy and recurrent surgical approach [1,4]. Molecular diagnostics
usually identifies bacteria that are not detected by standard micro-
biological cultures and allows to set a more appropriate antibiotic
therapy [5]. In our experience, a proper multidisciplinary manage-
ment is crucial to prevent sequelae, mainly chronic infections and
disturbances of bone growth. Nonetheless, further studies in a
pediatric population are required in order to delineate the optimal
management of surgery-associated osteomyelitis.
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Pathogen Site Sequele *K-
wire
1 11,2 M 21 39 P.
aeruginosa
femur no yes
2 11,7 M 8 26 K.
pneumoniae
femur no yes
3 5,2 M 60 28 ND tibia no no
4 16,3 M 5 21 S. aureus astragalus no no
5 6,4 M 15 50 E. cloacae femur no no





7 15,2 M 5 15 ND femur no no
8 8,5 M 51 67 S. aureus
MSSA
humerus no no





10 12 F 3 20 ND radius no yes
11 6 M 8 8 ND fibula no no
12 8,5 M 88 143 S. aureus
MSSA
humerus yes yes
13 6,3 F 32 31 ND radius no yes
14 12 M 2 7 ND fibula no no
* K-wire = Kirschner wire and/or external fixationA77
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Background
Foreign children have become over time a relevant fraction of the
EU and non-EU resident population (20,2%) in Italy. Between 2014
and 2018, 92.366 migrant minors arrived in Italy, 70.499 (76,3%) were
unaccompanied by a caregiver. Following the changes that have
characterized migrant paediatric population, these children face par-
ticular risks, including being exposed to discrimination and
marginalization.
Materials and Methods
Several protocols concerning health care interventions for migrant
children have been redefined from time to time, according toemerging issues, by the National Working Group for Migrant Children
(GLNBM – SIP, http://www.glnbi.org, http://www.sip.it).
Results
Between 2016 and 2018, the GLNBM was panel member of the
National Giudelines Program concerning the screening for com-
municable and non-communicable diseases among migrants at
the border and in the welcome centres [1]. In the meantime,
international guidances and reports on refugee and migrant
health were recently published [2,3,4]. Concerning all above, the
GLNBM SIP made the commitment to update the latest proce-
dures for the health-reception of migrant children drafted in
2013, in order to take into consideration current scientific evi-
dence to support paediatricians in the management of children
and young people with migrant background, avoiding any stan-
dardized approach as well as to focus attention on epidemio-
logical and infectious aspects without any real benefits in terms
of public health. A comprehensive individualized health assess-
ment by a well-trained pediatrician can identify health care needs
that might otherwise go undetected for prolonged periods of
time. In addition, the link of newly arrived migrant children and
their families with primary health care and specialist services, re-
duces costs. In this regard, according to the Convention on the
Rights of the Child (1989), Italy guarantees free foreign children’s
access to pediatric health services as well as their National
Healthcare System (NHS) registration, independently from legal
status of their parents [5].
Conclusions
A public health strategy to promote well-being and health in mi-
grant children should have a holistic framework, targeting risk
factors on individual, family and community levels. The particular
vulnerability of migrant minors, due to social fragility and inad-
equate reception, impose multisciplinary and transcultural ap-
proach, increasingly widespread. There is a need to improve
health professionals’ skills in culturally sensitive health education,
as well as culturally sensitive outreach programmes improve
awareness and uptake of services among migrant populations.
Eliminating barriers to access to healthcare and promoting pro-
tection of health of all people on the move, including those in ir-
regular status, needs to be prioritised [6].
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Recent studies on Internet use by minors show that 88% of Italian
children use it daily, a number that rises to 97% in the age range 15-
17 years and drops to 51% in the band 9-10 years [1]. The most
popular online activities among children are related to communica-
tion and entertainment, with an increasing tendency to privatize the
experience through smartphones. The 2017 figures show how teen-
agers of 9-17 years, without gender differences, spend, on average,
2.6 hours a day online [1].
It is now known that, despite the positive opportunities arising
from Internet development, an uncontrolled and excessive use
can lead to dependence and cause problems of physical, psycho-
logical and social health [2]. The web can be a dangerous tool
for children, as they don’t always understand its power; for in-
stance, due to their tendency to irresponsible behavior, adoles-
cence can easily engage in illegal and aggressive social
interactions without awareness of the consequences. There are
many other risks for minors connected to virtual navigation, be-
cause of its easy access and the space-time freedom it allows.
The consequences of uncontrolled Internet use are so serious
that it has led to the definition of a new type of dependence
called PIU “Problematic internet use”. Adolescents and young
adults are the subject most at risk [3]. Internet addiction has
been described as a comorbid for psychiatric depression, atten-
tion deficit/hyperactivity disorder, social phobia, anxiety and im-
pulse control disorders, and personality disorders. In Italy an
increasing phenomenon among young people, particularly adoles-
cents, is the "Hikikomori" syndrome, which identifies those who
isolate themselves from social life, locking up in their room and
refusing any direct contact with the external world. Hikikomori
no longer seems to be only a Japanese cultural syndrome, but a
social problem that affects all economically developed countries.
It has been estimated that in our country there are at least hun-
dred thousand cases [https://www.hikikomoriitalia.it/p/chi-sono-gli-
hikikomori.html]. It is therefore essential the stakeholder collabor-
ation to create a network, both to prevent and provide support
for minors and families who face these problems. In 2016 was
signed the "Protocollo D’Intesa", a memorandum between Police,
the Ministry of Education, the Emilia-Romagna Region and the
University of Bologna, about the conscious use of new technolo-
gies by young people and the prevention of cyberbullying [
http://istruzioneer.gov.it/wp-content/uploads/2018/03/def.pdf ].
This led to the creation of a listening point in the pediatric emer-
gency department of Sant'Orsola hospital, a center to inform but
also early identify and manage situations at risk.
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Severe asthma in childhood is a major public health problem and
burden to both patient and pediatrician. Despite the fact that con-
ventional treatment options for children with severe asthma are ex-
tremely limited, there are now some “revolutionary, and often life
changing, therapies” emerging for selected patients suffering with
severe asthma.
As our understanding of the underlying pathophysiology of the
asthma spectrum expands, a number of pathways have drawn atten-
tion and led to the development of new targeted interventions [1].
Among these, the pharmacological blockade of IgE represents a
novel successful strategy that has been applied to many different
therapeutic areas, whose severe asthma is one that had its greatest
development in the last 15 years [2]. Omalizumab, the first available
humanized monoclonal anti-IgE with pediatric indication (aged ≥ 6
years), is now recommended as add-on treatment for children with
severe allergic asthma. Binding to free IgE, omalizumab reduces cell-
bound IgE, down-regulates IgE receptors and prevents the release of
pro-inflammatory mediators [2]. The efficacy and safety of omalizu-
mab have been established by several randomized controlled trials
specifically conducted in pediatric patients [3]. Overall, omalizumab
was effective in reducing the rate of asthma exacerbations, the num-
ber of hospitalizations for acute asthma attacks and the related need
of oral corticosteroids in severe asthmatic children; these effects re-
sulted in better asthma control and improvement of quality of life of
children and their families [3]. Recent studies also reported a signifi-
cant decrease in the number of seasonal exacerbations triggered by
respiratory viruses in association with the restoration of antiviral de-
fenses (in particular type I interferon production) in treated subjects
[3]. A large amount of safety data showed that omalizumab is gener-
ally well-tolerated. The main side effects reported were local (pain at
the injection site, skin reactions) and with a short resolution; more-
over, there is no evidence to support an increased risk of malignancy
in patients treated with omalizumab [3]. Other biologic therapies
have provided new evidence of efficacy in the management of se-
vere asthma, such as anti-IL-5 and IL-4/13 monoclonal antibodies;
however, their efficacy and safety in children still needs to be sup-
ported by adequate research within the targeted age group [4]. The
approved biologics for pediatric severe asthma have emerged as im-
portant and effective treatments to improve asthma outcomes; they
are expensive therapies and require careful selection of suitable pa-
tients through identification of biomarkers in addition to clinical
need to justify prescribing.
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Obesity and its related health complications are a major health
concern worldwide. Obesity is also associated with and increased
mortality. Rarely, severe obesity in children can be the result of a
monogenic abnormality. Most of the genes involved belong to
the leptin/melanocortin pathway that controls food intake. Recent
studies have shown that some of these disorders can be success-
fully treated with recombinant leptin or with MC4R agonist drugs.
Other forms od severe obesity are part of complex developmen-
tal syndromes caused by monogenic disorders, imprinting defects
and other genetic and epigenetic alterations. There are more
than 20 rare syndromes associated with obesity, and most of
them present also with mental retardation. Exemples of these
syndromes are Prader-Willi syndrome, Bardet Biedl syndrome,
Alstrom syndrome, WAGR syndrome and others. However, the
large majority of forms of obesity are the result of a complex
interaction between predisposing genes and the environment.
More than 500 genetic loci have been associated with adiposity
traits. The function of most of these gene variants is unknown.
Some of them implicate pathways that act in the brain whereas
others are involved in pathways regulating adipocyte biology.
Some of these genes could be potential targets for the develop-
ment of anti-obesity drugs. Finally, recent research have shown
that obesity and its complications are associated with epigenetic
alterations. The implicated genes seem to play a role in the de-
velopment of obesity by controlling processes such as adipogene-
sis, inflammation, appetite and glucose tolerance. Epigenetic
modificatios also are involved in prenatal programming which ul-
timately results in predisposing the offspring.
Obesity and its related health complications are a major health
concern worldwide. Obesity is also associated with and increased
mortality. Rarely, severe obesity in children can be the result of a
monogenic abnormality. Most of the genes involved belong to
the leptin/melanocortin pathway that controls food intake. Recent
studies have shown that some of these disorders can be success-
fully treated with recombinant leptin or with MC4R agonist drugs.
Other forms od severe obesity are part of complex developmen-
tal syndromes caused by monogenic disorders, imprinting defects
and other genetic and epigenetic alterations. There are more
than 20 rare syndromes associated with obesity, and most of
them present also with mental retardation. Exemples of these
syndromes are Prader-Willi syndrome, Bardet Biedl syndrome,
Alstrom syndrome, WAGR syndrome and others. However, the
large majority of forms of obesity are the result of a complex
interaction between predisposing genes and the environment.
More than 500 genetic loci have been associated with adiposity
traits. The function of most of these gene variants is unknown.
Some of them implicate pathways that act in the brain whereas
others are involved in pathways regulating adipocyte biology.
Some of these genes could be potential targets for the develop-
ment of anti-obesity drugs. Finally, recent research have shown
that obesity and its complications are associated with epigenetic
alterations. The implicated genes seem to play a role in the de-
velopment of obesity by controlling processes such as adipogene-
sis, inflammation, appetite and glucose tolerance. Epigenetic
modificatios also are involved in prenatal programming which ul-
timately results in predisposing the offspring to the development
ov obesity.A81
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Electroencephalographic recording is routine in neonatal intensive
care units for the recognition of seizures, neurological monitoring of
the child with brain damage and, in the preterm infant, whose births
have increased.In newborns, epileptic seizures represent a neuro-
logical emergency that requires timely recognition, to determine the
etiology and treatment, as specific as possible. The problem is even
more complex when considering seizures in premature babies, where
the peculiarity of brain development can generate clinical and elec-
trographic crises with different characteristics at different times of
neuronal maturation. Carrasco [1] hypothesizes that in the extremely
preterm child the clinical and electrographic phenomenology of con-
vulsions reflects the specific pathophysiology of brain development
in that period of life. Newborns can present different types of convul-
sions: clonic, tonic, myoclonic (axial, focal, irregular), epileptic spasms
and thin crises, including autonomous signs or automatisms. The
main etiology is hypoxic-ischemic encephalopathy (about 45%) with
early crises and variable semiology, including all types of convulsions.
Stroke is associated with early-onset unilateral focal seizures and
interictal EEG is asymmetric, with focal or unilateral patterns. Other
etiologies are less often linked to epileptic seizures and must be
sought as brain infections, metabolic disorders, chromosomal abnor-
malities, innate metabolism errors, brain malformations and vitamin
B6 dependence [2]. Neonatal epileptic syndromes may present favor-
able prognosis (neonatal benign familial epilepsy) or unfavorable
(early infantile encephalopathy with epilepsy, early myoclonic en-
cephalopathy and partial migration in childhood) [3]. Knowledge of
neonatal EEG patterns is needed to correct recognize seizures and in-
terpretation of interictal brain activity.
The accuracy of the EEG background activity test recorded as an inte-
grated EEG in the amplitude or in the conventional EEG in the early
stages of the life of the preterm and the neonatal term [4] is desir-
able for the correct interpretation of the critical clinical picture, the
therapeutic choice and of the neurological development outcome.
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In addition to hereditary factors, eugnatic growth depends largely on
the existence of both a static and dynamic balance of all the orofa-
cial musculature. As expressed in Moss's theory of the functional
matrix, there is a relationship of mutual influence between form and
function, according to which the changes in size, shape and position
of each craniofacial skeletal component are modulated by the re-
spective functional matrices which perform the specific functions of
swallowing, breathing, chewing, and phonation. Mouth breathing
plays a central role in the development of malocclusion in the
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 39 of 64pediatric age as it interferes with the functional growth of the upper
jaw, whose reduced growth will be correlated not only to a trans-
verse growth deficiency of the nasal cavities, induced by a reduced
airflow from obstruction of the upper airways, due for example to
the presence of allergic rhinitis, but also from the postural changes
of the intraoral soft tissues, as it happens for the tongue that, by as-
suming a low position at the level of the oral floor, will no longer
perform its role of functional matrix of the palate, thus contributing
to a transverse growth deficit of the latter. These positional modifica-
tions of the soft and structural tissues of the skeletal segments con-
tribute to the pathognomonic definition of both the extra and
intraoral aspect of the mouth breathing child. Therefore, allergic rhin-
itis is one of the main causes of malocclusions in the pediatric age,
contributing with a significant threefold increase of the risk. It is esti-
mated that in Italy the prevalence of allergic rhinitis for subjects in
the age range from 6 to 14 is 33-35%, with an incidence that in the
last five years showed an increase of 5%. Pathognomonic clinical
signs define the typical adenoid facies, characterized by accentuated
dark circles, narrow nostrils, and labial incompetence. Associated
dentoalveolar alterations are a transversal hypodevelopment of the
maxilla, anterior openbite, increased overjet, and marginal gingivitis,
typically correlated to the lack of humidification of this soft tissue. In
light of the above, although numerous epidemiological studies show
that allergic pathologies are significantly increasing in the pediatric
population, many of the malocclusal conditions associated to airway
obstruction can be resolved by means of interceptive orthodontic
therapies, aimed at preventing the onset of more serious dentoskele-
tal alterations. In this sense, the role played by the pediatrician is fun-
damental in identifying occlusal alterations and in making parents
aware of the need of a preventive dental examination.A83
Biologic therapy in pediatric chronic non-infectious uveitis
Ilaria Maccora, Gabriele Simonini
SODc di Reumatologia, AOU ANNA MEYER, Dipartimento NEUROFARBA,
Università degli Studi di Firenze, Italia
Correspondence: Gabriele Simonini (Gabriele.simonini@unifi.it)
Italian Journal of Pediatrics 2019, 45(Suppl 3):A83
Uveitis is a broad term for inflammation involving the eye, the esti-
mated prevalence in the pediatric age is 31 per 100,000 patients of
whom the 21% are associated to Juvenile Idiopathic Arthritis (JIA).
Chronic pediatric uveitis can be a complex therapeutic challenge,
that if not appropriate, can lead to significant visual impairment and
blindness without treatment. Unfortunately, there are no standard-
ized treatment protocols for pediatric non-infectious uveitis; recently,
the SHARE initiative has given us recommendation for the diagnosis,
screening, treatment and management of uveitis associated to JIA.
There is agreement for the first-line therapy with topical corticoste-
roids, although systemic corticosteroids are used in more severe
cases. In children with severe and refractory uveitis, disease-
modifying antirheumatic drugs (DMARDS) and biologic agent have a
pivotal role in order to achieve remission and minimize corticosteroid
side effects. Methotrexate is usually the first line-steroid-sparing
agent, whilst anti-tumor necrosis factor-α (anti-TNFα) agents, as adali-
mumab and infliximab are currently used as second line agents, in
case of failure. Anti-TNFα may be used as first-line treatment in those
patients with a severe and complicated disease presentation. How-
ever, it has been shown a higher probability of maintaining remission
on adalimumab than infliximab during the time of treatment, and a
better efficacy of Adalimumab if used as first anti-TNFα therapy. Eta-
nercept is not recommended for treating chronic non-infectious uve-
itis. When the first anti-TNFα agent failed, there is evidence that
increasing adalimumab dose and/or administration or switching to a
second anti-TNFα both result in efficacy. In children with anti-TNFα
resistant uveitis Abatacept, Tocilizumab and Rituximab are other pos-
sible options. Abatacept is a soluble fusion protein composed of hu-
man cytotoxic T lymphocyte antigen 4 (CTLA-4), and have shownpromising results without significant difference in improvement in
those patients who received Abatacept as first-line therapy versus
second-line. Tocilizumab is anti-IL6 is an emerging treatment for uve-
itis and cystoid macular oedema. Rituximab and canakinumab are
progressively showing an emerging role in chronic resistant uveitis.
The lack of randomized controlled trials and the absence of guide-
lines make difficult the timely and optimal treatment in this clinical
setting. Since fair and limited evidence exists, the best way of taper-
ing medications is still a challenge.A84
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Antibiotic resistance (AR) levels in Italy remain among the highest
in Europe. This is presumably linked to excessive use of antibi-
otics, which are used in the community by about 1.5 million
people (2.5% of the population) every day. The incidence of Kleb-
siella Pneumoniae resistance to carbapenems increased from 1.3%
in 2009 to 27% in 2011 and 33% in 2015, resulting in about
2000 cases of bacteremia per year. A similar phenomenon has
also been observed with other pathogens (E. Coli, P. Aeruginosa,
S. Aureo) [1]. The causes of AR development are complex, but un-
doubtedly include the excessive and inappropriate use of antibi-
otics. The size of the problem has led researchers to search for
new drugs to combat AR, but the slowness in achieving useful
results means that there is no short-term solution. Could comple-
mentary and alternative medicine (CAM) help fight AR? Some re-
ports have shown that the use of CAM in therapeutic settings
based on integrated medicine (IM), a model that combines the
use of both conventional medicine and CAM , can produce a
general saving in health expenditure [2], mainly due to the re-
duced prescription of conventional drugs. Several studies demon-
strate that limiting the prescription of antibiotics for respiratory
tract infections can lower AR [3]; see for example Friedman and
Whitney’s excellent editorial of April 2008 [4]. A therapeutic ap-
proach that limits the use of antibiotics can therefore counteract
AR. In 2018 Van der Werf and coll. compared the prescriptive be-
havior of GPs who had adopted IM with the behavior of conven-
tional GPs, finding that the prescription of antibiotics by the first
group was 22% lower [5]. Similar results were obtained in other
studies investigating homeopathy [6]. A recent study by our
group in children with acute otitis showed that antibiotics were
prescribed in 33% of cases treated with homeopathy, versus 62%
in the control group (p 0.006). In conclusion, there is literature
evidence demonstrating that the use of CAM integrated with
conventional medicine can reduce the use of antibiotics, thus
making this a useful strategy to help combat AR.
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Autoinflammatory diseases (AIDs) are monogenic disorders [1] char-
acterized by overproduction of IL-1β. Remission, prevention of com-
plications, control of inflammation, a good quality of life are goals of
the treatment. A personalized treatment must be started preco-
ciously [2] and approved by clinicians, patients and their families,
considering children in these long-lasting treatment decisions. A
common therapeutic approach is effective in multifactorial AIDs,
where inflammatory cytokines are increased by different triggers, as
sJIA, Kawasaki disease, HLH, IBD, Steven Johnsons Syndrome, auto-
immune diseases: the infusion of high doses of IVIG, modifying cyto-
kines and immune response. IVIG are effective in the resolution of
fever, hepatitis and/or cholestasis also if triggered by infections [3].
Anti-TNF-α drugs are effective in IBD and Bechet disease; Infliximab
in the control of fever in refractory KD, not improving coronary artery
lesions (CAL). Anakinra, IL-1 receptor antagonist, is effective on clin-
ical manifestations and CAL [4-5]. Treatment of sJIA improved with
anti-IL-1 (Canakinumab, Anakinra) and anti-IL-6 (Roactemra) bio-
logical drugs. The early employ of Canakinumab in a “therapeutic
window” increases the possibility to gain the remission [6]. Systemic
Lupus Erythematous and monogenic interferonopathies are success-
fully treated with JAK inhibitors, a high selective treatment. Remis-
sion is now evaluated by clinimetrics to define the efficacy of
treatment.
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The scientific literature reports an increasing number of actions
aimed at providing mobile robots that allow telepresence experi-
ences to bed-ridden adult patients [1]. A recent review published in
BJM Open [2] shows that the use of such robots is increasing very
quickly. The nationality of the authors of the articles analyzed in this
work is mainly Italy. The use of humanoid and empathic robots such
as Nao and Pepper is spreading also in Italian pediatric hospitals. It
follows that it is possible and appropriate, as already happens for
adults, to use these robots not only for rehabilitation, surgery and
distraction [Dawe et al 2019] but also to promote inclusion, by
employing them as a telepresence robot. In this case it is no longer
the medical-nursing staff that "guides" the robot used for the patient
but the patient himself who uses the humanoid robot as a "courtesy
body", a robotic avatar, controlled from the bed or from the stay. At
present, applications of this kind reported in literature are very scarce
and focused exclusively in protected contexts (hospitals and other
places of care) but not in other environments (museums, schools,
homes for holidays, mountain refuges). The number of articles con-
taining the keywords "robot" and "telepresence" has increased expo-
nentially in the period 2000-2017. Yet, nothing has been published
to date regarding the developmental age. The aim of this work was
therefore to verify whether, within a pediatric hospital, humanoid ro-
bots can have an inclusive role in contexts typical of the develop-
mental age (school, sports, oratory, summer camps). In particular 3
models of humanoid robots were used in extra-hospital settings and
remote-controlled by a underage patient. From these preliminary ex-
periences, telepresence robotics carried out with humanoid and em-
pathic robots seems to be promising for hospitalized children.
Entrusting a small robot avatar use to each underage patient, with
the goal to reach an earlier inclusion, is not only technically possible
but also sustainable from the social, economic and environmental
points of view. The use of BCI (Brain Computer Interface) technolo-
gies in children could make this opportunity universal.
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Kawasaki disease (KD) is an acute, systemic vasculitis [1,2]. According
to the “Revised International Chapel Hill Consensus Conference No-
menclature of Vasculitides” of 2012, its target are small and medium
diameter vessels in each organ and apparatus. (3) KD is a self-limited
disease with unknown, probably multi-factor, aetiology, which pri-
marily affects infants and children under five years. Diagnosis of
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 41 of 64Kawasaki disease is clinic, based on diagnostic clinical criteria, sup-
ported by the results of blood and instrumental exams. This presen-
tation aims to highlight news in guidelines than those published in
2008 [2-4]. We will evaluate the differences in the definition of differ-
ent forms, new laboratory applications updates in therapy both in re-
sponder- patients (eg. changing the length and dosage of anti-
inflammatory therapy with ASA),and in non-responders, and in major
risk patients (adding the steroid therapy).
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Micro- and macrovascular complications continue to be a major con-
cern for people with type 1 diabetes (T1D), particularly those diag-
nosed at a young age, who are exposed for a longer period to the
metabolic derangements of diabetes. Although HbA1c is a major risk
factor for their development, and the main focus of current screen-
ing and treatment strategies, recommended targets are rarely
achieved. Thus, there is a clear need for improved markers to identify
subjects at risk at an early stage and to develop additional interven-
tion strategies to prevent future complications. Among early markers,
increased urinary albumin excretion is considered as the earliest clin-
ical manifestation of nephropathy, and an independent risk factor for
retinopathy and cardiovascular disease. My work with cohorts of
childhood-onset T1D (Oxford Regional Prospective Study (ORPS), Ne-
phropathy Family Study (NFS), Adolescent Type 1 Diabetes cardio-
renal Intervention Trial (AdDIT)) has highlighted the value of urinary
albumin excretion (measured by albumin-creatinine ratio (ACR)), as
an early marker of renal, retinal and cardiovascular complications. In
the contemporary AdDIT cohort (n 800), an ACR in the top tertile of
the normal range was associated with increased glomerular filtration
rate, dyslipidaemia and increased arterial stiffness during early ado-
lescence (age 11-16 years). In addition, adolescents with the highest
ACR at baseline had higher rates of microalbuminuria and retinop-
athy, and greater increases in carotid intima-media thickness and car-
diovascular markers (blood pressure, high-sensitivity C-reactive
protein) during a subsequent 2-4 years follow-up period. Of note, in
this young cohort there were no major differences in HbA1c across
tertiles of ACR, and the effect of ACR on complication risk was inde-
pendent of glycaemic control. These data support the concept that
risk stratification using ACR during early adolescence may be critical
for the early identification of patients at risk of developing renal, ret-
inal and cardiovascular complications and to guide the implementa-
tion of preventive and treatment strategies to reduce the burden
associated with vascular complications of diabetes.A89
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Cornelia de Lange (CDLS) is a genetic syndrome firstly described in
1993 by the homonym Dutch pediatrician [1]. Peculiar facial dys-
morphisms, prenatal and postnatal growth retardation, psychomotor
and cognitive delay, microcephaly, hirsutism, small hand and feet or
more severe upper limb major anomalies represent the key features
of the disease. Various major malformations ( palate, heart, genital,
urinary tract, central nervous system) have been described with dif-
ferent frequency but none of them is part of the “core phenotype” of
the syndrome. Behavioral and communication problems are fre-
quently observed. Several medical complications are part of the nat-
ural history of the disease. Gastro-esophageal reflux is the more
frequent of them. [2].
A wide variability of the phenotype has been observed so that
Liu and Krantz stated that up 20-30% of the patients can show a
so called “mild phenotype” [3]. The molecular history of the dis-
ease started in 2004 with the discovery of the first CdLS gene:
NIPBL gene [4,5]. In the following years pathogenetic variant in
several other genes, all related to the cohesion pathway, have
been described in CdLS/ CdLS like patients (SMC1A, SMC3,
HDAC8, RAD21, BRD4) and somatic mosaicism has been demon-
strated too [6,7,8,9,10,11]. In addition variant in other genes usu-
ally related to different diseases have been observed in cohort of
CdLS like patients (ANKRD11, EP300 TAF6, AFF4, KMT2A, NAA10)
[12,13,14,15]. In 2018 an international group of professionals,
strictly in contact with the CdLS World Federation, published the
first international consensus statement in which recommendations
related to clinical/molecular diagnosis, medical follow-up from
pediatric to adult age, rehabilitation and behavioral issues have
been discussed [16]. In this consensus it was stated the existence
of a wide CdLS spectrum which includes patients with “classical”
and “non classical” CdLS phenotype mostly related to mutation in
cohesin genes; these phenotypes should be distinct from others
not overlapping with the CdLS spectrum but sometimes related
to cohesion genes mutation too. A clinical score has been define
in order to differentiate the two possibilities
References
1. De Lange C. Sur un type nouveau de degenerescence (typus
Amsterlodamensis). Arch Med Enfants. 1933;36,713–719.
2. Luzzani S, Macchini F, Valade A, Milani D, Selicorni A. Gastroesophageal
reflux and Cornelia de Lange syndrome: typical and atypical symptoms.
Am. J Med Genet. 2003;119A, 283–287.
3. Liu J, Krantz ID Cornelia de Lange syndrome, cohesin, and beyond. Clin
Genet. 2009;76:303-1
4. Krantz ID, McCallum J, DeScipio C, Kaur M, Gillis LA, Yaeger D, et al.
Cornelia de Lange syndrome is caused by mutations in NIPBL, the
human homolog of Drosophila melanogaster Nipped-B. Nat Genet.
2004;36:631-5.
5. Tonkin ET, Wang TJ, Lisgo S, Bamshad MJ, Strachan T. NIPBL, encoding a
homolog of fungal Scc2-type sister chromatid cohesion proteins and fly
Nipped- B, is mutated in Cornelia de Lange syndrome. Nat Genet.
2004;36,636–641.
6. Musio A, Selicorni A, Focarelli ML, Gervasini C, Milani D, Russo S, et al. X-
Linked Cornelia de Lange syndrome owing to SMC1L1 mutations. Nat
Genet. 2006;38,528–530.
7 Deardorff MA, Kaur M, Yaeger D, Rampuria A, Korolev S, Pie J. Mutations
in cohesin complex members SMC3 and SMC1A cause a mild variant of
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 42 of 64cornelia de Lange syndrome with predominant mental retardation. Am J
Hum Genet. 2007;80:485-94.
8. Deardorff MA, Wilde JJ, Albrecht M, Dickinson E, Tennstedt S, Braunholz
D, et al. RAD21 mutations cause a human cohesinopathy. Am J Hum
Genet. 2012 ;90:1014-27.
9. Olley G, Ansari M, Bengani H, Grimes GR, Rhodes J, von Kriegsheim A,
et al. BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de
Lange-like syndrome. Nat Genet. 2018;50:329-332
10. Deardorff MA, Bando M, Nakato R, Watrin E, Itoh T, Minamino, et al.
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin
acetylation cycle. Nature. 2012;489:313-7.
11. Huisman SA, Redeker, EJW, Maas SM, Mannens MM, Hennekam RC, et al.
High rate of mosaicism in individuals with Cornelia de Lange syndrome.
J Med Genet. 2013;50:339–344.
12. Saunier C, Støve SI, Popp B, Gérard B, Blenski M, AhMew N, et al.
Expanding the phenotype associated with NAA10-Related N-Terminal
Acetylation Deficiency. Hum Mutat. 2016;38:755-64.
13. Parenti I, Gervasini C, Pozojevic J, Graul-Neumann L, Azzollini J, Braunholz,
et al. Broadening of cohesinopathies: exome sequencing identifies muta-
tions in ANKRD11 in two patients with Cornelia de Lange-overlapping
phenotype. Clin Genet. 2016;89:74-81
14. Woods SA, Robinson HB, Kohler LJ, Agamanolis D, Sterbenz G, Khalifa M.
Exome sequencing identifies a novel EP300 frame shift mutation in a
patient with features that overlap Cornelia de Lange syndrome. Am J
Med Genet A. 2014;164:251-8.
15 Izumi K, Nakato R, Zhang Z, Edmondson AC, Noon S, Dulik MC, et al.
Germline gain-of-function mutations in AFF4 cause a developmental syn-
drome functionally linking the super elongation complex and cohesin.
Nat Genet. 2015;47:338-44.
16 .Kline AD, Moss JF, Selicorni A, Bisgaard AM, Deardorff MA, Gillett PM,
et al. Diagnosis and management of Cornelia de Lange syndrome: first
international consensus statement. Nat Rev Genet. 2018;19:649-666.
A90
Immunotherapy for aeroallergens: when, how, where and why
Alberto Martelli, Francesca Atzeri, Lorenza Serradori
Department of Pediatrics. G. Salvini Hospital. Garbagnate Milanese. Italy
Correspondence: Alberto Martelli (agmartelli@asst-rhodense.it)
Italian Journal of Pediatrics 2019, 45(Suppl 3):A90
Allergen Immunotherapy (AIT) is a proven therapeutic option for the
treatment of allergic rhinitis and/or asthma. AIT is the only therapy
that can change the natural history of the allergic disease and AIT is
still the only treatment of pollen allergy, providing a long-term effect.
Some obstacles still reduce its practical implementation. Among
them, the understanding of the mode of action and dose effects, the
difficulties of the administration routes and the lack of recognition of
AIT as a drug. More effective preparations with faster onset and re-
duced doses are likely to improve compliance.
The decision to prescribe AIT for the child should be individualized
and based on the relevance of the allergens, the persistence of
symptoms despite appropriate medications according to guidelines
as well as on the availability of good-quality and efficacious extracts.
However, there are intercontinental differences in AIT therapeutic
products in terms of their application and regulation.
The three major limitation of subcutaneous immunotherapy (SCIT)
are the pain perception inherent to its route of administration, the
fear of repeated injections particularly among young children, and
the possibility of inoculating directly into the vein, with immediate
and dramatic side effects. In adults, systemic reactions may happen
in 2.4% to 50% of patients and 0.2% of injections. In children, lower
rates have been reported. These were the main reasons for the de-
velopment of specific immunotherapy by alternative ways, including
epicutaneous and sublingual specific immunotherapy (SLIT). SLIT is
burdened by poor compliance to treatment. Usually the severity/per-
sistence of seasonal symptoms in subjects during allergen immuno-
therapy was noted to be much lower than in trials of
pharmacotherapy. Needle-free injectors are not young anymore. Ini-
tially developed as an alternative to the use of syringes, they have
been extensively utilized for mass immunizations. In recent years
needle-free delivery technology has gained momentum in otherclinical areas. This “liquid needle” has sufficient force to pass through
the skin and enter the subcutaneous tissue. The device utilizes a low
cost, single use disposable ampule that minimizes the potential for
cross-contamination, a serious issue that has been observed with jet
injectors equipped with multiuse components.
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Background
The word lymphadenopathy (LAP) identifies a condition in which
lymph nodes are abnormal in size, number or consistency. The devel-
opment of a cervical LAP in childhood is quite common, while the
development of axillaries or inguinal LAP is unusual. Studies have es-
timated the incidence of cervical LAP ranged from 41% in the pre-
school age to 90% in children of 4 to 8 years old.[1]
Causes of LAP are explained by a wide number of aetiologies, that
can be benign and self-resolving or malignant. Paediatricians must
know the correct approach to LAP in order to optimise its pathway
of diagnosis and treatment.
Materials and methods
A systematic review of the literature was performed searching on
PubMed: "Lymphadenopathy"[Mesh] AND (Review[ptyp] AND
("infant"[MeSH Terms] OR "child"[MeSH Terms] OR "adolescent"[MeSH
Terms])). The research was performed on the 12th May 2019. Known
publications on the management of LAP were added, also if ex-
cluded by PubMed results.
Results
The literature research reported 20 articles; 3 of them were focused
on LAP [1-3]. A further review was added to the analysis [4]. All the
papers agree that the main cause of LAP is the reactive/infective aeti-
ologies, while less frequent causes are chronic lymphadenitis, primi-
tive tumour as lymphomas, and rarely are IgG4-related disease,
Kikuchi-Fujimoto disease, lymphoproliferative syndrome, etc. The first
evaluation of a LAP is the clinical history and physical examination.
Some symptoms could be associated with a high suspicion of malig-
nancy: non-tender, firm or hard lymph nodes, diameter >3 cm, supra-
clavicular localization, axillary or inguinal in the absence of skin
changes, persistent or generalized form, systemic signs as persistent
fever, itching, night sweat, weight loss, fatigue, petechiae or other
hemorrhagic lesions, hepatosplenomegaly, symptoms related to me-
diastinal and/or abdominal masses.
Ultrasonography is the first radiological exam to perform if there is a
chronic LAP or a suspicious of malignancy. Ultrasonography features
that suggest a malignancy are: heterogeneity of the node, round
shape, absent hilum, irregular borders, cystic necrosis, or irregular
blood flow patterns to the capsule. Patients who continue to have
persistent symptoms despite appropriate therapies, should require a
biopsy. The fine needle aspiration biopsy is not recommended due
to its low sensitivity.
Conclusions
Paediatricians meet patients with LAP throughout their career. A
prompt identification of the signs and symptoms of malignancies
have to lead the paediatrician to refer its patient in a second level
hospital with a Paediatric Oncology and Surgery.
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Translational research (TR) encloses i) the process of applying discov-
eries arisen from basic research to the development of clinical trials
and ii) the research which promotes the adoption of best clinical
practice [1]. The main aim of TR is to integrate basic research (T1),
patient-oriented research (T2) and population-oriented research (T3)
in a multidisciplinary environment so as to improve the public health.
The process is multidirectional, implying that new knowledge gener-
ated at each step could be applied in the other research phases to
improve outcomes. The genome editing technology such as retro-
viral vectors and CRISPR-Cas9 system represents the most clamorous
success of recent TR. For example, De Luca et al. have applied retro-
viral gene therapy and stem-cell technologies to treat patients af-
fected by junctional epidermolysis bullosa (JEB). They developed a
method to extract stem cells from patients skin, add functional genes
in them and grow healthy skin on scaffolds in vitro. Thus, they suc-
cessful implanted this genetically modified skin in JEB patients for
the first clinical trial (2002), replacing sloughed-off skin on the legs of
a patient [2]. This is a good example of TR, in which the clinical out-
comes were based on decades of basic research, albeit clinical know-
ledge during the follow-up also generated further insights into
human skin biology, such as on the self-renewal mechanism of epi-
dermis, thus completing concepts of basic research. Another example
is the combination of CRISPR/Cas9 technology as a genome editing
tool and CAR-T cell therapy (engineered T cells that express chimeric
antigen receptors), which recently leads to further improvement of
leukemia immunotherapy. Despite only 7 years have passed since
CRISPR-cas9 system was used in eukaryotic cells at Berkeley, results
of recent trials have led to an unprecedented FDA approval of Yes-
carta® and Kymriah® for the treatment of children with refractory B-
cell acute lymphoblastic leukemia. However, they are personalized
therapies and thus too expensive (from $373,000 to $475,000) to be
applicable in Europe to ensure access to these therapies for all pa-
tients under the current functioning of healthcare systems [3]. In con-
trast, reverse translation (RT) (from bedside-to-benchtop) is a new
concept of research approach which allow minimizing failed clinical
trials, thus providing only expected and unexpected results useful for
further basic and clinical explorations. A classic example of RT is drug
repurposing arisen from clinical observations of side effects unrelated
to its primary therapeutic goal [4]. The repurposing of statins for kid-
ney protection shows well the pivotal role of RT in uncovering mech-
anism of action and highlights how clinical trials may redirect basic
research to new therapeutic targets, thus leading to cost-effective in-
novative therapies [4, 5].
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Background
Febrile respiratory infections (RTI) are the most frequent infections in
childhood. Although more than 80% of RTIs recognize a viral eti-
ology, clinical features and common laboratory tests, especially in
the beginning, may fail to discriminate a bacterial or viral origin,
leading to an inappropriate use of antibiotics and the development
of bacterial resistances. “AutoPilot-Dx” (NCT03052088) is an EU
funded, multinational, prospective study designed to assess sensitiv-
ity and specificity of the ImmunoXpert™ method in differentiating
viral or bacterial etiology of RTIs in children, evaluating three bio-
markers: C-reactive protein (CRP), TNF-related apoptosis-inducing lig-
and (TRAIL) and interferon-γ-induced protein 10 (IP-10).
Materials and methods
Children aged between 30 days and 17 years, with fever >38° C for
less than 7 days, not treated with antibiotics for more than 48 hours,
without clinical signs of localization, were included in the study. Each
child was assessed for "ImmunoXpert™", and for nasal and nasopha-
ryngeal swab with polymerase chain reaction for viruses and bac-
teria. ImmunoXpert™ provided an overall score between 0 and 100,
suggesting bacterial (100-65), viral (0-35) or indeterminate (36-64) eti-
ology. Clinical features and the results of swabs were also evaluated
by a blinded team of experts, which proposed an etiological
suspicion.
Results
Of the 657 enrolled children, 465 were classified as viral. Of them,
317 and 57 were defined as having non-severe and severe viral dis-
ease, respectively. TRAIL levels were markedly increased in all viral
patients 171±136 vs 68 ± 27 pg/mL; p<0.001). Patients with severe
viral infection exhibited significantly lower TRAIL levels as compared
to non-severe infection (non-severe 158±114; severe 107±60; p=
0.001), implying that viral-induced TRAIL levels may be counterba-
lanced by the severity state. Age and time from fever onset were not
found to be confounders. IP-10 levels were significantly higher in
viral than in the bacterial infections (22.2±28.5 vs 62.4±31.0; p=
0.003). Notably, common bacterial markers such as CRP, white blood
cell counts and neutrophil counts exhibited no significant difference
between viral and bacterial groups. ImmunoXpert™ showed a sensi-
tivity of 96.1% and a specificity of 95.3% for the identification of viral
etiology.
Conclusions
ImmunoXpert™ has a sensitivity and specificity in discriminating viral
infections higher than that of many laboratory tests, common anam-
nestic parameters and clinical objectivity, suggesting its potential for
reducing abuse of antibiotics.
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Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening
hyperinflammatory syndrome caused by a severely dysregulated im-
mune response. It is characterized by highly activated lymphocytes
and macrophages that infiltrate tissues and produce large amounts
of proinflammatory cytokines. A set of clinical, laboratory, and histo-
pathological features define the acute syndrome, including unremit-
ting fever, hepatosplenomegaly, cytopenia, hypofibrinogenemia,
elevated ferritin, liver enzymes, triglycerides and hemophagocytosis.
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etiologically diverse subtypes, affecting all ages. In the current classi-
fication, it is subdivided into primary and secondary forms. Primary
HLH (pHLH) refers to cases associated with several inherited mono-
genic disorders. Secondary HLH (sHLH) complicates various medical
conditions, including infections, malignancies, and rheumatic dis-
eases. By convention, sHLH seen in rheumatic disorders is termed
macrophage activation syndrome (MAS). In childhood, this condition
occurs most commonly in systemic juvenile idiopathic arthritis (sJIA).
Primary HLH and MAS share many similarities in their genetic back-
ground, pathogenic and cytokine pathway, clinical and laboratory
features. However MAS develops in the context of an underlying
highly inflammatory condition, while pHLH is a primary disorder with
genetic basis. It is, thus, conceivable, that other contributors might
be involved to the development of sHLH, including MAS, such as in-
fections or underlying inflammation. Hemophagocytic syndromes are
potentially fatal and require immediate recognition to initiate prompt
treatment. While diagnosis of pHLH is based on HLH-2004 criteria
definitely confirmed by genetic results, sHLH and especially MAS
diagnosis is often challenging, due to the lack of a single pathogno-
monic marker and to the overlap with other confoundable condi-
tions, such as sepsis or flare of underlying disease. Classification
criteria for MAS complicating sJIA were published in 2016; however
no universally embraced diagnostic criteria for MAS in other condi-
tion are available so far. Furthermore, the discrimination between
MAS and pHLH might be difficult, especially when MAS develops as
the first manifestation of a rheumatic disease.
Because no controlled studies on the treatment of MAS are available,
the management of this condition is largely empiric. The mainstay of
the therapy is constituted by high doses of corticosteroids.
Cyclosporine-A is considered as adjunctive first-line treatment in
MAS, due to its role in pHLH treatment and to numerous reports of
marked efficacy. In the last years increasing evidence supports the
use of anakinra in the treatment of MAS associated with sJIA. Re-
cently, the dramatic effect of the anti INF-gamma in pHLH led to plan
a trial in sHLH with promising results.
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Over the past two decades, the treatment of pediatric rheumatology
diseases has been revolutionized by the increased tendency toward
early aggressive interventions and the availability of the novel bio-
logic medications. Focusing on juvenile idiopathic arthritis (JIA), the
most common rheumatic disease in childhood and the filed in which
the greatest efforts in therapeutic trials were made, we analyse the
multiple steps done in the last twenty years in the management of
rheumatic diseases. Since the introduction of methotrexate in the
early ‘90s, the treatment of JIA was dramatically improved by the
availability of biologic medications, especially anti-tumor necrosis fac-
tor (TNF) in polyarticular JIA and anti interleukin-1 and interleukin-6
in systemic juvenile idiopathic arthritis. Intrarticular corticosteroid in-
jections (IACI) revolutionized not only the treatment of oligoarticular
JIA, but also significantly reduced the use of systemic corticosteroid
therapy even in polyarticular JIA patient, with a pivotal effect in limit-
ing treatment toxicity. A more rational approach to the management
of JIA is being fostered by the recent publication of therapeutic rec-
ommendations, consensus treatment plans, and advice for the opti-
mal care. Due to the increasing potential of attaining inactive disease
in children with JIA, there is an urgent need for randomized con-
trolled trials, analyses of clinical data sets, and expert advice to guide
discontinuation of medications once complete disease quiescence
has been achieved. Other open issues to address include: identifica-
tion of pathways biomarkers to better personalize treatment of dif-
ferent diseases, comparison of different strategies in order to
minimize treatment toxicity, increasing international accessibility ofstandardized care and implementation of international registry to
carefully monitor long term safety of treatments.A96
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The great pathologist and statesman Rudolf Virchow (1821 - 1902)
already suggested the existence of a socio-biological transition,that is
how our body (i.e. cells and the DNA) is affected by the way we lead
our lives. In other words, the way good and/or bad emotions, nutri-
tion and pollutants are epigenetically recorded by our cells through-
out our entire life from the zygote to embryo to fetus and adult life
[1]. Germ cells are particularly susceptible to the socio-biological tran-
sition and they are able to transfer the epigenetic marks to the fu-
ture generations. In particular, mother-fetus interactions can assign
prospective negative health predictors to the newborns depending
on the mother’s and father’s socio-economic status [2].
Here we present some examples emphasizing the role of the current
socio-economic inequalities as predictors of health outcomes.
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Point-of-care ultrasonography (POCUS) is a safe, non-invasive and ef-
fective diagnostic or procedural guidance ultrasound [1] performed
by a clinician to help guide the evaluation and management of the
patient, complementary to a medical examination, introduced by the
American College of Emergency Medicine (ACEP) in the 90s. [2]. It
can be used in hospital and non-hospital settings to exclude severe
pathological findings, to increase clinical diagnostic suspicions and to
monitor therapy, using a portable ultrasound system at the “point of
care” of the patients and reducing at the same time the risks associ-
ated with ionizing radiations [3].
Applications. POCUS is largely applied for evaluating pediatric re-
spiratory symptoms identifying pneumonias (sensitivity of 96% and a
specificity of 93%) [4], pleural effusions and distinguishing between
parapneumonic pleural effusion and empyema. It can be used in the
management of children with bronchiolitis [5] [6] It has also demon-
strated 100% accuracy in diagnosing pneumothoraces and useful to
guide needle aspiration [7,8]. Focused cardiac ultrasound should be
considered for assessing patients with hemodynamic failure; it en-
ables physicians to diagnose pericardial effusions, assess cardiac con-
tractility and left ventricular enlargement with 91% accuracy. [9] It is
useful even during pulse checks during cardiac arrest resuscitation
[10] and for categorization of shock state and initial management
strategy [11]. Several protocols have been created to a global ap-
proach to a critical patient. Rapid Ultrasound for Shock and
Hypotension (RUSH) exam includes standardized views of the heart,
inferior vena cava, lungs and abdomen in order to categorize the
type of shock. [3] Focused Assessment with Sonography in Trauma
(FAST) [12] is applied to assess identification of free fluid at the initial
evaluation of the patient with thoracic or abdominal trauma. It allows
to check hemothorax, pericardial effusion and tamponade, and to
identify an intra-abdominal source of bleeding [11] .The E-FAST (Ex-
tended FAST) allows to check for pneumothorax.
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(understanding the clinical indications, having the technical skill for
image acquisition, the ability to interpret the images and to integrate
the findings clinically) in order to be credentialed (through local cri-
teria required to utilize POCUS in their clinical practice) and thus
granted privileges by an institution to perform POCUS [13]. Pathways
for obtaining basic POCUS competency are training based and
practice-based [14]. It’s mandatory maintaining competency partici-
pating in CME (Continuing Medical Education) as well as perform a
minimum number of POCUS examinations annually [13].
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An adverse event following immunization (AEFI) is defined as any unto-
ward medical occurrence which follows immunization and which does
not necessarily have a causal relationship with the use of the vaccine.
The adverse event may be any unfavourable or unintended sign, anabnormal laboratory finding, a symptom or a disease. An AEFI is de-
fined as serious if it results in one of the following outcomes: death,
hospitalization or extension of a pre-existing hospitalization, persistent
or severe disability, congenital malformation.
Causality assessment usually will not prove or disprove an association
between an event and the immunization. It is meant to assist in de-
termining the level of certainty of such an association. A definite
causal association or absence of association often cannot be estab-
lished for an individual event. In 2013 the WHO published the User
Manual for the revised classification on causality assessment of ad-
verse events following immunizations, which aims to standardize the
process of attribution of the causal link between adverse events and
vaccines.
In AIFA’s Vaccine Report 2017, accounts of suspected adverse reactions
in 2017 have disclosed an increasing trend, on one hand suggesting a
general improvement in the performance of the vaccinovigilance system
in Italy on the other hand hinting at possible external factors that might
have influenced the progress of reports, referring to the new vaccination
legislation. In fact, 57% of the reports for all vaccines were received from
"another healthcare provider", with those coming from citizens or pa-
tients exceeding those coming from doctors. The in-depth analysis of the
cases at the level of the individual report and the general trend do NOT
SUGGEST, in fact, the presence of additional risks beyond those known
that could modify the benefit / risk ratio of the vaccines used.
Recognizing and discriminating adverse reactions to vaccines presup-
poses a background of knowledge on the disease observed, on the
type of vaccine administered, on the plausible timing for the presenta-
tion of that specific reaction with that specific vaccine. Once an adverse
reaction has been established, it remains to be determined if in the par-
ticular case the picture observed can be correlated to the vaccination,
taking into account the presence or absence of alternative causes.
From the overall results of the analyses conducted for type of vac-
cine in 2017 no possible association between suspected additional
risks and vaccines emerged at the moment and therefore, no safety
signals that may elicit a vaccine safety alert.A99
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The task of the Hospital Pediatrician, with regard to vaccinations, is
essentially to adapt the vaccination calendar to the various situations
known as "at risk", including both the "allergy risk" in subjects suffer-
ing from severe forms of allergies and / or adverse reactions to previ-
ous vaccine doses, and the "risk of complications of vaccine-
preventable infectious diseases" that may occur more frequently in
subjects with chronic diseases and / or worsen the prognosis of the
underlying disease. In specific situations, therefore, both physio-
logical and pathological, vaccinations must be carried out taking pre-
cautions that require special knowledge, adapting the vaccination
calendar to the subject, based on the specific problem.
In a hospital setting, frequently encountered situations could include:
1. Premature babies
2. Patients treated with immunoglobulins or other blood
products
3. "Non-responder" subjects
4. Alterations in the immune system
5. Chronic conditions
6. Pre- and post-solid organ transplantation
7. Pre- and post-bone marrow transplantation
8. Anatomic or functional asplenia
9. Allergic patients and / or with a previous vaccine dose reaction
Anyhow, reference to true and false contraindications to vaccinations
and to precautionary measures will be most helpful in choosing the
vaccination to be administered.
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each specific patient is essential in choosing the vaccine in vari-
ous types of chronic disease; this may require to anticipate the
minimum age set by the calendar for that given vaccine, apply-
ing instead the lowest possible age in which to carry out that
particular vaccination; it may also be important to adapt the
interval between subsequent doses to the shortest possible inter-
val between doses, for a given vaccine. This requires using spe-
cific tables showing both the minimum age at which the child
can be vaccinated and the minimum interval between doses. On
the other hand, for those children with a history of “IgE medi-
ated” allergic reaction to a previous vaccine dose, it is possible
to adopt the vaccination method based on “desensitization”. In a
nutshell, although the vaccination calendar remains an element
of constant reference in the active immunization of the popula-
tion, it must be considered an agile and dynamic tool adaptable
to each particular situation, allowing, in most cases, to direct the
choices of health care professionals in the irreplaceable role of
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Anemias represent an important burden disease in migrant chil-
dren, and therefore 2012 CDC guidelines recommend routinary
screening for anemia. The highest prevalence rate is observed in
Africa (62%), but the majority of cases are in South-East Asia and
in Eastern Mediterranean (WHO 2015). Iron-Deficiency Anemia
represents the most common cause of anemia in immigrant chil-
dren, but hemoglobinopathies are also frequent. Thalassemias are
very well known in Italy, but many hemoglobinopathies have be-
come frequent only with the arrival of immigrants from other
countries.
One of the best known of these conditions is sickle cell disease (SDC)
in its main forms SS, S-β0, Sβ+ and SC, common in children originat-
ing in central Africa, but also from other countries (as Middle East).
SDC is characterized by very severe vaso-occlusive painful crises, but
also acute thoracic syndrome, stroke, aplastic crises, and very serious
infections (especially in the first 5 years of life) requiring antibiotic
prophylaxis after the second month of life, mainly in SS and S-β0 ge-
notypes. Priapism is quite common but very often misunderstood by
the affected subjects themselves. Please refer to the AIEOP Guide-
lines for further details. HbE disease is frequent in some groups of
immigrants, particularly in those from Southeast Asia. Both heterozy-
gotes and homozygotes subjects are asymptomatic, but can have hy-
pochromic microcytosis and mild anemia. However, in carriers of
both the hemoglobin E gene and beta-thalassemia severe anemia
may result.
HbC disease is frequent in people originary from West Atlantic Africa.
The anemia is mycrocitic, usually mild or moderate, with a slight de-
gree of hemolysis, sometimes with splenomegaly.
The high frequency of hemoglobinopathies in migrant children
makes an early diagnosis essential either by a simple blood cells
count (CBC) as already indicated in the National Guidelines “Sa-
lute Migranti”) or by a more sensitive globin chain analysis. Re-
cently, low-cost, rapid and easy diagnostic tests by finger sticks
for SCD and other hemoglobinopathies have been developed,
making the diagnosis faster and cheaper. Currently the estimated
sensitivity is estimated to be up to 97.6% for HbSS detection, but
further studies are needed. For children born in Italy, neonatal
screening is strongly recommended and it is now widespread in
different reference centers. Currently, however, a regional neo-
natal screening is present only in Friuli Venezia Giulia fornewborns considered at risk. In Udine since October 2018 a
screening with CBC, high-performance liquid chromatography,
and genetic studies in selected cases is performed in all
newborns.
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Cystic Fibrosis (CF) is the most common genetic disease with an om-
inous outcome that affects the Caucasian population. Classically, the
CF is known as a respiratory disease, where it causes repeated infec-
tions and progressive bronchiectasis formations until the develop-
ment of respiratory failure. Respiratory exacerbations are a critical
event for the CF patient, leading to a deterioration in quality of life,
increasing lung damage, costs and intensity of care. Continuous
monitoring of the patient's clinical situation helps to prevent and / or
minimize exacerbations, through a timely recognition of symptoms
of exacerbation, with positive consequences for the patient's life ex-
pectancy and the rationalization of hospital admissions. Since 2001,
at the Center for Cystic Fibrosis of the Bambino Gesù Children’s Hos-
pital I.R.C.C.S. in Rome, we apply the telemonitoring of respiratory pa-
rameters in the follow-up of patients at home. From February 2018 a
nurse assists the doctor in the management of the service. Currently,
around 40 patients are followed in the project, ranging in age from
11 to 50, from central-southern Italy and the major islands. The re-
sponsible nurse collects, analyzes, evaluates the transmissions of spi-
rometric data, which the patients perform weekly from home and
send to a dedicated platform. Together with other parameters (SpO2,
nocturnal saturimetry, heart rate, PA, blood glucose and body
weight) makes an assessment of the patient's clinical status, which
also occurs through the responses of the same to a questionnaire on
subjective symptoms (shortness of breath for small 'sputum, in-
creased sputum,etc.). The interview with the doctor allows the nurse
to discuss "the assistance plan", on the basis of which they decide
the therapeutic interventions that will be communicated to the pa-
tient, or to the parents, through a telephone interview. The virtual
contact with the patients is the fulcrum of the intervention of the re-
sponsible nurse, who has the possibility to evaluate their care needs,
to request further data transmissions or to call to hospital for assess-
ments and treatment under Ambulatory, Day Hospital or Ordinary
Hospitalization. The nurse is also responsible for monitoring the
proper functioning of the instruments used by the patients, dealing
with the calibration of the spirometer, the updating of the indicators
on which the measurements of FEV1 (weight and height) and of the
instrument's software are based, interfacing with the company re-
sponsible for the assistance of the same.
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During the last few decades there has been an increase in the preva-
lence of allergic diseases and it has been predicted that by 2025, half
Table 1 (abstract A102). Clinical principles of allergen specific
immunotherapy
CLINICAL PRINCIPLES OF ALLERGEN SPECIFIC IMMUNOTHERAPY
Immunotherapy is effective only in IgE-mediated diseases such as allergic rhinitis,
allergic asthma and stinging insect anaphylaxis.
Successful therapy require years to reach maximal benefit. Efficacy is dose
dependent .
Either sublingual route (SLIT) and subcutaneous route(SCIT) could be used in
clinical practice.
Allergen(s) in the patient’s indoor and outdoor environments could display local
and regional difference.
Risk factors for systemic reaction such as of uncontrolled or severe asthma or high
allergen exposure need to be considered.
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lergic respiratory diseases is based on allergen avoidance,
pharmacotherapy, allergen immunotherapy and patient education.
Vaccines are utilized in medicine as immune modifiers. So too is
allergen specific immunotherapy (AIT). Therefore, in contrast to
symptom control by pharmacotherapy: AIT aims to modify the
immune system via tolerance induction [2], and is potentially able
to alter the course of allergic disease [3,4]. A significant body of
data accumulated regarding the efficacy and safety of AIT vac-
cines in adults and in children both for respiratory allergy and
for venom hypersensitivity and recent data look promising also
for IgE-mediated food allergy. However AIT for many reason re-
mains underused. The European Academy Allergy and Clinical Im-
munology (EAACI) guidelines provide a series of
recommendations and also the clinical relevant steps to be
followed to move AIT for major allergic diseases closer to being
embraced by the medical community [5-9]. The appraisal of AIT
in allergic children was reported by Società Italiana di Allergolo-
gia ed Immunologia Pediatrica (SIAIP) [4]. In order to achieve suc-
cessful results it is important to begin AIT in childhood when
bronchial asthma and other allergic comorbidities (i.e rhinitis) are
often less severe than in adults and children show usually one or
few sensitizations [10]. In this context pediatricians should know
the local and regional aerobiology and be aware of the potential
allergens in the patient’s indoor and outdoor environments.
Currently the efficacy of AIT is no longer considered as a generic
“class effect” and each AIT product is evaluated according to its sci-
entific evidence. This led to the approval of single AIT preparation by
European (EMA) and American (FDA) medical regulatory agencies
[9,11]. Relief of allergic symptoms and long-lasting efficacy represent
two goals that can be attained in allergic children treated with AIT.
Clinical principles of allergen specific immunotherapy represent the
key concepts in order to implement a good clinical practice. (Table1).
These effects are of particular relevance in pediatric patients: in
whom the careful selection of allergic children is the most important
question to by faced for suppressing or reducing allergic symptoms
through modification of antibody responses, lymphocytes responses,
and other target cell responses to allergen.
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Vascular anomalies represent the most common cause of pediatric
soft-tissue masses and encompass a broad and heterogeneous
spectrum of lesions representing a diagnostic and therapeutic chal-
lenge. Particularly, the infantile haemangioma is the most common
vascular anomaly encountered in children. Despite the International
Society for the Study of Vascular Anomalies (ISSVA) classification has
expanded over the years and is now widely adopted, haemangioma
and vascular anomalies may be still misunderstood and inaccurate
nomenclatures keep on creating considerable confusion in the clin-
ical practice. Unfortunately, the term “haemangioma” is still generally
applied to denote any vascular anomaly. Since the treatment strat-
egy depends on the type of vascular lesion, correct radiological as-
sessment is therefore crucial. Imaging plays a pivotal role in the
differential diagnosis between the vascular masses in children. Gray-
scale ultrasonography (US) combined with color-Doppler US repre-
sent the first modality of choice for the initial assessment and
characterization of a vascular lesion, usually allowing differentiation
between hemangiomas and other vascular anomalies. Magnetic Res-
onance (MR) imaging coupled with MR angiography is the second
level method useful to evaluate deeper lesions and their relationship
to adjacent structures and is mandatory for the uncertain cases and
in the assessment of syndromes associated with vascular tumors. Im-
aging findings of infantile haemangiomas and differential diagnosis
with other vascular anomalies will be discussed.
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The Association of Italian Paediatric Hospitals (AOPI) has carried out a
project for the realization of the standard costs of paediatric hospital
admissions, respecting the international requirements of the Clinical
Costing. The standard costs were divided by production factor /
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 48 of 64activity, type of hospitalization (ordinary, outliers, 0-1 days, day hos-
pital), DRG, age group (0-28 days; 29 days-365 days). ;> 365 days- <6
years;> 5 years- <18 years). The project focused on hospital dis-
charges in the period 1 January-31 December 2016 of 12 hospital
companies. The "size" of the activity examined was the following:
124,681 resignations for acute cases (ordinary admissions, outliers, 0-
1 days); 199,611 days of access for day hospital / day surgery; 2.219
Short remarks. By "size" the database of paediatric DRG research is
the second most important in Europe (after Germany), among those
that respect the dictates of Clinical Costing. With reference to the re-
sults of the research, with particular reference to the comparison
with the tariffs, it is known that these do not cover costs; but this is
not the only problem. The real problem lies in the fact that the
current tariff system is inconsistent with the reality of the costs to be
borne by patients. The study found that the fee for hospitalization as
a whole "covers" 63% of the costs actually incurred. However, if we
analyse the data more deeply, we find that the tariffs do not "affect"
the different types of hospitalization in the same way. In fact, while
for day hospitals the average rates cover 45% of costs; for other
types of hospitalization the situation is quite different. For example,
for outliers (the usually "longer" and complex hospitalizations and
with the highest number of hospitalization days in percentage in in-
tensive care), the rates reach less than one-third of the costs (32%).
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The continuous improvement in treatment and care of childhood
cancer has led to increased long-term survival rates. This has driven
the attention to long-term endocrine consequences. Both treatment
and neoplasms may affect several endocrine glands (pituitary, thy-
roid, gonads, etc), leading to growth failure, hypothyroidism, adrenal
insufficiency, impaired puberty and fertility, metabolic disorders and/
or reduced bone density. Recent data show that 40% to 50% of
childhood cancer survivors will develop at least one endocrine dis-
order over the course of their lifetime. Therefore, the endocrine mon-
itoring plays a crucial role for early identification and treatment,
especially for younger patients who underwent radiotherapy and/or
therapy with alkylating agents. Growth hormone (GH) replacement
therapy raises the issue of safety and data about the risk of second
neoplasia are still debated, whereas the risk of primary cancer relapse
seems to be not increased. Particular attention has been paid in the
last years on strategies to preserve fertility. In conclusion, the follow-
up of childhood cancer survivors requires a multidisciplinary ap-
proach, and, considering that endocrine disorders may occur many
years after the diagnosis and/or the end of treatment, long-term
endocrine surveillance is needed.
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There is now ample evidence that physical activity is an integral part
of a healthy lifestyle as it contributes to a significant reduction in the
risk of developing chronic diseases and improves mental health and
wellbeing. Education for regular movement and healthy eating helps
children to grow in good health and to prevent the problem ofoverweight, obesity and numerous diseases of young and adult age.
As suggested by the American Academy of Pediatrics, children
should practice at least 60 minutes of diversified and fun-filled phys-
ical activity per day. There is no better sport than another: it is im-
portant that physical activity is varied and fun, preferably in the
open air, although exercising outdoors can expose children and ado-
lescents to air pollution that can have adverse effects especially on
respiratory health. The main air pollutants which can damage airways
are: benzene, sulfur dioxide (SO2), particulate matter with an aero-
dynamic diameter of less than 2,5 microm (PM2.5 ) and less than 10
microm (PM10), ozone (O3), nitrogen dioxide (NO2) and carbon mon-
oxide (CO). Similarly to outdoor pollutants, indoor pollution is a prob-
lem of considerable relevance for respiratory health in
developmental age, in consideration of the fact that children spend
more than 90% of their time indoors. Several studies suggested an
association between increment of indoor concentrations of PM10 and
PM2.5 and increased incidence of asthma and exertion asthma symp-
toms. In this context the pediatrician plays a role of primary import-
ance not only as responsible for the health of the child but also as
an educator and promoter of a healthy lifestyle. This report summa-
rizes the latest scientific knowledge on the link between exposure to
air pollution and adverse health effects in children and aims to
underscore the importance to achieve the involvement of the global
health community, in particular health authorities, in order to reduce
the burden of air pollution with the ultimate goal of promoting chil-
dren’s health and climate benefits.A107
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Erythrocytosis is characterized by an increase in the red blood cell
mass defined by hemoglobin and hematocrit values above 97th per-
centile for age and sex. It can be due to physiological processes, as
high altitude living, pathological condition, as dehydration, or per-
sonal habits, as smoking. These conditions, as well as iron deficiency,
a potential confounding factor, have to be ruled out before any add-
itional examination for absolute erythrocytosis. First line exams in-
clude Oxygen Saturation evaluation, venous blood gas analysis with
p50 measurement and plasmatic erythropoietin (Epo) dosage, whose
results may guide the molecular screening. Low plasmatic levels of
Epo are typical of the Primary erythrocytosis, showing endogenous
erythroid colony formation in vitro, as the Familial erythrocytosis type
1 or the Polycythemia Vera. High, or inappropriately normal, Epo
values are a feature of the erythrocytosis due to a defective Oxygen
Sensing mechanism or to abnormal hemoglobin with high oxygen
affinity (1-5). The proper therapeutic approach is still debated due to
the rarity and heterogeneity of these conditions and, to date, a
patient-tailored therapy and follow-up are recommended. Keeping a
good hydration and avoid any kind of physical activity that can in-
crease blood viscosity (i.e. diving with oxygen tank, climbing, sky-
diving, smoking) is mandatory, as well as performing venous
thromboembolism prophylaxis when needed.
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In this work we describe a survey aimed at nurses who collaborate in
the manage the pediatric family surgery. Carried out in order to ana-
lyse the current role of the nurse. The data obtained show the de-
gree of nursing autonomy, the role and the activities they perform
within the clinic and their willingness to introduce new activities in
order to get to take charge of the whole family, thus expanding your
role. Also, the survey pointed out the degree of professional satisfac-
tion, the relationship with the pediatrician and the entire crew that
work in the clinic (secretary, health assistant, etc.). The report will de-
scribe the change in the role of the nurse from his origins to the
present day; the innovations brought in the nursing community and
the gradual implementation of training schools: initially boarding
schools followed by vocational training courses and finally by degree
courses. In our opinion, the new nursing professional should be
given more decision-making space both in the educational field and
in clinical practice and would have the right to be heard in decision-
making forums. To reduce overcrowding in hospital centers the new
health care system must face up to necessity of users to have access
to extra – hospital services, and health professionals have to use re-
sources to the new population’s demand. It is in this reality that the
figure of the family nurse arises; a link between the user and the
doctors of the territory, a facilitator that allows to guarantee to the
users the right hospital services and allows to manage the chronic
patient on the territory. About pediatric clinic, nurse takes care of the
whole family, no more like a small family unit, but, by now, an en-
larged "community".
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Background: Three decades ago, Barker noticed an odd correlation
on a map: the poorest regions of England and Wales were the ones
with the highest rates of heart disease. Why would this be, he won-
dered, when heart disease was supposed to be a condition of afflu-
ence of sedentary lifestyles and rich food? After comparing the adult
health of some 15,000 individuals with their birth weight, he discov-
ered an unexpected link between small birth size (1921-25)— often
an indication of poor prenatal nutrition — and heart disease in mid-
dle age (1968-78) [1]. Faced with an inadequate food supply, the
fetus diverts nutrients to its most important organ, the brain, while
skimping on other parts of its body — a debt that comes due de-
cades later in the form of a weakened heart [1-3]. The first 1000 days
of life, the period from conception to age of two, is fundamental for
body and brain development and is the best time to build healthynutrition and subsequent healthy growth [4]. In this crucial period
many growth drivers, such as genetic and epigenetic factors, and
hormonal regulation, can have important effects on fetal and postna-
tal growth, on development and on risk of developing common non-
communicable diseases later in life [5].
Material and methods: Aim of this talk, based on literature review,
was to develop and discuss a proposal of ten good practices to help
to prevent obesity in the unique window of opportunity, the first
1000 days of life.
Results: Good practices: 1. Both mother and father behavior matter,
even before conception. 2. Before and during pregnancy, at birth
and during early life body fat and composition should be measured.
3. Exclusive breastfeeding for the best start in life. 4. Begin weaning
between 4 and 6 months. 5. Fruit and vegetable liking begin early.
Repeated exposure up to 8 times are efficient strategies to increase
acceptance of food not well accepted at first. There is no need to
add sugar or salt during complimentary feeding. 6. Respect child ap-
petite. 7. Control animal protein intake. 8. Assure adequate qualita-
tive fat intake. 9. Parents have a model role in feeding, with TV and
other screens turned of during meals. 10. Promoting physical activity
and child has to get sleep sufficiently.
Conclusion: Given the suggestion described in this presentation, con-
certed public health efforts are needed to achieve the healthy objec-
tives for obesity and nutrition and to fight the childhood obesity
epidemic [6].
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In the early 1980s De Vries, Visser, Prechtl and Hopkins, described the
emerging of General Movements (GMs) in fetal life and their evolution
from preterm to 3-5 months corrected age. [1,2,3] During the first two
months post-term, GMs are described as having an elliptical form de-
fined “writhing”, thereafter at 6 to 9 weeks post-term age a more com-
plex type of movements gradually emerges involving the neck, trunk
and limbs, characterized by moderate speed with variable acceleration
in all directions and defined “fidgety movements” (FMs). The
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 50 of 64introduction in clinical practice of GMs assessment offered to neonatol-
ogists, developmental pediatricians and child neuropsychiatrists an im-
portant tool for early identification of infants with an increased risk of
neurological and developmental impairment. The persistence of atyp-
ical GMs (defined “poor repertoire”, “cramped synchronized” and “cha-
otic”), without a normally appearing FMs from 6-9 to 20 (mean 12)
weeks of age (corrected for prematurity), is generally considered an
ominous sign predictive of cerebral palsy (CP)[4]. The integration of
perinatal history, clinical evaluation, cerebral ultrasonographic-doppler
examination, biochemical and neurophysiological investigations, might
suggest in neonatal period a diagnosis and the relative prognostic pro-
file. Advanced cerebral imaging techniques (cerebral DWI and conven-
tional MR), carrying the most accurate neurodevelopmental prognostic
value, are not always available in all neonatological contexts. A recent
study showed in term infants with hypoxic ischemic encephalopathy a
strict correlation between GMs and the site and severity of brain lesions
assessed by early cerebral MR. Central gray matter involvement leads
to cramped-synchronized GMs and poor motor outcome [5]. Thus, the
assessment of general movements being non-intrusive, easy to acquire,
cost-effective and with high predictive values, is considered a reliable
prognostic clinical tool, especially in low-resource contexts. In recent
years many researchers implemented the studies on GMs, focusing on
their neural substrate and central pattern generators, more detailed as-
sessment of GMs, extraction of movement patterns from video records
for analysis of movements of skeletal key points and correlation with
long term neuropsychiatric disorders such as autism and ADHD [6-10].
Moreover, the opportunity for the clinician to receive home video re-
cords of GMs, might help to mark the dates of clinical assessment and
to plan a more individualized follow up. This opportunity has been re-
cently standardized, using a video recording application for smart-
phones, in research institutes to assist in early detection of CP and
other neurodevelopmental outcomes [11].
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Background
Headache in children is the most common cause of admission in the
Emergency department. The most common type of Primary head-
aches among children are migraine and tension type headache
(TTH), however their differential diagnosis is not completely clear and
they often are mixed headaches with few studies in literature. The
aim of our study is to identify and to manage the pain in the likely
primary headache in particular migraine and TTH among patients ad-
mitted in Pediatric emergency department in Meyer Hospital.
Materials and Methods
It is an observational, prospective, descriptive study lasted one year
(2016-2017). Children aged 4-17 years meeting diagnostic criteria for
likely primary headache according to the 2013 ICHD3-Beta were in-
cluded[1]. Pain level was assessed at the arrival, at 1 and 2 hours
after paracetamol (20 mg/kg orally or 15 mg/kg IV) or ibuprofen
(10mg/kg orally) administration according to OMS guidelines and
pain scales [2]. The primary end point was reached when the reduc-
tion of pain was by at least 2 points or intensity ≤ 3 at 2 hours after
drugs administration. The study was approved by Tuscany Pediatric
Ethics Committee on 22nd November 2016, approval number 1. In-
formed consent to publish has been obtained from the parents of
the children.
Results
Of 385 children 100 children had likely primary headache who had
35% TTH, 21%, mixed headaches, 54% migraine. All the likely primary
headache were confirmed by Headache Centre later 87% of children
reached the primary endpoint. Ibuprofen (OR 24.00) is more effective
in TTH at 2 hours after administration compared to paracetamol (OR
6.00). Paracetamol administered both orally (OR 2.00) and intraven-
ously IV (OR 2.50) is more effective in mixed headaches than ibupro-
fen (OR 1.75). Ibuprofen (OR 5.50) and paracetamol administered IV
(OR 5.50) are more effective than paracetamol administered orally
(OR 1.50).
Conclusion
It may need easier criteria for primary headache's diagnosis, in Emer-
gency department considering multidisciplinary approaches, including
family education for the correct management of pain in primary head-
ache in children. Ibuprofen maybe more effective in the migraine and
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 51 of 64TTH than paracetamol administered orally, but it needs more studies to
confirm our preliminary studies.
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Neuromuscular pathologies are characterized by structural and func-
tional alterations at the level of the motor unit, varying, in relation to
the site of the lesion, in diseases of the motor neuron, peripheral
neuropathies, myasthenic syndromes and myopathies. The classifica-
tion of these different forms of pathologies is constantly evolving in
relation to the new knowledge of molecular genetics, that have revo-
lutionized, in recent years, the etiopathogenetic and pathophysio-
logical features of numerous hereditary degenerative forms, allowing,
in many cases to isolate the genes and to identify the encoded
proteins.
Duchenne muscular dystrophy, characterized by progressive atrophy
and weakness of skeletal and myocardial muscles, is the most wide-
spread neuromuscular genetic disease in children. Prompt diagnosis
is an absolute priority in order to achieve an early therapeutic and re-
habilitative pathway, that has a positive impact on the progression of
the disease and that is capable of improving family members and pa-
tients’ quality of life. Children with neuromuscular disorders generally
have deficits in gross motor skills, but delays in fine motor and cog-
nitive skills may also be present. Careful anamnestic and neurological
examination of the newborn is essential for the early recognition of
risk indicators and related warning signs. For a thorough neuro-
evolutionary evaluation of the newborn, it is necessary to investigate
spontaneous motor skills, posture, muscle tone and osteotendinous
reflexes and to initiate, in case of clinical suspicion, a diagnostic
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Ataxia is a neurological sign consisting of impaired coordination of
motor activity. It is principally due to a dysfunction of the complex
circuitry connecting the basal ganglia, cerebellum and cerebral cor-
tex. Affected patients classically present a wide-based gait, truncal in-
stability, dysmetria, dysdiadochokinesia, intention tremor, dysarthria
and nystagmus [1-4]. From an etiological point of view, ataxia is clas-
sified as acquired, inherited or sporadic. The course may be distin-
guished in acute, intermittent and recurrent, chronic-non-progressive
and chronic-progressive. Only a few studies have described the dif-
ferent conditions that can be found in children presenting with acute
ataxia (AA), but conclusions were divergent because of the different
settings of recruitment, small sample sizes and heterogeneous study
designs [4–9]. Few data exist about the real incidence and preva-
lence of AA in childhood [4]. A large Italian multicenter study on AA,
conducted in a pediatric emergency setting, shows a frequency of
0.02% of all emergency attendances [5]. Two previous monocentric
pediatric emergency department-based studies reported a frequency
of 0.024% and 0.04% [8,9]. AA in childhood poses a diagnostic di-
lemma because of the broad differential diagnosis. While the mostcommon causes have a “benign” self-limited course, AA can be due
to potentially invalidating or life-threatening conditions, including
tumour and central nervous system infection, requiring early diagno-
sis and prompt intervention [1-3].
In a very recent Italian multicenter study it emerged that AA is a rela-
tively uncommon neurological emergency in childhood. Acute post-
infectious cerebellar ataxia is the first cause of acute ataxia in chil-
dren, with varicella-zoster the most frequently involved pathogen.
Brain tumors are the second most common cause of pediatric acute
ataxia while clinically urgent neurological pathology (CUNP) accounts
for over a third of cases. The Authors defined CUNP as any nervous
system disorder requiring early diagnosis and prompt medical or sur-
gical intervention to prevent disabling or life-threatening evolution,
namely neoplastic, cerebrovascular and infectious CNS disorders, de-
myelinating diseases, acute neuropathies (AN), genetic or metabolic
disorders, and CNS malformations [5]. In AA assessment, the pres-
ence of focal neurological or meningeal signs, hyporeflexia, ophtal-
moplegia, seizures, or a longer time of evolution of symptoms, is
associated with a higher risk of a severe underlying pathology [5]. A
careful history, together with a systematic general and neurological
examination, can help narrow down the differential diagnosis and se-
lected investigations are recommended to quickly identify patients
with potentially life-threatening causes of AA.
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The theme of appropriateness in care providing have been the
centre of health policy during the last 20 years, representing the
most important quality factor, bringing in itself the concepts of effi-
cacy, efficiency, adequacy, accessibility, timeliness. This paper aim to
highlights the complexity that characterise the concept of appropri-
ateness in healthcare, both in the organizational and in the prescrip-
tive dimension, and the lack adequate indicators/standards for its
assessment, in particular for childhood health care. Among the differ-
ent definitions reported in the literature, the one provided by the
Italian Health Ministry defined as “appropriate any health interven-
tion (preventive, diagnostic, therapeutic, rehabilitative) related to the
patient's (or community) provided in adequate manner and time,
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 52 of 64based on recognised standards with a positive balance between ben-
efits, risks and costs” [1]. Basing on this definition, we can do some
considerations:
– The need for efficacy indicators about health interventions
provided to patients;
– The need for optimization of available resources in order to
guarantee healthcare to each one and to the community, which
is an essential condition for the viability of the National Health
Service;
– The need for considering preferences and expectations of each
patient, avoiding any economic influence.
About efficacy indicators, we should consider that these are available
just for some health interventions, like the diagnostic or therapeutic
ones. The optimization of the use of available resources in order to
satisfy the different health needs of the community represent a vital
target for the National Health Service viability, strictly relating the
concept of appropriateness and the economic aspect of the health
services offered. The evaluation of the benefit/risk ratio for the
healthcare interventions and the need to consider the patient as the
pivot of the healthcare-related choices highlights the close connec-
tion existing between appropriateness and ethic.
Moreover, it is important that healthcare professionals indicate
clearly to the healthcare policy managers the appropriateness stan-
dards that the National Health System must guarantee to the differ-
ent stakeholders, firstly to the patients. Hence, the need to enrich
the current roster of indicators for appropriateness in paediatric
cares, both in the hospital setting and in the primary care.
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Background Encephalitis in paediatric age recognizes a wide range
of etiologies, clinical presentations, and outcomes. A major challenge
in diagnosis is that different symptoms may appear at different times
and different levels of intensity, so that the disease may mimic many
other disorders. Identification of the etiology is a priority, since it al-
lows for a prompt and specific treatment, avoiding unnecessary med-
ications and laboratory tests, and it may contribute to improve
prognosis.
Material and Methods A Medline research was made with the fol-
lowing terms ("encephalitis/diagnosis"[Mesh] OR "encephalitis/etiolo-
gy"[Mesh]) AND children, and with the filters “Review”, “Humans”,
“English”, “Child: birth-18 years”. We only kept articles published be-
tween January 2000 and May 2019.
Results: A total of 394 articles were obtained and 77 of them contrib-
ute to this review. The main limitations of the studies were their
retrospective design. Neurological manifestations of infections of the
CNS vary with the type and severity of the infection, and include
headache, meningismus, seizures, cognitive and behavioral distur-
bances, ataxia, and altered levels of consciousness up to coma. Auto-
immune encephalitis (AE) is a severe condition in which the immune
system attacks the brain, impairing function. In contrast to typical
cases of infective encephalitis, which tend to begin relatively
abruptly over 24-72 hours, AE can begin and progress insidiously,
often over a period of days to a few weeks. Neuro-psychiatric symp-
toms, such as anxiety, agitation, delusional or paranoid thoughts,mutism or catatonia, memory dysfunction, and visual or auditory hal-
lucinations, are the prominent manifestations of AE in both adults
and children. Approximately 50% of children with AE have seizures
or movement disorders (choreoathetosis and orofacial dyskinesia).
Several antibodies have been identified, including auto-antibodies di-
rected against NMDA, LGI1, CASPR2, VGKC-complex antibodies,
AMPA, and GABA. In some patients, encephalopathy can be part of a
paraneoplastic phenomenon, although in children with AE, an under-
lying malignancy is rare. Nevertheless, there is a group of patients
with suspected AE who are antibody negative in which etiology re-
mains unknown. Steroid-responsive encephalopathy associated with
autoimmune thyroiditis (Hashimoto encephalopathy) in children or
adolescents can begin abruptly or subacutely, producing seizures,
psychosis, chorea, tic, coma, migraine-like headaches, or acute focal
neurological dysfunction.
Conclusions. Infectious and non-infectious encephalitis share similar
clinical signs and symptoms. However, neuro-psychiatric symptoms
and refractory seizures are more commonly observed in either auto-
immune or unknown etiologies. The poor outcome, especially in the
latter, underlines the importance of future research in this area.
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In the last decades it has been observed an increase in antibiotic re-
sistance [1, 2], probably due both to drug misuse and to “drug al-
lergy” mislabeling. When dealing with a possible adverse drug
reaction, a careful word selection must be done: some reactions are
indeed due to collateral effects (type A reactions), others are hyper-
sensitivity reactions (type B), while only a few are true “drug allergy”.
Especially in childhood, “antibiotic allergy” mislabeling could be diffi-
cult to remove without proper (and sometimes extensive) evaluation,
and could, therefore, lead to antibiotic misuse. It is important to
properly and timely perform an allergological evaluation in order to
avoid those mislabeling errors.
Type A (Augmented) reactions are due to pharmacological properties
of the drug, are usually predictable, such as antihistamine drowsi-
ness, and should be addressed before antibiotic use. Type B (Bizarre)
reactions are, instead, unpredictable, and comprise 15% of all ad-
verse drug reactions. The vast majority are due to an immune system
alterations and are usually defined as “drug hypersensitivity” (DHR)
[3]. Some recognize inflammatory mechanisms or immunological re-
actions as described by Gells and Coombs. Hypersensitivity reactions
due to an apten-carrier mechanism (Type I) show typical IgE medi-
ated signs and symptoms (urticaria, angioedema, anaphylaxis). Other
type of hypersensitivity reactions have been described (Type II-IV)
and require specific in vivo and in vitro tests to be ruled out.
The allergological evaluation of DHR relies mostly on a careful anam-
nesis: timing of reaction, drug type and dose, signs and symptoms
description, presence of atopy, familiarity, cofactors such as concur-
rent infections, clinical evolution. According to type of reaction (im-
mediate or delayed, mild or severe) different skin and blood tests
could be performed, followed by a challenge test. In mild cutaneous
delayed reactions, updated guidelines suggest to directly perform an
oral challenge test [4, 5]. In SCAR (severe cutaneous drug reaction) al-
most all guidelines suggest to avoid drug without performing any
tests.
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Background
Neurodevelopmental disorders require early diagnosis and timely in-
terventions. Routinely pediatric assessments, properly implemented,
could be a strategic observatory for applying sustainable strategies
for the early detection of neurodevelopmental disorders. Last No-
vember 4th 2017, the Istituto Superiore di Sanità, the Società Italiana
di Neuropsichiatria dell'Infanzia e dell'Adolescenza together with the
Federazione Italiana Medici Pediatri, the Associazione Culturale Pedia-
tri, the Sindacato Medici Pediatri di Famiglia and the Società Italiana
di Pediatria signed an agreement within the framework of the pro-
ject ‘Osservatorio nazionale per il monitoraggio dei disturbi dello
spettro autistico’ to promote the implementation of the well-baby
check-up and establish a formal network between pediatricians and
child neuropsychiatrists throughout the entire Italian territory. The
education system is also crucial in the first years of life and, thanks
to the establishment of the integrated system 0-6, it will now be pos-
sible to promote new and more stable professionals and novel terri-
torial networks also between educators and health workers.
Materials and methods
The early detection of neurodevelopmental disorders tool, applicable
within the routinely pediatric assessment, was implemented in three
steps. First, we completed a systematic overview review that col-
lected the systematic reviews and meta-analysis describing early be-
havioral markers of neurodevelopmental disorders in the first three
years of the child's life. More than 1500 works were screened and 5
were selected.(1-5) The overview review provided evidences for de-
lays in the gross and fine motor development, in the expressive and
receptive language development, and reduced social engagement in
children later diagnosed with neurodevelopmental disorders. Second,
we collected and evaluated the existing national and international
protocols for the early detection of neurodevelopmental disorders.
(6) Third, the group selected in the reviews/protocols collected in the
steps 1 and 2 the items solved by the 90% of typical developmental
children.
Results
Using the materials systematically collected, the group developed a
protocol including 8 worksheets for each routinely pediatric assess-
ment at 1, 3, 6, 9, 12, 18, 24, 36 months. Each worksheet contains 6
to 8 questions about the infant/child neurodevelopment (motor, lan-
guage/social/communicative/play and emotion regulation/ self-
regulatory skills).
The present protocol will be disseminated on the Italian territory and
provided to all Italian pediatricians for its inclusion in the routinely
pediatric assessment. In addition, a brief and targeted training on the
protocol implementation will be provided in all local health author-
ities (Aziende Sanitarie Locali) for its widest dissemination.
Acknowledgements
Italian Ministry of Health Project – Capitolo 2S57 [Articolo 1, comma 401,
Legge 28 dicembre 2015, n. 208, recante “Disposizioni per la formazione del
bilancio annuale e pluriennale dello Stato (legge di stabilità 2016)”].The abstract is being presented on behalf of the ISS Neurodevelopmental
Disorders group.
References
1. Athanasiadou A, Buitelaar JK, Brovedani P, Chorna O, Fulceri F, Guzzetta
A, & Scattoni ML. Early motor signs of attention-deficit hyperactivity dis-
order: a systematic review. Eur Child Adolesc Psychiatry. 2019. doi:
10.1007/s00787-019-01298-5.
2. Fisher EL. A systematic review and meta-analysis of predictors of
expressive-language outcomes among late talkers. J Speech Lang Hear
Res. 2017;60:2935-2948.
3. Fuentefria RDN, Silveira RC, & Procianoy RS. Motor development of
preterm infants assessed by the Alberta Infant Motor Scale: Systematic
review article. J Pediatria. 2017;93:328-342.
4. Garrido D, Petrova D, Watson LR, Garcia‐Retamero R, & Carballo G.
Language and motor skills in siblings of children with autism spectrum
disorder: A meta‐analytic review. Autism Res. 2017;10:1737-1750.
5. Palomo R, Belinchón M, & Ozonoff S. Autism and family home movies: a
comprehensive review. J Develop Behav Pediatr. 2006; 27: S59-S68.
6. Ertem, IO, Krishnamurthy V, Mulaudzi MC, Sguassero Y, Balta H, Gulumser
O, et al. Similarities and differences in child development from birth to
age 3 years by sex and across four countries: a cross-sectional, observa-
tional study. Lancet Glob Health. 2018;6:e279-e291.
A118
Arfid: Avoidant/Restrictive Food Intake Disorder
Valentina Sottili, Giuseppe Banderali
Department of Clinical Paediatric, San Paolo Hospital, University of Milan,
Milan, Italy
Correspondence: Valentina Sottili (valentina.sottili@unimi.it)
Italian Journal of Pediatrics 2019, 45(Suppl 3):A118
DSM-5 defines Avoidant/Restrictive Food Intake Disorder (ARFID) as a
persistent failure to meet appropriate nutritional and /or energy
needs, associated to one or more among significant weight loss/fail-
ure to achieve expected weight gain, significant nutritional defi-
ciency, dependence on enteral feeding/oral nutritional supplements
and marked interference with psychosocial functioning. The disturb-
ance can't be better explained by lack of available food or by an as-
sociated culturally sanctioned practice. It doesn't occur exclusively
during the course of anorexia or bulimia nervosa, from which differ
for the absence of concern about body's weight or shape. Finally,
ARFID is not attributable to a concomitant medical condition or it
isn't better explained by another mental disease. When co-exist a
mental disorder, the severity exceeds that routinely associated with
the basal disease. Three primary presentations of ARFID are de-
scribed, which can occur independently or in combination,[1]and a
three-dimensional model is suggested into the pathogenesis [2] .
Firstly a sensory sensitivity may led to avoid eating some foods due
to aversions to specific tastes or smells (severe “picky and fussy
eaters” are more at risk). Secondly some patients show complete lack
of interest in eating, as fast eaters (decreased activation of the hypo-
thalamus and anterior insula). Thirdly children may stop eating en-
tirely following a traumatic experience meal associated as choking,
vomiting or other forms of gastroenterological distress (negative
valence systems).
Incidence and prevalence of ARFID in the general population are un-
known because of the lack of large epidemiological studies, even if
literature shows it might be common among children in the general
population. Males aged 8-13 years seem to be more at risk, [3] but
the disease may be present also in younger than 6 years.[4] A preva-
lence of 1,5% is described among gastrointestinal disorders aged 8-
18 years [5] and betweeen 7.2% and 17.4% across eating disorders.
[6] Psychiatric comorbidities, including anxiety disorders, autism
spectrum disorder and attention deficit hyperactivity disorder (ADHD)
are common among individuals with ARFID [7]. ARFID can lead to se-
vere medical sequelae due to malnutrition. Retrospective studies
show risk for amenorrhea, bradycardia, prolonged QT interval and
hypokalemia till to neurological degeneration because of folate defi-
ciency. It seems ARFID may also be the clinical presentation of PANS
(pediatric acute-onset neuropsychiatric syndrome) and PANDAS
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 54 of 64(pediatric autoimmune neuropsychiatric disorder associated with
streptococcal infections) [8]. There aren't still current guidelines in
treatment of ARFID.[9] A multidisciplinary approach is necessary [10].
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Background and aims : Functional gastrointestinal disorders (FGIDs)
are common disorders characterized by chronic or recurrent gastro-
intestinal symptoms, not related to structural or biochemical abnor-
malities. The etio-pathogenesis of FGIDs is still unclear. The diet
seems to play an important role in these disorders, in particular in
functional abdominal pain. Indeed, most adult and children with
FGDIs perceive their symptoms to be related to consumption of cer-
tain foods. In particular, gluten free diet (GFD) and diet with a low
consumption of Fermentable Oligosaccharides, Disaccharides, Mono-
saccharides, and Polyol (FODMAPs) have been proposed for the
treatment of these disorders, especially irritable bowel syndrome(IBS).
Therefore we want to provide an overview of the available literature
on the efficacy of a low FODMAPs diet and a GFD in reducing symp-
toms associated with functional abdominal pain disorders, focusing
on pediatric patients.
Methods: We analyzed randomized controlled trials (RCTs), prospect-
ive and retrospective studies, systematic reviews and meta- analyses,reporting the efficacy of the FODMAPs diet intervention or GFD in
FGIDs patients.
Results: In children, there is only one study that reported positive re-
sults of a low FODMAPs diet. Compared to typical american diet, chil-
dren had fewer daily abdominal pain episodes during the low
FODMAP diet (P<0.01). For the GFD, there is one randomized
Double-Blind Placebo-Controlled Crossover Trial for the Diagnosis of
Non-Celiac Gluten Sensitivity (NCGS) in children, which demonstrated
that the prevalence of NCGS is 0.36% in patient referred for gastro-
intestinal symptoms . More studies have been performed on the
adults. Most of these studies found an effect of low FODMAPs diet as
well as GFD on gastrointestinal symptoms control, however the dur-
ation of the trials and the content of FODMAPS or gluten in the diet
were all different and there is a lack of standardization of the trials.
Conclusion: FODMAPs-restricted diet may be an effective dietary
intervention for reducing IBS, and also in children there are promis-
ing data .Gluten may contribute to the occurrence of gastrointestinal
symptoms in patients with IBS, nevertheless data on the efficacy of a
GFD continue to be limited and the long-term efficacy remains
doubtful. Further studies are needed to better clarify the role of
these restriction diets , which need to be medically indicated and
closely monitored by a healthcare provider, since they can lead to
nutritional deficiencies especially in pediatric patients.
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Background
Pediatric andrology is the branch of medicine that deals with the
diagnosis and therapy of male reproductive organs diseases and mal-
formations that may compromise sexual activity and / or fertility.
Pediatric andrology includes male pubertal development from birth
to puberty and problems related to prevention of diseases con-
nected to sexual and reproductive functions.
Andrological diseases in children are important because, if not
treated precociously and adequately, may cause serious repercus-
sions on normal fertility and, sometimes, ease cancer outbreak.
Materials and methods
Andrological screening should be inserted within health examina-
tions. The need of such screenings and the necessity that the paedia-
trician becomes further aware of these aspects derive from a series
of epidemiological studies which highlight a high prevalence of
neglected and unsolved andrological diseases. The author has devel-
oped a new prevention model based on an Andrological Form to be
inserted in the periodic medical examination by the family
paediatrician.
This project has already been approved by the Italian Society of
Paediatrics and the Italian Andrology Society.
Results
Pediatric Andrologists, Pediatric Endocrinologists, Pediatric Surgeons
and Urologists are all convinced that the well-being of man passes
also through sexual health: precocious puberty, delayed puberty,
sexually transmitted diseases, varicocele, cryptorchidism and testicu-
lar cancer are often preventable and more often curable.
Already at birth and than as children sexual and reproductive health
should be checked. The increase of male genital diseases such as
varicocele, cryptorchidism, increased incidence of testicular cancer,
reduction in semen quality and increase of hypospadias are the ex-
pression of one single phenomenon: testicular dysgenesis syndrome
(TDS).
It is conceivable that TDS is the consequence of adverse environmen-
tal conditions. Data from important epidemiological studies show
that 1 out of 3 adolescents has an andrological disease. The first
cause of male infertility is varicocele. Varicocele occurs in the devel-
opment age (paediatric-adolescent age) and more and more cases
occur in prepubertal age often associated with testicular hypotrophy.
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 55 of 64Cryptorchidism is the second leading cause of male infertility. The
risk of developing testicular cancer is 3 to 4 times higher in a crip-
torchide patient. Early treatment of cryptorchidism reduces the risk
not only of infertility but also of testicular cancer.
Conclusions
These studies and physicians daily experience confirm the absolute
need to intervene in the early stages of male development, which is
why the pediatrician's role is irreplaceable.A121
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The perinatal period, defined as the time from the 20th week
post-conception to the 28th day of corrected age is crucial for
the development of neurological functions. Even in the absence
of overt brain damage, neonates may be at risk of neurological
impairment leading to developmental disorders later in life. A
dedicated and comprehensive neurological evaluation is import-
ant to timely suspect brain dysfunction and plan interventions
during the appropriate developmental window. To this goal,
enormous advancements have been made in the last century. In
the early days, infant functioning was associated with the model
of reflexes, subsequently, implemented by models looking at
more generalized motor functioning. These were, however, poor
indicators of higher cerebral functions. A most important advance
was the introduction of the concept of state [1]. States were dif-
ferentiated, structured organizations of the brain, behaviour and
physiology. Different responses where elicited by the same stimu-
lus in different states, indicating that the infant’s brain was not
reflexive only. A more behavioural orientation was introduced by
Brazelton. His approach was innovative because recognized that
neonate is able to regulate its own level of arousal and states, to
habituate, to attend and orient, to organize his motor acts and
to communicate through its behaviour [2]. The psychologist Als
[3] further expanded the behavioural approach proposing the
Synactive Theory of Newborn Behavioral Organization and Devel-
opment. She suggested that development is the maturation of
the way the child adopt to handle the experiences from environ-
ment in order to maintain his homeostasis (the fundamental
neurological function for survival), rather than the attainment of
individual abilities. Other important advancements were intro-
duced by Dubowitz [4] who proposed a grading system for
muscle tone and posture and by Precthl [5] who characterized
the endogenously generated complex and spontaneous neonatal
movements (General Movements). Bearing in mind the fundamen-
tal steps made by the pioneers of modern neonatal neurological
examination can help even the busy clinician to implement the
traditional examination with the observation of the general
movements and behavioural states. The examination may be fur-
ther improved by including observation of the autonomic and
motor stability at rest or during handling, the behavioural states
transition and the interaction with the caregiver, inspired by the
Als’s theory. The gestalt impression of abnormality will suggest
the need for a more formal and specialized evaluation.
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Children with intellectual disability experience pain more frequently
that healthy children.
In a cross sectional multicentre European study, in 2010, Parkin-
son et al. estimated a prevalence of pain of 60-73% in children
with cerebral palsy[1]. In 2003 on 4 weeks period, Breau et al. re-
corded that each week 35%-52% of children with intellectual dis-
ability have pain. Mean pain duration is longer than 9 hours per
week, giving a huge impact on their quality of life. Children with
the fewest abilities have more nonaccidental pain[2]. The prob-
lem also concern the severity of pain: in a study based on health
professionals perception, pain is perceived as mild in 61,1%, as
moderate in 25%, as severe in 13,9%[3]. Children with intellectual
disability often suffer from chronic conditions and associated dis-
eases that could evoke continuous or recurrent pain, like gastro-
esophageal reflux, chronic constipation, muscular contractures,
hip dislocation, pathologic bone fractures and tooth problems.
Moreover, they frequently need invasive diagnostic or therapeutic
procedures that can be painful and cause of stress. Pain in these
children is often not recognized or underestimated: most of them
have communication difficulties and can’t self-report their sensa-
tions, but they show their suffering in different ways, like atypical
facial responses, laughing, hypertonicity or increased spasticity,
hands clapping, behavioral changes or aggressiveness (head
banging, self-biting or other self-injurious behavior). The parents
or caretaker know how to recognize every change in their child’s
behavior, so they should be consulted regarding their perception of
pain. Therefore, currently-used scales for pain assesment in pediatric
age are not applicable to cognitively impaired children, but it’s advis-
able to use specific validated scales for cognitive impairment patients
that include pain signs typical for these children, for example the
FLACC Revised scale [4]. Pain is often under-treated with lower doses of
analgesic or anesthetic drugs, because of possible side effects, pharma-
cokinetics interactions with other drugs in polytherapy or problems
due to comorbidity, like gastro-intestinal or respiratory diseases or epi-
lepsy. Moreover, given the wide variety of causes of intellectual disabil-
ity, pre-existing medical problems, individual sensitivity and co-
medication in these patients, it’s not easy to set up large-scale pharma-
cological trials. During treatment, measurement of pain is mandatory
and essential to determine the effectiveness of therapy. Intellectual dis-
abled children care is complex on many aspects, but every clinician has
to recognize, measure and manage pain too, in order to improve the
quality of life of these patients and their families.
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2006;16:258-65.Table 1 (abstract A123). Documented consequences of weight stigma
on health
1. Increase of depression and anxiety, low self-esteem, risk of suicidal ideas
2. Increase of unhealthy/extreme eating habits, body image dissatisfaction , eating
disorders
3. Increase of weight, obesity comorbidities and death rate among the population
4. Decreased motivation toward physical activity, treatment requests, plans to
change and self-efficacy
5. In health care, shorter examinations, faster and less compelling messages,
greater physical distance between physician and patient
Table 2 (abstract A123). New tasks to develop in obesity’s Health
Network
1. Work with families and support good qualities and intentions
2. Accept obesity as a disease, indeed a chronic disease, and actually take care of
it. Because treatment of all diseases is a health professional’s task, including social
and incurable ones.
3. Accept that once obesity has been established, weight loss results can be small.
In fact, even avoiding further weight gains reduces physical and mental
comorbidities and improves quality of life.
4. Become aware of the stigma that pervades us all, deal with it, and reduce it in
all areas, by training colleagues, nurses, teachers and media to form a network.A123
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Is there any development in obesity treatment?
Obesity prevalence keeps rising among poorest countries and minor-
ities in rich countries, during adolescence, and severe forms are in-
creasing. Classic treatments lead to modest results [1] and this calls
for the design of longer, complex and expensive studies, which are
difficult to be implemented within public health. The acceptance of
the treatment among patients is quite low at early stages (<50% of
subjects) and it decreases after a year (only <25%) [2-3].
New treatments aim for a multifactorial, rather than a multidisciplin-
ary, and intersectoral project [4], to be carried out jointly by politics,
industry, media, and schools, starting with obesity stigma. Stigma –
which nowadays is spreading and increasing – concerns, alas, the
pediatric field too [5]. Only lately, it has been acknowledged as an
obstacle to treatment. It consists of the well-known mechanism of at-
tributing negative qualities to a stranger, based only on features such
as gender, religion or race. Nowadays, most discriminations concerns
body weighty. Stigma can be the result of a “conscious” or even “un-
conscious” prejudice, the latter one prevailing among professionals
too. Failure to achieve the expected results in obesity treatment
leads to disappointment and guilt in pediatricians, who blame fam-
ilies and try to scare them despite the evidence of genetic and envir-
onmental factors. Lastly, the patients, especially if stigmatized during
childhood, eventually accept the stigma, share it, and mock them-
selves: the “internalization” phenomenon [6-9]. Stigma has already
proved to lead to mental and physical health deterioration (Table 1).
When mockery adsorbs all the energies, the healing process hails to
a stop; when it is repeated in time, it nullifies the only good treat-
ment: self-efficacy.
Everyone today, including healthcare professionals, knows how diffi-
cult is to heal from obesity. Lack of confidence in the results in
addition to mockery makes treatment unsuccessful. On the contrary,
professionals who followed an educative, non-judgmental, trust-
based, and collaborative approach have seen surprising and unex-
pected results.
What can we do differently, then?
The path is long and challenging. Above all, it’s urgent to
revolutionize the professional training by focusing on equal relation-
ships with families, collaboration between sectors, treatment of
stigma through verbal (avoid all words linked with guilt or shame)
and non-verbal (more insidious) communication, and a new evalu-
ation of the results (Table 2), based on attitudes more than anthropo-
metric parameters.
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The promotion of sport, physical activity and correct lifestyles in chil-
dren and adolescents favors the start of virtuous social behaviors, re-
spect for rules and opponents. It is essential to adopt a correct
lifestyle that includes regular physical activity, a moderate and bal-
anced diet and excludes the intake of substances that are harmful to
the body such as smoking, drugs and alcohol abuse. Physical activity
improves the learning abilities and adaptability of adolescents to
daily tasks, promotes good emotional control, improved self-esteem
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 57 of 64and increases socialization skills. From a physiopathological point of
view, the practice of regular physical activity in children is an import-
ant form of prevention of respiratory and cardiovascular diseases,
obesity and metabolic disease. Regular physical activity with an ad-
equate workload reduces minute ventilation and lactic acidosis, im-
proves maximum oxygen consumption (VO2max), strengthens the
muscle groups involved during exercise, increases capillary
vascularization and the number of mitochondria. In particular, in our
previous study we assessed the influence of Body Mass Index (BMI)
on cardiopulmonary function in a cohort of asthmatic children. We
selected 435 subjects (73.3% boys, means age 12.5 ± 2.5 years). All
subject underwent a cardiopulmonary exercise test to measure max-
imal oxygen uptake (VO2max). According to BMI percentiles children
were classified as underweight if <5th percentile, as normal weight
(N) if between the 5th and the 85th percentile, as overweight (OV) if
between the 85th and the 95th percentile and as obese (OB) if >95th
percentile. Overall 415 patients were included in the study. Asthma
was reported in 197(47.5%) children: 133 (67.5%) with normal weight,
37(18.8%) were overweight and 27(13.7%) were obese. Non asth-
matic children were 218 (52.5%): 172(78.9%) N, 26(11.9%) OV,
20(9.2%)OB. Particularly, VO2max (ml/min/kg) was significantly lower
in OB and O than N children, in both asthmatic and non-asthmatic
children (Asthmatic:N:=43±8.6,OV=40.6%±8.7,OB=38.3±5; Non Asth-
matic:N=51.6±9.9,OV=48.2±9.9, OB=44.5±7.7;F = p < 0.0001). We
found an association between high BMI and childhood asthma. Over-
weight/obese children had lower VO2max respect the normal weight
group. Finally, the practice of regular physical activity determines the
reduction of risk factors for respiratory and coronary disease, through
the reduction of heart rate and arterial pressure at rest, serum trigly-
ceride concentration, intra-abdominal and total body fat and lastly of
insulin requirement resulting in improved glucose tolerance.
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Global developmental delay (GDD) is a significant delay in two or
more of areas of developmental domains: gross and fine motor,
speech/language, cognitive, social/personal and daily living activities
[1]. Such delays are evaluated through norm-referenced and age-
appropriate standardized measures of development [1]. This term is
usually reserved for children younger than 5 years of age. Intellectual
disability (ID) is characterized by childhood or adolescent perform-
ance in standardized cognitive tests of at least 2DSs below average
[2]. Intelligence quotient, adaptive behaviour and systems of support
afforded the individual are included in the ID evaluation [3].
The etiological diagnoses of GDD and ID overlap and early detection
of these disorders is of crucial importance for possible treatment [4].
Nevertheless, they are not always identifiable and the diagnostic rate
varies according to the severity of GDD/ID being nearly 80% in cases
of severe ID and 24% in mild forms [5]. Flow charts are aimed to limit
time-consuming tests [6]. The initial step includes clinical history
(family pedigree, pregnancy and birth history) and detailed physical
examination. Child’s developmental status evaluation in all domains
(gross and fine motor, language, socioemotional and cognitive) can
either point toward a specific diagnosis or guide laboratory testing
[6]. These steps are crucial because the underlying cause is identified
by history and examination alone in about one third of cases while
in the remaining the clinical assessment prompts appropriate investi-
gations even though some diagnoses are only possible through in-
vestigations [6]. Chromosome microarray (CGH array) and X-fragile
test are recognized as a first-line investigation in children with GDD/
ID [1,5,7]. When no etiological diagnosis has been identified follow-
ing history and physical examination, metabolic test panel for inborn
errors of metabolism (IEM) is recommended as well as brain imaging(MRI) [8]. TreatableID.org (www.treatable-id.org) contains an algo-
rithm that is regularly updated and describes 81 treatable IDs by
their biochemical defects, diagnostic tests, clinical features and treat-
ment options [9]. It has been developed to help clinicians in the
work up of these patients. In conclusion, patient’s history and phys-
ical examination are still the mandatory first steps. If a specific diag-
nosis is suspected, investigation to confirm that etiology should be
ordered first. This should not delay the referral to rehabilitation ser-
vices while waiting for the results. Test for treatable inborn errors of
metabolism in children with unexplained GDD/ID should be per-
formed, even if clinical suspicion is absent. Genetic exams, in particu-
lar CGH array and X fragile tests are first line investigations for
unexplained GDD/ID.
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Pediatric emergency department (PED) overcrowding is consid-
ered an international crisis, widely involving hospitals all over
western countries. It compromises physicians’ work and increases
PED length of stay, with higher morbidity rates for patients [1].
While it remains unclear whether PED overcrowding might repre-
sent the cause or the effect of rising hospital admissions, these
phenomena are indubitably connected [1]. Indeed, the reasons
behind this issue are numerous and complex, but an increasing
number of accesses (input) and a lack of inpatient beds (output)
appear to be crucial factors [2]. Among the elements influencing
PED input, nonurgent visits are considered the most important
[3]. The misperception of primary care physician’s role has been
highlighted as one of the determinants for the larger numbers of
low-acuity PED admissions [4,5]. However, flu season is another
recognized cause of higher PED flow [3]. On the other hand, the
major factor of output induced PED overcrowding is considered
to be the hospital bed shortage [3]. There are studies supporting
the hypothesis that output is the principal rate‐limiting step in
PED crowding [2,6]. In this setting, high hospital census leads to
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 58 of 64prolonged waits for admitted patients, which in turn leads to
PED boarding and decreased ability to place and evaluate new
patients. However, there are contradictory evidences suggesting
that this might not be the only driving force behind PED crowd-
ing and that there could be a significant variability depending on
hospital characteristics (such as geographical location) [7,8]. As
for its causes, a definitive solution to the problem is still to be
found too and PED overcrowding continues to significantly affect
both quality and access to care. Instruments to identify and as-
sess PED overcrowding have been proposed, such as the Score
for Pediatric Emergency Department Overcrowding (PEDOCS), and
markers of PED overcrowding have been described, including
measures of patient volume, operational processes at PED and
delays in transferring patients to inpatient beds [7]. Feasible solu-
tions for PED overcrowding can include the addition of
personnel, the adoption of observation units to increase hospital
bed access, specific pathways for nonurgent referrals, ambulance
diversion and destination control [3].
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Background
Acute rheumatic fever (ARF) is a multisystem complication of group
A streptococcal (GAS) infection. The incidence of ARF in the 5-14
years age group varies greatly in different geographic areas, with the
lowest incidence in the US and Western Europe (0.5-3 out of 100 000
per year).
In 2015 a new version of Jones Criteria has been published [2], inci-
dence less than 2 out of 100.000 per year was established as low-risk
(LR) populations.
Due to the lack of nationwide epidemiologic data in Italy, it is diffi-
cult to apply the epidemiologic standard of Jones criteria.Aim of our study is to estimate the incidence of ARF in a metropol-
itan area of Central-North Italy and to study the clinical characteris-
tics of the disease in a developed country.
Materials and Methods
We retrospectively analyzed the data of all patients with ARF aged 5-14
years old, diagnosed according to the classical and now LR Jones cri-
teria [2], referred to Sant’Orsola-Malpighi Hospital of Bologna from
January 2012 to December 2017 and living in the province of Bologna.
Results
We identified a total of 34 patients. Every year the annual incidence
of ARF was above 2 out of 100.00. The mean incidence was 5.0/
100.000 with the highest value in 2013 (10.5 out of 100 000). Carditis
was present in 27 patients (79.4% of cases) while chorea in 10 chil-
dren (29.4%). In 4 patients the diagnosis of ARF was made after the
detection of subclinical cardiac. Only 4 patients presented polyarthri-
tis at diagnosis while 17 had polyartralgia and 6 monoarthritis. Ten
patients presented with fever (≥38.5°C), 18 children had elevated in-
flammatory markers as erythrocyte sedimentation rate (ESR) ≥ 60
mm/h and/or C-reactive protein (CRP) ≥3.0 mg/dL.
Conclusions
Our study confirms the previous published data of Breda et al. [3]
and Licciardi et al. [4] in other Italian areas supporting the evidence
for high risk (HR) in our region. Furthermore, this study shows that in
our population only few patients had the classical polyarthritis pres-
entation while monoarthritis and polyarthralgia are more frequent,
supporting the need to consider the latter as major criteria. It is im-
portant to consider the new HR criteria for arthritis in order not to
miss diagnosis. A careful clinical history is needed because the dem-
onstration of GAS infection is often difficult. These data may
strengthen the hypothesis to consider our whole country as a HR
area for ARF. A nationwide study is mandatory.
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The diabetic ketoacidosis is one of the most frequent endocrine dis-
eases in pediatric age all over the world and in Italy [1]. Its preva-
lence varies from 10 to 70% among the T1DM onset cases [1].
The DKA is a metabolic disorder caused by the total or partial insulin
deficiency and it is characterized by hyperglycemia, acidosis and ke-
tosis defined according to ISPAD criteria: blood glucose value > 200
mg/dl; pH < 7,3; HcO3- < 16 mmol/L, ketonemia or ketonuria [2].
The main risk factors of DKA are: age < 5 years old (in particular age
below 2 years), a diagnostic error, the membership to ethnic minor-
ities, the absence of health protection system, a low BMI, possible
previous infections, a delay in beginning treatment, the family low
sociocultural level, eventual psychiatric disorders. In 38% of DKA
cases, before the onset a medical examination is done without mak-
ing the correct diagnosis [1]. On the contrary, protective factors for
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 59 of 64possible DKA are: high T1DM prevalence in population, high family
sociocultural level, a first-degree relative suffering with T1DM. The
most feared DKA complication is cerebral edema, that occurs in 0.5-
0.9% of all cases [2]. Recently, the “PECARN FLUID Study” [3] has
been completed and, on its basis, ISPAD [2] suggests a fluid resusci-
taton over 24-48 hours (with 0.45% and 0.9% saline solutions) in pa-
tients with a 5-10% deydration level. So, if we consider these range
values, there doesn’t seem to be differences between different proto-
cols used to prevent cerebral edema.
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There are many studies that document the benefits of physical activ-
ity in school-age and adolescent children (6-17 years) as well as in
adulthood (> 18 years), evidence that led to the drafting of specific
guidelines and specific guidelines policy choices for health protec-
tion. In recent years more interest has been placed in analyzing the
effects of physical / motor activity even in preschool, from 0 to 6
years [1]. A positive correlation emerged between physical / motor
activity in these age groups and multiple health indicators such as
musculoskeletal health (bone mineral density, bone mineral content,
skeletal area, vitamin D), motor skills (motor skills of basic and pur-
pose, locomotor skills and object control), psychosocial health (self-
efficacy, self-esteem, prosocial behavior, quality of life), cognitive de-
velopment (language development, attention span, executive func-
tioning), various cardiometabolic parameters (pressure , insulin
resistance, adiponectin, leptin, tot / HDL cholesterol, triglycerides) [2].
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Background
The process of drug administration is very complex and in the
pediatric population it can lead to higher errors than in other age
groups [1-5]. The process includes the preparation of the drug to be
administered, which may include mathematical calculations in orderto obtain a correct and accurate dose 6-7. So, mathematical skills are
essential in avoiding errors and harm to patients and calculation
skills must be acquired and practiced by nursing students [6-8]. The
objective of the study is to test the computational skills of students
enrolled in Italian Degree Courses in Pediatric Nursing (CLIP) and a
sample of nurses of a Northern Italy Children's Hospital.
Materials and Methods
A cross-sectional survey was conducted on students enrolled in 7
Italian undergraduate nursing courses and on a sample of pediatric
nurses working in a pediatric hospital. The tool used to test calcula-
tion skills is a questionnaire built by 7 expert professionals (pharma-
cologists, pharmacists, pediatricians and nursing professors in the
pharmacological field). The questionnaire includes 38 excercises di-
vided into 6 sections, including infusion rates in ml / h and in drops
/ min, parenteral and enteral administration, concentration trans-
formation from percentages to mg and ml to mg. An abbreviated
form with 25 questions was used for professionals. The difference in
the scoring of correct answers between the various groups was
tested with the Wilcoxon test for the sum of the ranks (two groups)
or Kruskal - Wallis (more than two groups). The differences for which
the p value was less than 0.05 were considered significant. All tests
were two-sides and were performed with the SAS V 9.2 program.
Results
Pediatric Nursing Students: 144 questionnaires were collected. The
average of the correct answers is 27.08 (± 6.98) on 38 questions. The
average of the correct answers varies based on the course CLIP, but
also on the basis of the high school of origin, the gender and the
year of graduation.Pediatric nurses / nurses professionals: 90 ques-
tionnaires were collected (87%). The total average of the correct an-
swers was 21.2 (± 3.6) and the main differences where found among
departments (p <0.0001).
Conclusions
The results of this study show that there is a lack of computational
skills in pediatric nurse and students. It suggests that it is necessary
to introduce an effective method for their improvement in order to
avoid calculation errors during the preparation of drugs.
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Background
Life expectancy in children with Down syndrome (DS) has increased
significantly over the last decade, but children with DS remain at
higher risk of neonatal and infant mortality than children without DS,
respectively (1.65% vs. 0.36% and 4% vs. 0.48%). Important causes
for increased mortality in DS are congenital heart disease, leukemia,
testicular cancer and sepsis. In addition, respiratory tract infection
represents the second leading cause of death, in children with DS,
up to the age of 18. Children with DS show a high susceptibility to
recurrent infections (RI), caused by immune defects and abnormal-
ities of the airways. Our goal was to investigate the effects of Pidoti-
mod on RI prevention in children with DS, comparing immune and
clinical parameters before (T0) and after (T1) the treatment of
Pidotimod.
Material and methods
The study was conducted at the Down syndrome outpatient Center
of Bambino Gesù Children’s Hospital, in Rome. We reviewed, retro-
spectively, the medical records of all children with a positive history
for RI during 2016 and 2017 and who received oral prophylaxis of
Pidotimod. The study was approved by Bambino Gesù childrens hos-
pital’s Ethics Board, approval number 1753.
Results
Thirty-three children met the inclusion criteria (males: 51.5%; average
age: 6 years ±SD: 3). We found a significant decrease in the number
of children with upper respiratory infections (82% at T0 vs 24% at T1;
p=0,0001) and with lower respiratory infections (36% at T0 vs 9% at
T1; p=0.003) after treatment with Pidotimod. We demonstrated also
a significant decrease in number of children hospitalized for respira-
tory infections (18% at T0 vs 3% at T1; p=0.03). We measured T and
B cells in the peripheral blood and B cell function in vitro at T0 and
T1. We found that the response to CpG improved at T1. A significant
increase of B cells frequency (p=0.0009), B cell proliferation (p=
0.0278) and IgM secretion (p=0.0478) were observed in children with
DS after treatment. Conclusions: our results provided the evidence
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The increase in migratory flows towards our country over the last
thirty years has led to the arrival of new types of children from geo-
political contexts different from the Italian one; many of them might
be under-immunised and lack vaccination card, putting them at in-
creased risk of vaccine-preventable diseases. Furthermore, children
belonging to foreign families are more likely to undertake trips to
their parents' countries of origin, with an increased risk of coming
into contact with non-endemic infectious agents in our country. Con-
sidering that sub-optimal immunity was registered, in recent years,
also in native-born population, the fear for infectious diseases out-
breaks is understandable1. Hence, the need to create a new health-
care first approach, always in order to facilitate, as soon as possible,
the regular access of these children to the paths provided by the Na-
tional Health Service for the pediatric population. There is no inter-
national consensus on the vaccination strategy to follow for recentlyimmigrated child, although the prevalent opinion is to avoid the ex-
penditure of economic resources and to establish or favor migrant
immunization as quickly and easily as possible. Different guidelines
produced in several countries (USA, UK, Canada, Australia, New Zea-
land, Italy) share the idea of accepting the vaccinations performed,
provided they are validated by official documentation; instead, in
subjects without documentation, an age-tailored catch-up strategy is
appropriate because reduces the interval between doses and num-
ber of accesses in health facilities concentrating more vaccinations
on the same day. Finally, it is considered useful to carry out an HBV
screening only in subjects coming from endemic areas2. The Migrant
Child Working Group of the Italian Society of Pediatrics, over the
years (2002, 2007, 2013) proposed more editions of an Healthcare
Approach for Migrant Children Programme, always incorporating
international indications on vaccination: now, that Programme needs
a review, setting up different strategies for different groups of mi-
grant children, taking into account international data on vaccine im-
munity, but also the organization problems of our health services
and the mistrust sometimes manifested towards vaccination prac-
tices; mostly, we need trying to make this particular health problem
an opportunity to get better the life conditions of these new italian
citizens.
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One of the current challenges in the childhood and adolescence
neuropsychiatric field is the early identification of vulnerabilities, in
particular about psycological and behavioral development, also con-
sidering the increase in mental disorders (the WHO reports an in-
crease between 10 and 20% in the developmental age) and the
anticipation of the age of psychopatology onset. Taking into account
both biological and environmental/social factors, variables and speci-
ficities of the evolutionary phases must be considered. In fact, in the
developmental period (from birth to adolescence) the same symp-
tom or behavior can assume physiological or pathological connota-
tions depending on the age of presentation or its persistence.
Hypotheses and theories about development and neuropsychiatric
pathologies have always been based on the observation of behav-
iors, and over time different diagnostic, pathogenetic and thera-
peutic approaches have followed. Starting from the first observations
of doctors and psychoanalysts and arriving at an analysis of what has
changed over time can make us understand, both clinically and his-
torically, what risks and what benefits derive from changes in man
and his social being. Consequently being able to identify the early
signs of vulnerability, especially of psychopathology, becomes the
new frontier to counteract the increase in disorders and the anticipa-
tion of the age of onset. In this regard, the following may be paradig-
matic: in 1964 two American pediatricians, Green and Solnit, and in
1996 Leslie and Boyce, had described the "vulnerable child syn-
drome" to describe how an 'anxious' affective and educational style
can effect behavioral and relational organization, due to an emo-
tional perception of difficulty not so much related to the severity of
the child's clinical condition, as to the parents' experience in educat-
ing a child perceived as vulnerable. The increase in the survival of
premature or perinatal suffering began to result in an increase in par-
ental anxieties compared to the future of the children themselves, an
aspect that still today is current and extended to increasingly
Italian Journal of Pediatrics 2019, 45(Suppl 3):162 Page 61 of 64extreme situations (survival, birth and even fertilization). Finally, the-
ories and observations on those components of anger and aggres-
sion that today represent a psycho-behavioral emergency will be
described, reaffirming the importance of observation in clinical prac-
tice and the complexity underlying expressed behaviors.
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All around the world there is still a wide debate about pros and cons
of commercially prepared vs. home-cooked baby-food [1]. Unfortu-
nately, this debate is often overcharged with ideology, instead of sci-
ence, thus increasing the gap between supporters and opponents of
both preparations. As it happens frequently, the truth lies some-
where in between. Two major and undeniable cons of industrial
baby-foods are the high cost (when compared with a similar recipe
prepared at home), and the homogeneity of taste, which is always
the same, at least until the recipe undergoes some change. Most
other disadvantages attributed to commercial baby-foods are ideo-
logically driven and provenly false, at least in Italy and in most Euro-
pean countries, such as: excess of salt and sugar (totally eliminated
in Italy by most companies), presence of artificial flavours and preser-
vatives (forbidden by laws), low quality of ingredients (unlikely, if not
proven), contributing to general environment’s pollution (jar’s glass
and lid’s steel are both perfectly recyclable). The majority of commer-
cial baby-foods provides a correctly energy-dense meal with greater
vegetable variety per meal then their home-cooked counterparts.
Two negative aspects, on the contrary, are rarely considered: the por-
tion size for meat-based preparations may be too big, and the recent
decision from companies to diversify the percentage of meat in their
products (20-30-40%) make difficult for families to understand when
the preparation can be used for one meal, and when for more.
Besides, the jar is often used as a measure for home-prepared ho-
mogenized meat, thus leading to exceed paediatrician’s advice.
Home prepared foods are for sure cheaper, and provide the child
with never the same taste. Nonetheless, Italian (European?) families
rarely have a correct eating style, and this affects the quality of the
child’s meal: reduced variety of vegetables, and in scarce quantity;
excess of proteins; presence of salt; inadequate type/quantity of fats;
inappropriate cooking methods. Safety about toxics and pollutants is
another big difference between the two types of baby-food, that
should be taken into consideration, since legislation for commercial
baby-foods is much stricter than for commonly consumed (even bio!)
foods. All the above mentioned aspects should be considered –with
the help of a wise paediatrician– by families, who should be aware
of the risks/advantages of their choices.
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The comprehensive management of enuresis includes the global know-
ledge of the disorder and must understand in particular the underlying
psychological factors. They are mainly classified as causal, favoring, react-
ive, coexisting. In the context of neurodevelopmental and child psychi-
atric disorders, enuresis is more frequent in attention deficit /
hiperactivity disorder and is often accentuated by stress; rarely but signifi-
cantly, the onset of secondary enuresis in school age, specially in a girl,
can raise suspicion of posttraumatic stress disorder, also related toabuse.or domestic violence. When we listen the child with enuresis and
his parents, it is therefore important to collect the necessary elements to
highlight the presence and the role of this factors and disorders in the in-
dividual case. In general ayway, listening to the child is aimed at gather-
ing mostly what psychological problems he presents, then how the
enuretic disorder lives and if he has feelings of inferiority, rejection, sham.
From the parents we listen what problems the child presents at their
opinion and specifically how they live the enuretic disorder of the child
(included the possibility of consequent mistreatment) and how they think
they can help him, and how much they perceive the burden of trouble
for him. In our diagnostic-therapeutic observation, in parallel we gradually
give information about the enuretic disorder to the child and the family,
starting from its frequency and then listing the role of familiarity, habits
on drinking, eating and sleeping, with a first return on hygiene related to
this. Subsequently we indicate the essential lines of the diagnostic pro-
cedure and of the treatment; at the same time we express a prudent
confidence in the solution of the disorder. In the following meetings we
verify the compliance with the psychoeducational advice provided, the
difficulties encountered and any corrections to be implemented. So let's
evaluate with parents the opportunity for psychological counseling if
problems or concerns have emerged. In this process we like to privilege
the relationship with the child so that he can understand, share the vari-
ous passages; we use drawings, examples, metaphors. And the children
feel the commitment on our part and respond with equal commitment
and with a particular satisfaction.A136
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Epidemiological data of Recurrent Respiratory Infections (RRIs) are difficult
to detect and evaluate, first of all due to a non-uniform definition of this
condition. The prevalence of IRRs in the unselected pediatric population
can vary between 5 and 25%, especially in preschool [1,2,3], taking into
account that on average, in this age group, there can be between 3 and
5 episodes / year. Exceptions are the first 12 months of life, in which it
may be considered normal to present up to 6.3 episodes of acute respira-
tory infection (ARI) [1, 2]. It is estimated that in Italy about 6% of pre-
school children are affected by RRIs [6].The incidence is related to the
various risk factors, even if some are more complex to evaluate or have
given discordant results. The age of entry into the community, for ex-
ample, in some studies appears to be a protective factor, inversely associ-
ated with the risk of Influence-Like Illness ILI (at 1 year, adjusted
Incidence Rate Ratio-aIRR: 1.4, IC 95%: 1.1–1.9, at 4 years aIRR : 1.1, 95%
CI: 0.8–1.4, not significant) [7], in others it does not involve risk differences
(P = 0.74) [8]. The incidence of respiratory diseases is, in Italy, comparable
to that of Western Europe and different from the global one. [9]. Table 2
shows the DALYs (Disability-Adjusted Life Year) due to the different types
of ARIs, by age group and geographical location, therefore it gives us the
measure of how much these pathologies in pediatric age affect our
health compared to all other possible causes of disability and death. RRIs
do not differ in duration and severity from those found in children with a
normal number of respiratory diseases. In 80% of the cases the agents re-
sponsible for these infections are rhinoviruses, parainfluenza viruses type
1, 2, 3 and 4 and influenza viruses type A and B. The remaining 20% of
IRR episodes are caused by β-hemolytic streptococcus of group A. Far
more rarely the agents responsible are Haemophilus influenzae,
Streptococcus pneumoniae and Moraxella catarrhalis [6]. Very in-
teresting is the dramatic decrease, from 1991 to 2017, of both
Pneumococcus pneumoniae and HIB infections, for which univer-
sal prevention measures have been prepared, both for RSV and
for influenza, for which preventive interventions have been
adopted targeted only to subjects at risk. (Table 2) [9].
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Accessed 6 September 2019.Table 1 (abstract A136). RRIs incidence in Italy and in the world (%
new cases on all new cases of all age-related diseases)[9]
Respiratory infections (% of total new cases) <5 years
Italy Global
Lower Respiratory Infections - LRIs ======= 1.73
Upper Respiratory Infections - URIs 74.93 44.38
Otitis 4.18 3.59
Respiratory infections (% of total new cases) 5-14 years
Italy Global
Lower Respiratory Infections - LRIs ==== 1.61
Upper Respiratory Infections - URIs 69.25 46.21
Otitis 1.23 1.37
Table 2 (abstract A136). DALYs (Disability Adjusted Life Year) due to








26.52 (15.38-36.08) 9.26 (4.08 – 15.3) -65.1
RSV 2.39 (1.51-3.54) 1.1 (0.66-1.66) -53.87
Influenza 1.37 (0.89-2.0) 0.61 (0.39-0.62) -55.2
<5 years
DALYs /100.000








Haemophilus influenzae 113.66 (32.08-209.9) 5.93 (1.35-12.05) -94.78
RSV 67.18 (39.84-113.18) 13.31 (7.62-21.48) -80.19
Influenza 10.47 (6.34-16.22) 2.09 (1.27-2.19) -80.0A137
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Migrations and international adoptions by themselves do not cause
growth or endocrine disorders, but it is not uncommon to find these
problems in such children, especially if they came from developing
countries (DC). Here we consider only growth, puberty, thyroid and
dysvitaminosis D. GROWTH: The migrant child usually grows regularly
and at percentiles slightly lower than those of the peers of the coun-
tries of arrival but higher than the compatriots who remain at home.
These studies have been carried out mostly in countries with average
tall statures (North Europe). The weight, expressed as BMI, increases
and exceeds the average of the country in which one lives, especially
in later generations, with increased incidence of obesity and its ser-
ious consequences up to DM2 and metabolic syndrome. All this may
depend on various endogenous and exogenous factors that influ-
ence growth, such as genetics, puberty (time, duration), nutritional
status (malnutrition, dysvitaminosis), psycho-physical stress (aban-
donment, child labor, violence, migrations and adoptions itself), and
endocrine disruptors, including maternal alcohol and drugs in preg-
nancy. These factors can counteract growth, but the classic endo-
crine pathologies (GH deficiency in the head) are no more common
in migrant children than in native children. PUBERTY. In the case of
migration, the behavior is similar to that of growth: it adapts to the
characteristics of native peers and is often anticipated compared to
compatriots. Precocious puberty is no more frequent than in native
peers except in the case of girls adopted by DC, in which it is 10-20
times more frequent. The main causes are the nutritional and psy-
chological improvements (love, parenthood, security, support). All
the factors already mentioned for growth are valid also for puberty.
THYROID: many children, who come from areas with iodine defi-
ciency, where congenital hypothyroidism also appears to be more
frequent, once they take normal iodine amounts they run the risk of
developing autoimmune thyroiditis. Moreover, the frequent finding
of elevated TSH at arrival must be rechecked over time, observing,
but not always, normalization in the following year. RICKETS: the risk
is frequent both on arrival and after and it is due to the more pig-
mented skin and to nutritional and cultural factors and must be pre-
vented and early recognized.
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Pertussis is an endemic, underdiagnosed, bacterial respiratory infec-
tion caused by Bordetella pertussis. Despite a widespread vaccination
program, pertussis continues to be a common worldwide infection in
paediatric and adult populations peaking every 2 to 5 years. The
World Health Organization estimates that in 2016, 139.535 cases
were reported, with 89.000 estimated deaths. Even if 95% of re-
ported cases occurred in developing countries, epidemics have re-
cently been reported in Europe, US, Canada and Australia too.
Infants are known to acquire pertussis from adolescents’ and adults’
contacts that return susceptible to the disease because of waning
immunity as well as from unvaccinated children. Clinical manifesta-
tions may be different depending on age: in previously immunised
or infected adolescents and adults pertussis can be atypical and
often asymptomatic, with the main symptom being persistent cough.
Severe symptoms are common in infants; however, cases with atyp-
ical clinical presentations do occur and may be often unrecognized,
especially during the winter season, when other respiratory viruses
circulate [1]. Serious complications (neurological, respiratory and nu-
tritional), even if relatively rare, can be fatal. Pulmonary complications
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most of the deaths. Risk factors for severe cases are: leukocytosis
with lymphocytosis, young age, low birth weight, prematurity and in-
creased pulse and respiratory rates [2]. The cause of deaths in infants
is irreversible pulmonary hypertension associated with aggregates of
white blood cells in pulmonary arterioles due to leukocytosis with
lymphocytosis. No medications provide symptomatic relief from
pertussis-associated cough. Antibiotics eliminate Bordetella pertussis
from nasopharynx and reduce the risk of transmission; they have
not, however been shown to reduce the duration or severity of
cough [3]. In infants with extreme leucocytosis, an exchange blood
trasfusion must be considered [2]. Recent recommendations made
by Italian experts, in accordance with WHO, demonstrate that the
best cost-effective intervention in newborns pertussis prevention is
the vaccination with dTap vaccine in the pregnant woman, ideally
between 27 and 36 weeks’ gestation to optimize transplacental
transfer of maternal antipertussis antibodies to the fetus and to pro-
tect the newborn in the window time from the birth to the first vac-
cination. Many studies have shown that vaccinating pregnant
women will prevent most infections and virtually all deaths in infants
during the first 2 months of life [4].
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Background
P-Alarm is one of the several tools grouped under the name PEWS
(Paediatric Early Warning Scores/Systems) available over the world.
PEWS records and measures the child’s vital signs (heart and respira-
tory rates, pressure) and behaviors. The parameters are weighted
and the overall score provides indications on clinical deterioration of
the child, often allowing prevention of severe events. Traditionally,
PEWS are found in the Emergency Department or Intensive Care
Units, but pediatric inpatient units are beginning to use them as well.
The aims of this study were: 1) to verify the applicability of the P-
Alarm in a Paediatric unit, 2) to adapt and validate it in the pediatric
inpatient unit of the San Paolo hospital.
Materials and methods
the P-Alarm was chosen after a literature review (PubMed, Cochrane
Library and CINAHL) and back-translated after written consent from
the author. All nurses working in the outpatients unit were trained to
use the tool; all children admitted between Dec 12, 2016 and Jan 27,
2017 underwent monitoring with the P-Alarm.
Results
129 children were enroled (72 males, 57 females, age 4 weeks-18
years). The P-Alarm showed an excellent validity and good internal
consistence (Cronbach’s alpha=0.80). A total of 1547 observations
were conducted. In 18 cases (2 children) clinical deterioration was
present; the P-Alarm correctly identified 17 cases. One child showedsignificant alteration of the P-Alarm, which led to activation of the
medical emergency team. In this case, the P-Alarm allowed early de-
tection of clinical deterioration.
Conclusions
the Italian version of the P-Alarm is a valid, simple and reliable tool
for clinical monitoring of childred admitted to inpatient units. It al-
lows early recognition of severe deterioration, thus saving precious
time for early medical intervention.A140
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Background
Emergency pediatric care is recognized as an environment with a
high risk of error due to numerous factors. In 1999 the medical insti-
tute reported "To Err is Human", in this article it is stated that medical
errors remain one of the main causes of morbidity and mortality
throughout the United States and that every year between 44,000
and 98,000 American patients die due to errors committed by health
personnel [1,2.3]. Between 2007 and 2009, the British National Health
Service - NHS - conducted a national survey to study the
phenomenon of errors in the pediatric field. This study found that
79% of incidents involving children and 94% of those involving new-
borns occurred in the critical area and that the therapeutic error in
pediatric patients was 3 times that found in adult patients
[4,5,6,7,8,9]. The purpose of our work is to re-evaluate the literature
on errors reported in pediatric emergency departments in order to
identify which strategies are proposed to reduce human error.
Method
We have carried out a systematic review of the works published on
Pubmed over the past 5 years using the following keywords: errors,
pediatric emergency. 439 articles were found, of these 45 are reviews
and 67 clinical studies. Full texts were available for 67 publications.
Conclusion
We have summarized the recommendations and strategies reported
in the literature to reduce errors in pediatric urgency. We believe that
error prevention should be considered a priority of health care and
we believe that simulation can prove to be a fundamental educa-
tional method to reach this goal: reduce errors and improve safety.
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Antibiotics represent the most widely prescribed therapeutic agents in
the paediatric population. During 2017, 41% of outpatient Italian chil-
dren and adolescents received one or more antibiotic prescriptions.
The prevalence was greater in preschool-age children (50%) and de-
creased afterward with increasing age [1]. Italian children and adoles-
cents have a 3-fold higher likelihood of receiving an antibiotic
prescription than their peers living in the Netherland or UK. Moreover,
nearly 1 out of 5 outpatient children treated with antibiotics in Italy re-
ceive a cephalosporin, while this class is scantly prescribed out-of-
hospital in other European countries [2]. Differences exist at regional
and local level in the antibiotic prescription profile. The South of Italy is
characterized by an higher prescription prevalence and a greater use of
cephalosporins and macrolides [3]. Amoxicillin, the first choice anti-
biotic drug for the most common infections in the paediatric popula-
tion, is scantly prescribed, covering 20% of antibiotic prescriptions, but
with wide differences between and within regions. In Lombardy region
a better quality of antibiotic prescriptions was observed in local healthunits where paediatricians have been engaged in educational and
training programmes. No differences were found in the qualitative pro-
file between family paediatricians and emergency department physi-
cians. It is worth to be noticed that only in 6 out of 56 emergency
departments in Lombardy region amoxicillin was prescribed to more
than 50% of children treated with antibiotic for pharyngotonsillitis.
In conclusion, more should be done to improve rational use of antibi-
otics in the paediatric population, and educational interventions in-
cluding health professionals and parents are strongly needed.
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